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 Abstract 
Medaka is an excellent lower vertebrate model in stem cell biology. This fish has given 
rise to first nonmammalian ES cell lines and the first spermatogonia stem cell line SG3 
from the adult testis. My study focused on two medaka orthologus genes, Oct4 and Stat3, 
which are key regulators in vertebrate development and pluripotent stem cells. Although 
they are essential for maintaining the mouse and human stem cell pluripotency, little is 
known about their roles in non-mammals. More importantly, the molecular mechanism 
underlying how they regulate the pluripotency has remained elusive. Hence, as a first step 
towards the elucidation of the molecular mechanisms underlying the stemness in the 
medaka model, this study aimed at identifying and characterizing the medaka oct4 and 
stat3 orthologs. 
Analysis of sequence homology, gene structure, chromosome synteny, protein structure 
and expression patterns at the RNA and protein levels have led to the notion that the 
medaka oct4, i.e, Oloct4, indeed encodes the medaka ortholog of the prototype Oct4 first 
identified in the mouse. This notion is supported by two experiments revealing OlOct4 as 
an octamer-binding transcription factor: Overexpressed OlOct4 protein is localized to the 
nucleus in stem cell cultures; In DNA-protein interaction experiments OlOct4 can bind to 
the octamer consensus oligo. Reporter assays demonstrate that the medaka Oct4 can 
regulate transcription from the medaka and human Oct4 promoters as well as the mouse 
Nanog promoter. This regulation has been found to be mediated through the newly 
identified Oct4-Sox2 composite element (OSE) that is present also in the medaka 
promoter. Furthermore, the medaka Oct4 promoter activity is down regulated by retinoic 
acid that is known to induce stem cell differentiation in mouse and medaka ES cells. 
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   xii   
Similarly, the medaka stat3 ortholog has been characterized. Importantly, two transcript 
variants were identified, one coding for a novel protein isoform here designated as Stat3b 
that has an insertion of 20 amino acids in the transcription activation domain. The two 
variants are widely co-expressed at a similarly high in adult tissues, in accordance with 
the finding that the Stat3 activity/function is largely modulated at the posttranscriptional 
levels.  One exception does exist in expression: In the kidney the stat3b RNA is barely 
detectable. Interestingly, overexpression of the two variants differentially regulates the 
transcription activity for the Oct4 and Nanog promoters, in consistence with the 
identification of a STAT binding site in the medaka Oct4 promoter. This experiment 
provides first evidence for molecular networking between the Stat3 signalling pathway 
and Oct4 as well as Nanog in controlling stemness in medaka. Since these genes are 
highly conserved in sequence, regulation, function and more importantly, the presence of 
STAT site also in the human Oct4 promoter, it will be interesting to determine whether 
this is also the case in mammals and how Stat3 regulate stemness gene expression. 
In summary, work with the medaka orthologs of mammalian oct4 and stat3 in this study 
has clearly demonstrated that stemness genes are highly conserved between fish and 
mammals, and experimental analyses in this easy-to-do model system will provide 
valuable insights into also mammalian systems. 
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Chapter I Introduction 
1.1 Stem cells  
1.1.1 Developmental potency of stem cells 
 
Stem cells are unspecialized cells that have the capability of self-renewal for producing 
identical unspecialized daughter cells and the potential of differentiation into specialized 
cells. Stemness refers to the undifferentiated status of self-renewing stem cells. Stem cells 
show a hierarchy of developmental potency in mouse (Fig. 1-1). Totipotent stem cells 
include the zygote and the 8-cell morula that have full potential to develop into an entire 
new organism and every cell type. Subsequently, these totipotent stem cells specialize 
into pluripotent cells that exist only in the inner cells mass (ICM) of the blastocyst stage. 
The pluripotent stem cells are undifferentiated cells which have wide potential to give 
rise to three primary germ layers, the endoderm, mesoderm, and ectoderm as well as 
primordial germ cells (PGC). Pluripotent stem cells undergo further specialization into 
multipotent cells. The multipotent stem cells are committed to give rise to a limited 
number of cells, which have a particular 
function in tissues and organs. Stem cells 
may also be bipotent or unipotent. Examples 
are liver progenitor cells that can give rise to 
hepatocytes and bile ductal cells, and germ 
stem cells whose differentiation generates 
only gametes. 
 Fig.1-1. Stem cell hierarchy in mouse (Adapted from
Wobus & Boheler, 2005). 
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1.1.2 Fundamental features of stem cells  
Since stem cell renewal and differentiation take place at early stages of embryogenesis, 
the early developing embryo is an ideal system for the in vivo analysis of stem cells. So 
far, three typical types of embryonic cell lines with pluripotent capabilities have been 
derived from different origins: embryonic carcinoma (EC) cell line from teratocarcinoma-
s, embryonic stem (ES) cell line from blastocyst and embryonic germ (EG) cell line from 
PGCs. Among them, ES cells have been best characterized. The first ES cell lines were 
derived from the ICM of blastocyst-stage mouse embryos by culturing ICM cells on 
mitotically-inactivated mouse embryonic fibroblast (MEF) feeder cells (Evans and 
Kaufman, 1981) or in the presence of an EC cell-conditioned medium (Martin et al., 
1981). The use of a feeder layer or a conditioned medium is to inhibit spontaneous 
differentiation. Recently, human ES cell lines have been established initially on MEF 
feeder layers, and they now have been cultivated on human feeder cells to avoid 
xenogenic contamination or under serum-free conditions instead of feeder cells as had 
been previously done for mouse ES cell lines (Boiani and Schöler, 2005).  
Mouse ES cells (mESCs) and human ES cells (hESCs) have shown generic similarities 
and differences (Table 1-1). Both exhibited an almost unlimited self-renewal capacity in 
vitro and retained the ability to develop into many somatic cell types. Even mESCs were 
recently directed into germ cells (Hubner et al., 2003; Ginis et al., 2004) though hESCs 
not known. In addition, they both can form teratoma in vivo after transplantatio (Ginis et 
al., 2004; Boiani and Scholer, 2005). Moreover, they both express core transcription 
factors controlling pluripotency: Oct4, Nanog and Sox2 (Okamato et al., 1990; Rosner et 
al., 1990; Schöler et al., 1990; Yuan et al., 1995; Niwa et al., 2000; Mitsui et al., 2003; 
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Chambers et al., 2003; Avilion et al., 2003). Furthermore, they also express specific cell 
surface markers like CD9 and CD133 and possess enzyme activities such as alkaline 
phosphatase and telomerase (Forsyth et al., 2002; Carpenter et al., 2004). Despite some 
similarities between mESCs and hESCs, there exist obvious differences (Table 1-1). For 
instance, mESCs and hESCs differ in the culture medium. mESCs maintain their self-
renewal abilities under the feeder-cells-free culture conditions with addition of serum and 
leukemia inhibitory factor (LIF),while hESCs do not   (Williams et al., 1988; Laurence 
etal., 2004). mESCs can be cultured in the medium supplemented with both bone 
morphogenetic proteins (BMP) and LIF without feeder cells and serum, but hESCs can 
not (Ying et al., 2003). On the other hand, hESCs are able to produce trophoblast cells in 
response to BMP, whilst mESCs do not (Xu et al., 2002). mESC can retain their 
undifferentiated state promoted by fibroblast growth factor-4 (FGF-4) added in the 
culture medium, whereas hESCs can not (Nichols et al., 1998; Xu et al., 2002). In 
addition, mESCs and hESCs differ in the expression of several cell surface antigens. 
Undifferentiated mESCs show high expression of Stage-specific embryonic antigen 
SSEA-1 while hESCs do not express. In contrast, hESCs specifically express several cell 
surface antigens like SSEA-3 and 4, TRA-1-60, TRA-1-81 and GCTM2, but mESCs not 
(Henderson et al., 2002). Furthermore, mESCs can form simple and cystic embryoid 
bodies (EB) after aggregation in culture whereas hESCs only form cystic EB (Thomson 
et al., 1998). These differences suggest that caution must be paid in exploration of data 
that has accumulated on the properties of mESCs for studies using hESCs or stem cell 
lines from other species. Thus, a better understanding of stem cell biology requires 
comparative analysis of stem cells from different species. In this regard, stem cells from 
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medakafish, one of the most distant vertebrate relative to the human, is of particular 
interest.  
Table 1.  Comparison of ESCs from mouse and human  
Undifferentiated state marker Mouse  Human 














































In vitro culture requirements   
Feeder-cell dependent  
LIF dependent   







Growth characteristics   
Ability to form trophoblast  
Teratoma formation in vivo  
EB formation 









           *: Adapted from Boiani and Scholer, 2005, Wobus and Boheler, 2005. 
1.1.3. Signaling pathways modulating pluripotency in stem cells  
While a precise definition of the physical and genetic features that distinguish a stem cell 
from other cell types remains elusive, stem cells do have distinct dual functional 
similarities: on one hand, they have the capacity to self renew and they are involved in 
the generation or regeneration of tissues; on the other hand, they have the potential to 
differentiate into various types of cells (Blau et al., 2001). It is the potential of stem cells 
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to give rise to mature, differentiated cells that has motivated stem cell research in the past 
decade. Recent progress has been made to unravel how stem cells regulate self-renewal 
and pluripotency using mESCs and hESCs as a cell model. Remarkably, several 
intracellular signaling modulate pluripotency of mESCs, including LIF/gp130/Stat3, 
BMP/Smad, Wnt/Catenin/TCF, Phosphatidyl Inositol 3 (PI3) kinase and Ras/Raf/ERK 
pathway, and some of these pathways are known to engage in crosstalk with each other 
(Okita and Yamanaka, 2006). The signaling pathways and potential crosstalk between 
them are displayed in Fig. 1-2. The cytokine LIF and its downstream effector Stat3 are 
essential for maintenance of pluripotency in mESCs. LIF stimulation also induces other 
signaling pathway like PI3 kinase and Ras/Raf/ERK pathway. In addition, LIF and BMP 
can cooperate to maintain the pluripotency of mESCs. Moreover, Stat3 activated by LIF 
can induces c-Myc expression and then c-Myc may activate its targeted genes for self-
renewal. C-Myc has been reported to be the target gene of ERK or GSK3β, both of which 
are important downstream effectors for self-renewal (Fig. 1-2). However, some of the 
intracellular signaling pathways are not engaged in regulating of pluripotency outside 
mESCs. For example, LIF/Stat3 seems not promoter self-renewal of human and monkey 
ES cells while BMP4 functions in mESCs show a bit differences in hESCs (Xu et al., 
2005; Okita and Yamanaka, 2006). 
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 Fig.1-2. Intracellular signaling pathways and potential crosstalk between them in mouse ES cells.  
(Reprinted from Okita and Yamanaka, 2006). 
 
1.1.4. Transcription factors controlling pluripotency of stem cells 
Transcription factors are DNA binding proteins with various structured motifs to regulate 
the expression level of other genes that involved in many cellular and biochemical events. 
To determine the cell fate of stem cells, transcription factors may be regulated by 
intracellular signaling pathways as described above. However, it is not clear about the 
precise mechanisms by which of these factors are regulated (Fig. 1-3). Recent studies 
have shown that several transcription factors such as Oct4, Stat3, Sox2, FoxD3 and 
Nanog can play important roles in controlling pluripotency of ESCs and complex 
interactions between them may exist  (Chambers, 2004; Boiani and Scholer, 2005; Boyer 
et al., 2005; Loh et al., 2005). Among them, transcription factors Oct4 and stat3 are the 
two famous key regulators that have been characterized ealier in mESCs. To have a better 
understanding of transcription factors implicated in stem cell biology, in the next two 
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sections, the properties of these two regulators will be highlighted from the following 
areas: the genetic and protein structure, expression patterns and regulation mechanisms as 

















Fig. 1-3. Transcription factors in early mouse developmental stage (A) and mouse ES cells (B). (A): Oct4, 
Nanog, Sox2 and FoxD3 control development of embryonic stem cells from toripotent to pluripotent 
development stages. (B): self-renewal and pluripotency of undifferentiated mouse ES cells is regulated by 
nuclear transcription factors Oct4, Sox2, Nanog and Stat3, and tightly regulated interactions between 
extra/intracellular signaling pathways (Integrin, Wnt, BMP4 and LIF). [Adapted from Wobus and Boheler, 
2005 (A), Boiani and Schöler, 2005 (A)]. 
 
1.2 Transcription factor Oct4 
1.2.1 POU (Pit-Oct-Unc) family 
POU (Pit-Oct-Unc) family of transcription factors were originally named by four 
transcription factors Pit-1, Oct-1, Oct-2, and Unc-86, which possess a highly conserved 
 
A 
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bipartite DNA-binding domain called POU domain: a POU-specific domain (POUs) and 
a homeodomain (POUh) (Herr et al., 1988). These two subdomains are joined by a 15-56 
amino acid flexible linker region and both are required for high affinity sequence specific 
DNA binding (Herr et al., 1988; Sturm and Herr, 1988; Greenstein et al., 1994; Klemm et 
al., 1994; Herr et al., 1995; Phillips and Luisi, 2000).  
POU domain transcription factors have been divided into six classes based on the 
composition of the linker region and of the amino terminal homeodomain (Wegner et al., 
1993). Some representative members of each of these classes are: class 1 protein Pit1 
(POU1F1); class II proteins Oct1(POU2F1), Oct2 (POU2F2), Oct11 (POU2F3); class III  
proteins Oct6 (POU3F1), Brn-1 (POU3F3), Brn-2 (POU3F2) and Brn-4 (POU3F4); class 
IV proteins Brn-3A (POU4F1)and Brn-3B (POU4F2); Class V protein Oct4 (POU5F1); 
Class VI protein Brn-5 (POU6F1) and Rfp-1(POU6F2). These transcription factors are 
involved in a broad range of biological functions ranging from housekeeping gene (Oct-1) 
to neurogenesis (Brn-1, Brn-2) and upto the development of immune responses (Oct-1, 
Oct-2). 
Oct-4, also called Oct-3, is only member of POU domain transcription factor family, 
which is associated with stem cell pluripotency (Piesce and Schöler, 2001). It was first 
identified as Oct-3 in P19 stem cells through gene trapping approach (Okamato et al., 
1990). Independently, Rosner ands Schöler described the specific expression of Oct3/ 
Oct4 in early stem cells and germ cells of the mouse embryo (Rosner et al., 1990; Schöler 
et al., 1990). The mouse gene located at the t-locus on chromosome 17 is specifically 
expressed in the undifferented stem cells (Schöler et al., 1990). Like other OCT protein, 
the defining feature of Oct4 is its ability to bind to and activate transcription through the 
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'octamer' DNA sequence 5'-ATGCAAAT-3' (Okamato et al., 1990; Rosner et al., 1990; 
Schöler et al., 1990). Later, Oct4 also was found in human (Takeda etal., 1992).The gene 
in human and mice has been designated as POU5F1 and Pou5f1, respectively. 
1.2.2 Structure and function of Oct4 Protein  
As a member of POU family of transcription factors, the fundermental feature of Oct4 
protein is the highly conserved POU domain consisted of two structurally independent 
subdomains (POUs and POUh) (Fig. 1-4A). Through this POU domain, DNA-binding 
domain (DBD), Oct4 protein exhibits incredible diversity in the recognition of cognate 
octamer motifs and in regulating expression of target genes. Notably, Oct4 has been 
found to be functionally important in regulating other genes expressed specially in ESCs 
such as fgf4, opn-1, utf1, fbx15, sox2 and nanog, in cooperation with Sox2 through 
composite Oct and Sox motifs (Yuan et al., 1995; Nishimoto et al., 1999; Botquin et al., 
1998; Tomioka et al., 2002; Tokuzawa et al., 2003; Chew et al., 2005). These composite 
Oct and Sox motifs are non-palindromic motifs with invariant comparative directionality. 
This directional requirement reflects side chain interactions between the HMG (high-
mobility group) domain of Sox and the POUs of Oct4 that stabilize the ternary Oct4-
Sox2-DNA complex (Fig. 1-3B; Reményi et al., 2003). 
The regions outside the POU domain are N-terminal and C- terminal domains that reveal 
little conservation. The N-terminal domain (N-domian) is rich in proline and acidic 
residues while the C-terminal domain (C-domain) is rich in proline, serine and threonine 
residues (Pan et al., 2002). The N and C domains of Oct4 have been suggested to play 
roles in transactivation whereas they are not critical for DNA binding (Brehm et al., 
1997). The C domain is subject to cell-type-specific transactivation mediated by the POU 
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domain of Oct4 and phosphorylation, whereas the N-domain is not, indicating that the C 
domain may activate certain targets, which do not respond to the N domain. This was 
proved by the facts that N domain can function as transactivation domains in all cell 
types examined when fused to the GAL4-DBD, while C domain  can not in some cell 
types (Brehm et al., 1997; Niwa et al., 2002). In addition, a nuclear localization signal 
195RKRKR was identified in mouse Oct4, which is responsible for Oct4 localization in 
the nuclei and required for the transactivation of its target genes (Pan et al., 2004). The 
correct protein level of Oct4 is crucial for maintaining stem cell pluripotency, whereas 
high or low level of Oct4 could lead to stem cell differentiation by activating and 
repressing its downstream genes (Niwa et al., 2001). The precise mechanism by which 
Oct4 achieves these diverse biological functions remains unknown. More work will be 












Fig.1-4. Interaction of  Oct4-POU/Sox2-HMG on UTF1 gene. Schematic illustration of Oct4 domains (A) 
and Oct4-POU/Sox2-HMG complexes formed on UTF1 gene (B): model of Oct4-POU/ Sox2-HMG/UTF1 
(left) and close-up view of the HMG/POUS interfaces on UTF1 (right). [adapted from Pan et al., 2002  (A) 
and Reményi et al., 2003 (B)]. 
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1.2.3 Expression pattern of Oct4   
In mouse, Oct4 is expressed in pluripotent and germ cells of the developing embryo. Oct4 
expression is active from the 4- cell stage up to the morula-stage embryo (Palmieri et al., 
1994). At the blastocyst stage, Oct4 remains high in ICM but is rapidly downregulated in 
trophectoderm (TE). After implantation, Oct4 is expressed in the epiblast, downregulated 
during gastrulation, and later confined to PGCs (Pesce et al., 1998). Oct4 also is 
expressed in the three mouse embryonic stem cell lines derived from early embryos, i.e, 
EC, ES and EG cells (Niwa et al., 2000; Tanaka et al., 2002). Moreover, Oct4 maintains 
the pluripotency of ES cells at the appropriate level. High or low level of Oct4 expression 
leads to spontaneous or induced differentiation (Niwa et al., 2000). In addition, oct4-
deficient mouse embryos targeted disruption of the endogenous oct4 gene fail to form an 
ICM, while in vitro blastocyst-like structures resulted from developed by deletion of oct4 
were comprised of TE cells and failed to implant (Nichols et al., 1998).  
Adult expression of Oct4 in mice has initially limited to germ stem cells, oogonia in the 
female and spermatogonia in the male (Rosner et al., 1990; Schöler et al., 1990; Pesce et 
al., 1998). In addition, many germ cell tumors and a few somatic tumors show detectable 
expression of Oct4, consistent with the stem cell hypothesis of carcinogenesis (Tai et al., 
2005). More recently, Oct4 expression has been expanded into other pluripotent adult 
stem cells, e.g. human mesenchymal stem cells (hMSCs) in the bone marrows (Tai et al., 
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1.2.4 Regulation of oct4 gene expression  
 
1.2.4.1 Regulation by cis-elements of the upstream promoter 
 
Gene expression of oct4 is regulated by cis-elements on its upstream promoter sequence. 
In mouse Oct4 promoter, Okazawa et al (1991) proposed that expression of oct4 in ESCs 
is controlled by a distal upstream stem cell-specific enhancer that is deactivated during 
retinoic acid (RA)-induced differentiation by an indirect mechanism not involving 
binding of RA receptors. Schoorlemmer et al (1994) reported that the minimal GC-rich 
Oct4 proximal promoter (PP) is subject to negative regulation by RA in RA-treated P19 
ECCs and mediate repression activity is mediate by several members of the nuclear 
receptor family like COUP-TF1, ARP-1, and EAR-2. In addition to the above TATA-less 
PP, two enhancer elements were identified to be responsible for the cell-type-specific 
expression: 1.2 kb proximal enhancer (PE) and 3.3 kb distal enhancer (DE). PE is 
essential for expression of the oct4 gene and is specifically activated at the epiblast stage 
and its derived ECCs. In contrast, DE is active in the blastocyst and PGCs, ESCs and 
ESCs-derived germ cells in culture (Yeom etal., 1996; Hübner etal., 2003). Moreover, 
two binding sites (site 1A and site 2A) within these two enhances, homologous to the GC 
box, were identified by in vivo footprinting and they are crucial for the activity of PE and 
DE, respectively (Yeom et al., 1996). However, it is not known which transcription 
factors target these different enhancers to regulate oct4 expression. On the other hand, 
four conserved regions (CR1 to CR4) were revealed by comparative analysis of upstream 
promoter sequences among human, bovine, and murine Oct4 (66-94% conservation). 
CR1 contains a putative Sp1/Sp3 binding site and an overlapping hormone responsive 
element (HRE) in all three species. In addition, there are a large number of CCCA/TCCC 
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motifs within the upstream regions (Nordhoff et al., 2001). These sequences may be 
essential for oct4 expression, thus further dissection of the oct4 gene promoter/enhancers 
will reveal the specific cis elements that bind to corresponding trans-acting factors, 
which act together to mediate lineage-specific expression of oct4. 
1.2.4.2 Regulation by epigenetic mechanism 
In addition to the cis-elements, there is epigenetic mechanism that involved with DNA 
methylation and chromatin remodeling to regulate the activity of oct4. Methylation of 
genomic DNA is known to play a primary role in embryogenesis by silencing specific 
genes during development and/or differentiation. Jaenisch suggested that there must be a 
wave of de novo methylation occurring in the somatic cells of the embryo (Jaenisch, 
1997). This methylation is associated with low or absent expression of the oct4 transcript. 
DNA methylation in the region 1.3 kb upstream of the mouse oct4 gene was present 
following RA treatment of mouse OTF963 ECCs (Ben etal., 1995). The mouse Oct4 
promoter was later shown to undergo methylation at 6.5 days postcoitum in develping 
embryo, and a region in proximal enhancer (PE) was a cis-acting factor necessary for 
demethylation of oct4 locus in oct4-expressing cells (Gidekel & Bergman, 2002). 
Moreover, Oct4 enhancer region was hypomethylated in ESCs but hypermethylated in 
trophoblast stem cells (Hattori et al., 2004). In an attempt to study the possibility of 
reversing the differentiation process, Takayama et al. (2004) treated differentiated 
mESCs with a demethylating agent and found an increase of mouse oct4 expression. In 
addition, DNA methylation of specific sites within the promoter regions of human oct4 
may directly cause downregulation of its expression in RA-treated human NT2 cells 
(Deb-Rinker et al., 2005). Taken together, these studies demonstrated that expression of 
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oct4 is regulated by the changes of DNA methylation. The statue of DNA methylation is 
related to the changes of the chromatin structure of the mouse oct4 gene and the 
expression of DNA-N-methyl transferase (DNMTs) (Hattori et al., 2004). It is still of 
interest to determine how DNA methylation acts in concert with transcription factors   to 
control ES cells into undifferentiated or differentate state.  
1.2.4.3 Regulation of oct4 expression by transcription factors.  
So far, Oct4 and Sox2 are the best identified co-activators in the positive regulators of 
oct4 expression. Okumura et al (2004) have indicated that Oct4 and Sox2 can specifically 
bind to the novel cis-element Site 2B in ES cells, located 30 bp downstream from Site 2A 
in the DE of mouse Oct4 promoter, whereas a factor(s) present in both ES and NIH 3T3 
cells can bind to the site 2A. Moreover, Site 2B-mediated DE activity is necessary for the 
physiological level of oct4 in ES cells, where the knock-out of oct4 is inducible. Recently, 
Chew et al (2005) recently reported that oct4 and sox2 expression were retained in ES 
cells via the Oct4/Sox2 complex under a positive and potentially self-reinforcing 
regulatory loop. They identified a composite Oct/Sox element located within DE at CR4 
upstream of the major transcription initiation in the mouse and human Oct4 promoter and 
showed Oct4 and Sox2 interact specifically with Oct/Sox element by in vitro and in vivo 
experiments with nuclear extracts from ES cells. Following the specific knockdown of 
either Oct4 or Sox2 by RNA interference, the induced and endogenous gene expression 
levels of both oct4 and sox2 were reduced.  
In addition, several transcription factors of the nuclear receptor family can regulate oct4 
expression. Steroidogenic factor 1 (SF-1) and its isoforms can bind to its binding sites in 
mouse Oct4 promoter and activate oct4 expression in P19 ECCs (Barnea and Bergman 
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2000). LRH-1(liver receptor homologue 1) is expressed in undifferentiated ES cells, can 
activate oct4 reporter gene expression by binding to SF-1 response elements in its 
promoter region. On the other hand, in vivo disruption of the LRH-1 gene causes oct4 
expression disappearing at the epiblast stage and early embryonic lethality (Gu et al., 
2005). Germ cell nuclear receptor (GCNF) represses oct4 expression by binding of 
GCNF to a DR0 element located in the PP region of mouse oct4 (Fuhrmann et al., 2001). 
In GCNF/ embryos, oct4 expression is not extinguished in somatic cells and thus is not 
confined to PGCs after gastrulation, and the embryos die around embryonic day 10.5 
(E10.5) (Chung et al., 2001). GCNF was later suggested to be responsible for the 
repression of oct4 gene expression during stem cell differentiation (Gu et al., 2005). More 
importantly, the down-regulation of oct4 expression may subsequently inhibit some 
genes transcription and enhance the expression of other downstream target genes (Loh et 
al., 2006).  
1.2.5 Molecular interaction of Oct4 in ES cells  
Oct4 and Nanog  
Oct4 and Nanog, two homeodomain transcription factors, may be the best known 
regulators of mammalian early embryogenesis and ES cells (Nichols et al., 1998; Mitsui 
et al., 2003). The levels of both Oct4 and Nanog are critical for self-renewal and 
differentiation in embryonic development and ES cells. Overexpression of Oct4 leads to 
differentiation of mESCs into extra-embryonic endoderm and mesoderm, whereas 
increased expression of Nanog maintains mESCs in an undifferentiated state (Niwa et al., 
2001; Mitsui et al., 2003). In addition, loss of oct4 induces ICM and ES cells to 
differentiate into trophectoderm and extra-embryonic endoderm while depletion of nanog, 
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results in differentiation into primitive endoderm (Nichols et al., 1998; Mitsui et al., 2003; 
Chambers et al., 2003). Moreover, the differentiation induced by Oct4 expression is 
similar to that observed upon LIF withdrawal, in contrast with that the undifferentiation 
enhanced by Nanog expression is independent of that upon LIF for self-renewal (Niwa, 
2001; Chambers, 2003). Further experiments exposed that Nanog cannot function without 
Oct4, although Oct4 and Nanog have discrete and coordinated functions (Chambers, 
2003). In addition, the expression of Oct4 is required for Nanog-mediated self-renewal in 
ESCs (Chambers, 2003). This has been proved by the fact that the overexpression of 
Nanog could not reverse the differentiation when cells are lack of Oct4 expression. 
Recently, Loh et al. (2006) indicated that Oct4 and Nanog overlap substantially in their 
core downstream targets, which are important to prevent mESCs from differentiating. 
Oct4 and Wnt  
There are some clues that Wnt signaling has an effect on Oct4. Firstly, wnt3-deficient 
embryos express high levels of Oct4 (Liu et al., 1999). Secondly, activated Wnt pathway 
sustains Oct4 expression in mESCs and hESCs (Sato et al., 2004). Thirdly, induced Wnt 
signaling pathways do not lead ESCs to differentiation into neural cells but diverted to 
either epithelial or mesenchymal cells, similar to changed phenotypes caused by the 
levels of Oct4 expression (Haegele et al., 2003). 
Oct4 and Sox2 
The proteins Oct4 and Sox2 act cooperatively at promoters as discussed in section 1.2.4.3. 
Oct4, Sox2 and Nanog  
A first genetic link among Oct4, Sox2 and Nanog was revealed by the fact that Oct4 
interacts with Sox2 to drive pluripotent-specific expression of Nanog in both mESCs and 
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hESCs by binding to the Oct-Sox motif in the Nanog proximal promoter (Rodda et al., 
2005). Boyer et al. (2005) further indicated that Oct4, Sox2 and Nanog collaborate to 
form regulatory circuitry consisting of autoregulatory and feedforward loops in hESCs. 
They identified 353 genes that were bound by all three transcription factors and roughly 
half of these genes are expressed in hESCs. Thus, the three factors work together, rather 
than separately, to control whole sets of target genes in ES cells. The central factors Oct4, 
Sox2, and Nanog may play dual roles in governing the self-renewal and pluripotency: on 
one hand, they improve expression of pluripotency genes including themselves; on the 
other hand, they inhibit expression of differentiation-promoting genes. Moreover, their 
actions are reinforced through their target pluripotency genes to block differentiation 




Pan et al. (2006) proposed that Oct4, Nanog, and FoxD3 maintain their expression in 
pluripotent ES cells under a negative FoxD3-Nanog-Oct4 feedback loop. This was 
proved by the following facts: Firstly, FoxD3 activate nanog activity by reversing the 
repressive effect of Oct4. Secondly, both FoxD3 and Nanog promote the expression of 
oct4, while Oct4 sustains nanog activity by directly activating its promoter at sub-normal 
Fig. 1-5.  Regulatory Circuitry in hESCs. 
(Adapted from Orkin, 2005). 
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level but repressing it at or above normal levels. Thirdly, increased or decreased 
expression of FoxD3 or Nanog fails to increase or reduce the concentration of Oct4. In 
the same manner, overexpression of Oct4 or Nanog fails to rescue the loss of nanog or 
oct4, respectively. 
1.2.6 Oct4 in animals 
Mouse Oct4 Orthologues have been identified from human and bovine, which share a 
high level of conservation in their genomic structures and sequence compositions 
(Takeda et al., 1992; Van Eijk et al., 1999), thereby suggesting that oct4 plays a similar 
role in mammals. But there are some differences in oct4 expression among mammals. For 
instance, oct4 mRNA is expressed much higher in the ICM than in the trophectoderm 
(TE) of human blastocysts (Hansis et al., 2000), whereas Oct4 protein is detected in both 
the ICM and TE of bovine and porcine expanded blastocysts (Kirchhof et al., 2000). 
Additionally, oct4 expression was not found in human EG cells (Onyango et al., 2002). 
Therefore, oct4 expression patterns are variable among mammalian species.  
Oct4 initially had been thought to be a mammalian-specific gene due to the absence of 
homologs in the genomes of C.elegans and Drosophila and probably chicken (Pesce et al., 
2001). Now, non-mammalian oct4 homologs have been described in zebrafish, axolotl, 
lungfish and sturgeon (Takeda et al., 1994; Burgess et al., 2002; Johnson et al., 2003).  
In fish, zebrafish pou2 has been proposed to be an ortholog of the mouse oct4 on the 
basis of chromosomal synteny, phylogenetic sequence comparison, expression and 
functional data. pou2 plays multiple roles during development. It is expressed and 
involved in early proliferation and morphogenesis of the blastomeres, similar to mouse 
oct4 during formation of the ICM (Takeda et al., 1994). During early neural development, 
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pou2 activates gene expression in the midbrain and hindbrain primordium, and also is 
involved in hindbrain segmentation (Burgess et al., 2002; Hauptmann et al., 2002). In 
addition, pou2 functions in endoderm formation and maternal control of dorsoventral axis 
formation and epiboly (Reim et al., 2004; Reim and Brand 2006).  
1.3 Transcription factor Stat3 
1.3.1 STAT family member 
STATs in signal transduction 
In multicellular organisms, cell-cell communications is to facilitate adaptive responses to 
environmental changes. Signal transducers and activators of transcription proteins 
(STATs) are a family of latent cytoplasmic transcription factors that are activated in 
response to extracellular stimuli, which are involved in both signal transduction events as 
well as in the regulation of gene expression. Stats were originally discovered as two 
proteins (Stat1 and Stat2) which were involved in interferon (INF)-α and IFN-γ signal 
transduction (Schindler et al., 1992). Today, seven Stat family members (Stat1, 2, 3, 4, 
5A, 5B, and 6) have been identified in mammalian cells (Schindler and Darnell, 1995; 
Pellegrini and Dusanter, 1997; Takeda and Akira, 2000; Imada and Leonard, 2000). They 
are localized in three chromosomal clusters, suggesting that this family of transcription 
factors has evolved by gene duplication (Copeland et al., 1995).  
STATs structure   
All Stats contain long amino acids (aa) in the range about 750-850. They are composed 
by six conserved distinct functional domains, including an N-terminal domain, a coiled-
coil domain, a DNA binding domain (DBD), a linker domain, an Src-homology 2 (SH2) 
domain and a C-terminal transactivation domain (TAD) (Darnell, 1997; Oshea, et al., 
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2002). The schematic domain structure and a tertiary model of DNA-bound Stat dimmers 
are illustrated in Fig. 1-6. 
The N-terminal domain comprises approxiamately 130 aa, which is important for protein-
protein interactions and for dimer-dimer interactions to form tetrameric STAT molecules. 
Deletion of the amino terminus leads to STAT binding to single sites, tetramers are not 
formed. In addition, it has been shown that tetramer formation is necessary for a strong 
STATDNA interaction at adjacent sites and is important for maximal transcriptional 
stimulation (John et al., 1999; Vinkemeier et al., 1996; Xu et al., 1996; Zhang and 
Darnell, 2001). It has also been shown that the N-terminus regulates receptor recognition, 
phosphorylation, nuclear translocation, and dephosphorylation (Strehlow and Schindler, 
1998; Murphy et al., 2000). Coiled coil domain is consists of four-stranded helices 
(approxiamately 130-300 aa), which provides an extensive surface to interact with other 
proteins, for example c-Jun and CBP/p300 (Zhang et al., 1996). Studies also showed that 
this domain is involved in receptor binding and nuclear export (Zhang et al., 2000; Begitt 




















Fig. 1-6. The domain structure of STATs. 
Schematic representation (top)  
and the structure of DNA bound STAT  
dimer (bottom).  
(adapted from Oshea, et al., 2002) 
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The DNA binding domain (about 300-500 aa) contains several β-sheets, which 
determines DNA sequence specificity of individual Stats and mediates distinct signals for 
specific ligands (Horvath et al., 1997). Linker domain (about 500-575 aa) is a highly 
conserved structure connecting the DNA binding domain with the SH2 domain, but its 
function is still unknown. Mutations within this domain of Stat1 result in reduced binding 
times, suggesting this domain may regulate transcription (Yang et al., 1999; Yang et al., 
2002).  The SH2 domain (about 575-690 aa) is most highly conserved Stat domain, which 
mediates dimerization via SH2-phosphotyrosyl peptide interactions (Shuai et al., 1994). 
This domain plays important roles in signaling through it to bind to specific 
phosphotyrosine sites. C-terminal transactivation domain is poorly conserved domin 
among all Stats. A transactivation domain (TAD) at the C-terminal end of the molecule, 
38 to 200 residues in length, is involved in regulation of unique transcription complexes. 
This domain contains two features: a tyrosine residue (700) near the SH2 domain is 
phosphorylated upon activation and required for dimerization via SH2; a serine 
phosphorylation site, in the case of Stat1, Stat3, Stat4 and Stat5, has been shown to 
contribute to transcriptional activation and seems to be important for protein-protein 
interactions (Decker and Kovarik, 2000). 
STAT isoforms 
STAT isoforms are naturally occurringng splice variants lacking regions of the C-
terminal TAD including the serine residue, have a competitive dominant negative effect 
on gene induction mediated by the STAT pathway, counteracting the signaling of the full 
length STAT (α). They exert their dominant negative effects by blocking the DNA-
binding sites in STAT responsive elements. So far, multiple STAT isoforms generated by 
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alternative mRNA splicing have been described, designated as Stat1α and β, Stat3α, and 
β, Stat5A α and β, and Stat5B α and β (Schindler et al., 1992; Caldenhoven et al., 1996; 
Wang et al., 1996; Schaefer et al., 1997; 1996; Moriggl et al., 1996; Sasse et al., 1997). 
The alternatively spliced RNAs from Stat4 and Stat6 have been reported, but the 
corresponding proteins have not been identified yet (Hirano 1998). STATs expression is 
ubiquitous except for Stat4 only in myeloid cells and testis (Zhang et al., 1994). Stat 
activity is mainly regulated via complex post-translational modifications, instead at the 
transcription level. However, it is not well understood the regulation mechisms that 
generate STAT isoforms. 
RNA splicing is produced by removal of introns from primary transcripts to join the 
exons so that it expands a vast repertoire of functional diversity by producing multiple 
RNAs and proteins from a single gene. Stat3β is a naturally occurring isoform of Stat3 (α) 
and encodes an 80 kDa protein which also lacks the Ser 727 phosphorylation site 
(Caldenhoven et al., 1996). Compared to wild-type Stat3 (α), Stat3β has seven new amino 
acids and lacks an internal domain of 50 base pairs from the C terminal of Stat3 (Fig.1-7). 
In the case of Stat isoforms generated from proteolytic processing, Stat5 has been 
reported to be truncated by proteolysis at the transcriptional activation domain (Azam et 
al., 1997; Lee et al., 1999). The other two truncated isoforms Stat3γ and Stat3δ were 
recently identified in human myeloid cells (Chakraborty et al., 1998; Hevehan et al., 2002; 
Kato et al., 2004). Stat3γ (72KD) is a C-terminal truncated form of Stat3α and was 
proposed to be produced by limited proteolysis during granulocytic differentiation (Kato 
et al., 2004). Stat3δ (64KD) is a putative novel truncated isoform, which was expressed 
and activated in the early stage of granulocytic differentiation (Hevehan et al., 2002).  
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STATβ splice variants function as negative regulators of transcription and are 
thereforewidely used to study the role of STAT proteins. Recently, selective targeting of 
the stat3β isoform in mice was reported and these mice exhibit diminished recovery from 
endotoxic shock and hyperresponsiveness of some endotoxin-inducible genes in liver. 
This is the first in vivo evidence that STAT isoforms have essential in vivo functions 
(Yoo et al., 2002).  
 
Fig. 1-7. Alternative splicing of Stat3 pre-mRNA and generation of Stat3 isoforms. DBD, DNA binding 
domain; SH2, Src-homology 2; Y, tyrosine; S, serine. (Modified from Yoo et al. 2002). 
 
Mechanisms of STAT activation and regulation 
 
STATs are activated by numerous cytokines, growth factors and peptides etc. For 
cytokine receptors, it has been shown that receptor associated Janus Kinases (JAKs) 
phosphorylate STATs. Phosphorylation at conserved tyrosine residues allows STATs 
dimerization via reciprocal interactions between SH2 domains. Among STAT molecules, 
Stat1, Stat3, Stat4, Stat5a and Stat5b form homodimers with each other while Stat1 form 
heterodimers with Stat2 or Stat3. Following dimerization, STAT dimers translocate to the 
nucleus and bind to specific STAT DNA-binding elements, originally termed the gamma 
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interferon activated sequence (GAS) element (TTN5-6AA), in the promoter of target 
genes and activate transcription (Levy and Darnell, 2002)。 
Perhaps the best-studied pathway for STAT activation is the LIF/JAK/STAT pathway 
(Fig. 1-8). The receptor for LIF is a heteromeric complex consisting of gp130 and the LIF 
receptor (LIFR). Normally, the tyrosine kinase JAK is inactive by binding to the 
intercellular domain of this gp130/LIFR complex. Upon LIF binding, JAK kinase 
phosphorylates tyrosine sites at Y765/812/904/914 of gp130 and Y976/996/1023 of LIFR. 
Phosphorylation of these sites can recruit Stat1 and Stat3 interacting between SH2 
domains. Thus, STAT proteins form homodimers and/or heterodimers and then 
translocate into the nucleus, where they regulate expression of their targeted genes 
through specific binding elements (Okita and Yamanaka, 2006). In addition, Src 
homology domain 2 protein (SHP2) tyrosine phosphatase binds at Tyr759 and interacts 
with adaptor molecules such Gab1/2, p85 and Grb2 mediating the activation of 
intracellular signaling pathways such as the mitogenactivated protein kinase (MAPK) or 
















Fig. 1-8. LIF/JAK/STAT pathway.
 
(Adopted from Okita and Yamanaka, 2006) 
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1.3.2 Expression pattern of stat3 
Stat3 was initially identified as the acute-phase response factor (APRF), activated by IL-6 
(Wegenka et al., 1993). The stat3 cDNA was cloned one year later and encodes a protein 
of 770 aa resulting in a molecular weight of 88 kDa (Akira et al., 1994). Expressin of 
stat3 is ubiquitous and starts very early during post-implantation development in the 
mouse. Moreover, stat3 deficient mice develop into the egg cylinder stage but show a 
rapid degeneration between embryonic days 6.5 and 7.5. This is probably due to 
nutritional insufficiency, since stat3 is expressed at embryonic day 7.5 in the embryonic 
visceral endoderm, which is important for nutrient exchange between the maternal and 
embryonic environment (Takeda et al., 1997).   
In zebrafish embryos, stat3, jak1, and jak2b are expressed before gastrulation. In contrast, 
stat1, stat5, and jak2a are expressed after gastrulation (Oates et al., 1999). Zebrafish 
Stat3 is phosphorylated and located in the nucleus on the dorsal side shortly after the 
midblastula transition (MBT). Stat3 activity is not required for fate specification but is 
essential for anterior migration and convergence and extension. These results establish a 
role for Stat3 in the control of cell movements during gastrulation (Yamashita et al., 2002; 
miyagi et al., 2004). So far, zebrafish stat3 functions extend in developmental cell 
migration, vasculogenesis, branching morphogenesis, as well as neuronal pathfinding 
(Conway, 2006).  
1.3.3. Biological functions of Stat3 in pluripotency 
Stat3 can be activated by a variety of cytokines, including leukemia inhibitory factor 
(LIF), interleukin-6 (IL-6), IL-11, oncostatin M, cardiotrophin-1, ciliary neurotrophic 
factor, leptin, granulocyte colonystimulating factor, and epidermal growth factor (Takeda 
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et al., 1997). This family of signaling molecules has been implicated in many biological 
phenomena including cell survival, growth, proliferation, differentiation and cancer 
malignancies (Chapman et al., 2000). Interestingly, Stat3 is able to inhibit cell 
differentiation, following its activation with IL-6 or LIF. IL-6 was shown to induce 
differentiation effect on certain lines of PC12 cells that have been pretreated with nerve 
growth factor (NGF). Overexpression of a mutant gp130 that is defective to activate Stat3 
signaling results in PC12 cells differentiation without NGF treatment, while 
overexpression of Stat3DN (dominant negative) also causes differention of cells in the 
absence of NGF, which represses the IL-6 induced activation of Stat3. These facts 
suggest that Stat3 is negatively involved in PC12 differentiation (Ihara et al., 1997). In 
addition, self-renewal of mouse ES cells is dependent on LIF. Abrogation of LIF 
mediated self-renewal by overexpression of a Stat3DN promotes differentiation (Boeuf et 
al., 1997; Niwa et al., 1998; Raz et al., 1999). These results indicate that Stat3 is required 
for LIF mediated events in ES cells. In concordance with this, another study confirmed 
that Stat3 is necessary and sufficient for self-renewal of mouse ES cells by expressing a 
construct, in which Stat3 encoding sequence was fused to the ligand binding domain of 
the estrogen receptor (Stat3ER) (Matsuda et al., 1999). 
1.3.4 Molecular interaction of Stat3 in ES cells 
Stat3 and Nanog  
Extensive studies showed that Stat3 does not induce Nanog expression while Nanog does 
not activate Stat3 (Chambers et al., 2003; Mitsui et al., 2003) suggesting that they act in 
parallel. There are no difference in the phosphorylation levels, kinetics and distribution of 
Stat3 between ES cells cells expressed with normal or increaselevel of Nanog (Chambers 
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et al., 2003). In the like wise, Nanog levels are not affected, when Stat3 signalling 
molecules are altered by mutation of LIFR, induction of hyperactive gp130 and inhibition 
of JAK (Chambers et al., 2003). However, in the case of stat3 activating via the LIF 
receptor, the propagation of cells with high-level of Nanog expression is promoted and 
morphology of cells is changed from evenly distributed monolayers to tight cell adhesion 
(Chambers et al., 2003; Mitsui et al., 2003), suggesting that signals from Stat3 and Nanog 
may be synergetic.  
Suzuki et al. (2006) recently reported that there is a synergism between Stat3 and Nanog, 
when Nanog functions to block BMP induced differentiation of mES cells. In the 
presence of LIF, Nanog expression is increased by the binding of Stat3 and T (Brachyury) 
to the enhancer element in the Nanog promoter. Thus, the increased levels of Nanog 
contribute to disrupt the progression of mesoderm-differentiation induced by BMPs.  
Stat3 and Oct4  
There are three possibilities for the occurrence of interactions between Sta3 and Oct4. 
Firstly, knock out of Stat3 or Oct4 in mice lead to abnormal early embryo (no 
gastrulation) (Nicolas et al., 1998; Takeda et al., 1997). Secondly, as a member of 
signaling pathway, Stat3 may act as one of the candidates that function upstream of Oct4, 
which lacks of definite upstream target genes or signaling pathways reported to cooperate 
with in maintenance of pluripotent ES cells. Lastly, Stat3 inactivation caused by LIF-
withdrawal or expression of Stat3DN induces differentiation into multiple cell lineages, a 
similar phenotype caused by over-expression of Oct4 (Niwa et al., 2000; Niwa et al., 
1998). Whereas no direct interaction between Sta3 and Oct4 was purported by the fact 
that the increased Oct4 expression cannot prevents the above induced differentiation by 
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Stat3 inactivation (Niwa et al., 2000), It remains to define the protein factors that may 
interact with Stat3 and Oct4 and the precise promoters and enhancers targeted by Stat3 
and Oct4 in ES cells, since information about these is scarce. 
1.4 Medaka as a model organism 
1.4.1 General features of medaka as a model organism 
Like zebrafish, the Japanese medaka is a small teleost fish that represents an excellent 
model for the analysis of vertebrate development (Wittbrodt et al., 2002). Medaka has 
many advantageous features. Transparent embryos develop externally and can be viewed 
and manipulated at all stages. Moreover, its development is rapid and the organization of 
the embryo is simple. It is amenable to genetic analysis and has a short generation 
interval (2-3 months). A female medaka can produce eggs everyday while a female 
zebrafish can lay eggs per week, in contrast to mouse that may produce a litter of up to 15 
embryos in 21 days. On the other hand, medaka has a variety of important attributes not 
available in the zebrafish which may be useful for expanded experimentation. These 
features include genetic distance (possibly equivalent to the chicken and the human), a 
smaller genome (800 Mb), a shorter generation (two weeks), XY sex determination, 
tolerance of a wide range of temperature (1°C to 40°C), apparent lower incidence of 
chronic infectious diseases, and easy access to fertilized eggs, as well as many inbred 
strains that provide genetic diversity for phenotypic analyses (Wittbrodt et al., 2002). 
Notably, genomic information of medaka is also increasing rapidly with earlier several 
complete or almost complete vertebrate genome projects (e.g. human, mouse, rat, fugu 
and zebrafish). Now, the Medaka Genome Sequencing Project almost complete draft 
assembly covering above 91% of the genome (http://dolphin.lab.nig.ac.jp/medaka). This 
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information is invaluable to discover evolutionary mechanisms underlying the 
diversification of body forms and the increasing complexity of gene function of 
vertebrates, combined with developmental data gathered from other model systems and 
sophisticated post-genomic analyses. 
1.4.2 Medaka as unique model for stem cell research  
Medaka is an excellent complementary system to human and mouse for stem cell biology. 
Conditions for cell cultures from developing embryos and adult tissues have been 
established. Importantly, it represents the only vertebrate besides the mouse that has 
given rise to stable ES cell lines (Hong et al., 1996, 1998) and a spermatogonial stem cell 
line from the adult testis (Hong et al., 2004). Furthermore, it is the only vertebrate that 
has generated motile test-tube sperm from the spermatogonial stem cell line (Hong et al., 
2004). Although therapeutic stem cell applications will require the use of human stem 
cells, the fish medaka as a distantly related vertebrate to the human may provide valuable 
information for comparative approaches of understanding mechanisms underlying stem 
cell renewal, differentiation and transplantation biology.  
Medaka ES cell lines  
Several ES cell lines from midblastula-staged embryos have been established in a feeder-
free culture system. Medaka ES cell lines have been characterized to be a fish equivalent 
of mouse ES cell lines. These medaka ES cells have a normal karyotype, display 
pluripotency-specific gene expression and retain the ability to undergo spontaneous and 
induced differentiation (Hong et al., 1996). Upon microinjection into host blastula, these 
cells can give rise to a high frequency of chimera formation (Hong et al., 1998). Through 
ectopic expression of microphthalmia-associated transcription factor (Mitf), medaka ES 
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cells were able to predominantly direct into melanocytes (Bejar et al., 2003). Medaka ES 
cell lines offer a complementary system for stem cell biology and technology.  
Adult germ stem cell lines 
A spermatogonial (SG) cell line, SG3, have recently been cultured from adult testis. SG3 
cell retains the stem cell characteristics, including stable proliferation, a diploid 
karyotype, and the phenotype and gene expression pattern for spermatogonial stem cells 
(Hong et al., 2004). Importantly, this cell line is able to generate motile sperm in culture 
following meiosis and spermatogenesis (Hong et al., 2004). Therefore, SG3 serves as 
normal germ stem cell line to understand the stemness in germ stem cells. It also provides 
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1.5 The objective of this study 
Because of the essential roles of Oct4 and Stat3 in maintenance of stem cell pluripotency 
in mammals, and the unique features of the medaka, it seems equally important to 
understand the roles of Oct4 and Stat3 in medaka. The overall objective of the study was 
two fold, which include a molecular genetic and partial biochemical analysis of oct4 
homologue, a key regulator in vertebrate embryogenesis and  stem cells, coupled with 
exploration of the possibility of interacting with another regulator, stat3, using the fish 
model medaka.  
To this end,   the specific aims in first part of study were:  
1) to clone the medaka oct4  
2) to determine its expression patterns  
3) to analyze its transcriptional regulation activity  
4) to characterize its biochemical properties as an octamer-binding transcription factor. 
Similar study was done for the medaka stat3 in the second part. 
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Chapter II    Materials and Methods 
2.1 Materials  
2.1.1 Organisms 
Embryos and adults from orange strain of medaka were used in this study as biomaterial 
sources for molecular genetic and biochemical analyses. The fish was kept indoor in 
dechlorinated tap water and at ambient temperature of around 28°C with an artificial 
dark/light cycle of 14/10 h. Embryos were raised in dishes containing 1 × embryo rearing 
medium (ERM: 0.1% NaCl, 3 KCl, 4 CaCl2, 1.6 MgSO4, and 0.1 methylene 
blue) at 28°C until the desired stages were obtained. The developmental stages were 
defined according to Iwamatsu (1994). 
2.1.2 Cells 
Cell lines 
The following cell lines were used for transient gene transfer and expression. 
MES1 (Medaka Embryonic Stem) is a cell line that was established by culturing cells 
from blastula-staged embryos of medaka (Hong et al., 1996). 
SG3 (Spermatogonia) is a cell line that was derived from the adult testis of i3 strain 
medaka (Hong et al., 2004).  
SOK is a cell line that was derived from the adult testis of Sok strain medaka. This cell 
line was identified as sertoli cell culture (Liu T. & Hong Y., unpublished data). 
Or1 is a cell line that was cultured from the adult testis of medaka Orange strain. This 
cell line was characterized to be germ cells (Hong Y.unpublished data).  
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Bacteria strains 
Bacteria used for transformation was Escherichia coli DH 5α or Top10 (Invitrogen). E. 
coli cells were grown at 37°C in Luria Bertani (LB) medium in the absence or presence 
of different antibiotics concentrations (Ampicillin, 100µg/ml; Kanamycin 50µg/ml). 
2.1.3 Oligonucleotides 
The oligonucletides (oligos) were synthesized by proligo or 1st Base. They were used as 
primers in PCR, sequencing or expression experiments as probes. The oligos used in this 
study was listed in Appendix (Table 1).  
2.1.4 Plasmids  
The plasmids listed in table 2 were used as basic vectors for constructing recombinant 
vectors, or as references in expression analyses: 
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Table 2 Basic plasmids used in the study 
# 
 
Plasmids Structure: description Application Reference 
1 pGEM®-T Containing 3-T overhangs at the insertion 
site and coding region of β-galactosidase as 
well as T7 & SP6 RNA polymerase 
promoter  with multiple cloning region 
flanked by BstZ1.
To clone PCR products; 
To screen clones by blue-
white color and release 
inserts by double digestion; 





Similar to the above vector, except that 
multiple cloning region flanked by EcoR1, 
BstZ1, & Not1.  
To release inserts only by 
single-enzyme digestions. 




Puromycin acetyltransferase (pac) is fused 
to the red fluorescent protein (RFP) in 
pDsRed-N1 (Clontech). Kan+
To select & label transfected 






Puromycin acetyltransferase (pac) is fused 
to egfp in pEGFP-N1. Kan+ 
 
To select & label transfected 






MCS to clone a gene as fusion N-terminal 
to DsRed1. Kanamycin resistance for 
growth in E.coli 
The standard source for Dsr-




Basic promoterless vector containing MCS 
upstream of the egfp 
The standard source for egfp 
gene sequwence 
Clontech 
7 pGL3-Basic Basic promoterless plasmid containing the 
firefly luciferase (luc). Ampicillin resistance 
for growth in E.coli. 
To test regulatory sequences 
for transcriptional activity 




CMV enhancer/early promoter drives high- 
expression of Renilla luciferase in 
cotransfected cells. 
As an internal control for 





2.5-kb mouse nanog promoter was inserted 
(Kpn1+Xho1) ahead of luc in pGL3 
Promoter analysis  AJ. Cooney 
(2005)                
10 HuOct4-Luc 3-kb human POU5F1 promoter was cloned 
(BglII and NcoI sites) upstream of the luc in 
pGL3-Basic 
Promoter analysis  H.H.  Ng etal. 
(2005)                
11 pCMV-
muGCNF 
1.6-kb mouse gcnf cDNA with HA tag 
(CMV-HA:gcnf) 
Expression vector AJ. Cooney 




His-tagged Pou5f1 CDS (NM_013633) 
downstream of IRES in pTriEx-1.1.hygro 
(Novagen)  
Expression vector H.H.  Ng et al. 




His-tagged mouse Sox2 CDS (NM_011443) 
between XhoI and NotI sites downstream of 
IRES in pTriEx-1.1.hygro (Novagen)  
Expression vector H.H.  Ng et al. 
(2005)                
14 pCMV-
muNanog 
His-tagged mouse nanog CDS  downstream 
of IRES in pTriEx-1.1.hygro (Novagen)  
Expression vector H.H.  Ng et al. 
Not published     
15 pCMV-
OlSox2 
Medaka  Sox2 open reading frame inserted 
downstream of CMV promoter in pCvpr 





Medaka  Sox2 CDS downstream of CMV 
promoter in pCPpr (not clear if pr or rfp 
only) 
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2.2   Methods 
2.2.1 RNA work 
2.2.1.1 Isolation of total RNA from tissue and cells 
Isolation of RNA was performed using the protocol of TRIZOL Reagent (Invitrogen). 
Samples from tissues and embryos were disrupted and homogenized using plastic pestle 
homogenizer in 200 µl of TRIZOL on ice and then were mixed well with the additional 
800 µl of TRIZOL. For samples from cells grown in monolayer, cells were lysed directly 
in a culture dish by adding 1ml of TRIZOL Reagent to a well of 6-well-plate and 
collected after cell lysate was passed several times by pippetting. After homogenized, the 
samples were incubated for 10 min at 15 to 30°C to permit the complete dissociation of 
nucleoprotein complexes. Each sample was mixed vigorously with the addition of 0.2 ml 
of chloroform and incubated for 5 min. Following centrifugation at 12,000 × g for 15 min 
at 4°C, 0.5 ml of isopropyl alcohol was added into the upper aqueous phase and 
incubated for 1 h at -20°C. RNA was precipitated by centrifugation as earlier for 10 min 
and washed with 1 ml of 75% ethanol at 7, 500 × g for 5 min at 4°C. The RNA pellet was 
dried and dissolved in 50 µl of DEPC-treated ddH2O at 65 °C for 10 min. The isolated 
RNA was measured with an OD260/280 ratio of 1.6-1.8, prior to storage at -80 °C. 
2.2.1.2 Spectrophotometric determination of nucleic acids 
Spectrophotometric determination of nucleic acids bases on the fact that nucleic acids 
have maximum absorption of UV-light at wavelength of 260 nm, while proteins at 280 
nm. For measuring the concentration of DNA or RNA, a sample diluted in nuclease-free 
water or TE buffer is measured in a 1-cm-path quartz cuvette (Beckman 50 µl microcell) 
both at 260 nm and 280 nm in a spectrophotometer machine (Beckman). The reading at 
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260nm allows calculation of the amount of nucleic acids in the sample. An OD of 1 
corresponds to 50µg/ml for double-stranded (ds) DNA, 33µg/ml for single-stranded (ss) 
DNA, 40µg/ml for single-stranded RNA and 20-30 µg/ml for oligonuceoltide. The ratio 
between the readings at 260 and 280nm (OD260/OD280) provides an estimation for the 
purity of the nucleic acids. The values for pure DNA and RNA are 1.8 and 2.0, 
respectively.  
2.2.1.3 In situ hybridization (ISH) analysis of RNA 
2.2.1.3.1 Digoxigenin (DIG)-labeled RNA synthesis 
1 µg of linerized plasmid DNA (e.g. pGEM-T vector containing the cDNA fragment at 
EcoR I or Hind III site; the linerized method is in section 2.2.2.5.1) was used to 
synthesize the DIG-labeled RNA probe. The probe was prepared by in vitro transcription 
using a DIG-RNA Labeling kit (Roche Molecular Biochemicals) according to the 
manufacturer's instructions. The transcription reaction was performed at 37°C for 2 h in a 
total volume of 20 µl containing 4 µl of 5 × transcription buffer, 2 µl of DIG-NTP mix 
(10 mM ATP, 10 mM CTP, 10 mM GTP, 6.5 mM UTP and 3.5 mM DIG-UTP), 1 µl of 
RNase inhibitor and 1 µl of T7 or SP6 RNA polymerase. Following the reaction, the 
DNA template was digested by 2 µl of RNase-free DNase I at 37°C for 15 min, and then 
synthesized RNA was precipitated by 2.5 µl of 4 M LiCl and 75 µl of cold 100% ethanol 
after the digestion was stopped by 1 µl  of 0.5 M EDTA (pH 8.0). The RNA pellet was 
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2.2.1.3.2 In situ hybridization on frozen sections 
In situ hybridization of frozen sections of young and adult gonads was carried out as 
described by Shinomiya et al. (2000). Briefly, whole gonad tissues were fixed in 4% 
paraformaldehyde in 1 × PBS (0.8% NaCl, 0.02% KCl, 0.0144% Na2HPO4, and 0.024% 
KH2PO4, pH7.4) and routine histological techniques were employed for frozen 
embedding. Sections of 10 µm thick were hybridized. For hybridization of one slide, 100 
ng of digoxigenated probe RNA were redissolved in 50% formamide, 10% dextran 
sulfate, 2 × SSC (1×: 15 mM NaCl, 15 mM sodium citrate, pH 7.6). The hybridization 
mixture was denatured for 10 min at 80°C. Then 50 µl of the hybridization mixture were 
applied to each slide and sealed under a coverslip. Hibrydization was done with the 
antisense RNA probe at 65°C in a circulating water bath with shaking for 16-24 h. The 
probe was visualized by specifically immunostaining for digoxigenin. The slides were 
then washed three times for 30 min in 50% formamide, 2 × SSC at 65°C and once for 30 
min in 0.1 × SSC, pH 7.0 at 65°C and blocked with 4 × SSC, 3% bovine serum albumin, 
0.1% Tween-20 at 37°C for 30 min. Probes were detected with anti-digoxin antibody 
conjugated with alkaline phosphatase (AP)(Roche). Signals were developed by staining 
for purple color with NBT (nitroblue tetrazolium) and BCIP (5-bromo, 4-chloro, 3-
indolyl phosphate). As a control, several testis and ovary sections were stained with 
haemalum and eosin (HE) and different stages of germ cells were identified.  
2.2.1.3.3 In situ hybridization on whole embryos 
Whole-mount in situ hybridization (WISH) using a DIG-labeled riboprobe was carried 
out as described in EMBO course on medaka & zebrafish (2002). Similar to method 
described in 2.2.1.3.2, collected embryos were fixed with 4% paraformaldehyde and 
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treated by proper amount of proteinase K, then hybridized overnight with the probe in 
hybridization buffer (50% formamide, 5 × SSC, 50 µg/ml heparin, 500 µg/ml yeast tRNA 
and 0.1% Tween 20) at 65°C, followed by incubation with anti-DIG antibody. The 
hybridized signals were observed by staining for purple color with NBT and BCIP.  
2.2.2 DNA work 
2.2.2.1 Preparation of DNA  
2.2.2.1.1 Isolation of Genomic DNA from the whole fish 
Genomic DNA was prepared from the whole medakafish since the fish is tiny-sized. One 
ice-anesthetized fish was sterilized with 70% ethanol and excised into small pieces. The 
fish pieces were grinded with prechilled mortar and pestle in liquid nitrogen until minced 
to fine powder. The powder was suspended in 20 ml 1 × lysis buffer (10 mM Tris, 20 
mM EDTA, 1% SDS, 50µg/ml proteinase K). After incubation at 55ºC overnight, 50 µl 
of RNase was added to the solution and incubate at 37oC for 2 h. To extract DNA, 10 ml 
of Tris-saturated phenol and 10 ml of chloroform were added to the tube, mixed for 5 min 
after the addition of each solution. After centrifugation at 4000 rpm for 20 min, the 
aqueous (top) phase was transferred to a new 50 ml tube. The phenol/chloroform 
extraction was repeated 2 times as before, followed by extraction twice with 20 ml of 
chloroform. The supernatant was carefully transferred to a fresh tube. 0.1 volume of 3 M 
NaOAC (pH 5.2) and 2.5 volumes of ethanol were sequentially added, with an interval 
mixing by inversion. The DNA was winded out on a pippet tip and transferred to a 1.5 ml 
tube with 70% ethanol. The DNA pellet was washed twice with 1 ml 70% ethanol. After 
washing, DNA was dried briefly and resuspended in 1 ml of TE buffer at 60ºC for 14-48 
h. The dissolved DNA was measured by taking an OD260/OD280 to estimate the 
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concentration and purity, and also loaded on a 0.8% agarose gel to monitor the molecular 
weight. 
2.2.2.1.2 Isolation of plasmid DNA from E.coli 
Alkaline lysis method  
This method is performed based on the standard methods of molecular cloning. The 
resulting product can be used for transformation, restriction digestion and sequencing, etc. 
1.5 ml of overnight culture was spun down at 4000 rpm for 3 min. Following the 
supernatant was aspirated, cell pellet was resuspended in 100 µl Solution I (25 mM Tris-
HCl, pH 8.0, 10 mM EDTA, 10µg/µl RNAase) with vigorous vortex. 200 µl Solution II 
(0.2 M NaOH, 1.0% SDS) was added into the suspension and mixed gently by inversion. 
The tube was placed on ice 5 min. 150 µl Solution III [3M KOAc, pH 4.8 (60 ml 5M 
KOAc, 11.5 ml HOAc, 28.5 ml H2O)] was added and briefly mixed by inversion. After 
centrifugation at 14,000 rpm for 5 min, the supernatant was poured to fresh tube and 
precipitated by the addition of 800 µl of 100% ethanol at -80ºC for 30 min. The mixture 
was spun at 14,000 rpm for 10 min. The supernatant was removed and pellet was washed 
once with 500 µl of 75% ethanol. Following centrifuge at 14,000 rpm for 1 min, the 
supernatant was discarded and the tube was drained by leaving on bench with lids open 
for ~5 min. The extracted plasmid DNA was dissolved in 40 µl of TE (PH 8.0). 
Boiling method  
20 µl of bacteria culture was transferred from 2 ml of overnight culture to a fresh 1.5 ml 
tube. Following centrigation at 4000 rpm for 3 min, the pellet was resuspended in 3 µl of 
ddH2O and mixed by vortexing. STET working solution was prepared with the addition 
of 3.5 µl of freshly made lysozyme (10 mg/ml) into STET stock solution (20 g Sucrose, 
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10 mM Tris-HCl, pH 8.0; 100 mM NaCl; 50 mM EDTA, pH 8.0; 5% Triton X-100). 
With the addition of 8 µl of STET working solution, the bacteria suspension was boiled 
for 30 seconds and cooled to room temperature. The boiled mixture was incubated at 
37ºC for 1-2 h, after 1µl of restriction buffer and 0.2 µl of digestion enzymes were added. 
Following running gel with a whole volume of the reaction, it was determined that 
whether the plasmid contained the insert sequence or not.   
iNtRON Midi-preps 
This DNA-midiTM Plasmid DNA purification kit is designed for rapid isolation and 
purification of the plasmid DNA from 15-400 ml large scale cultured bacterial cells. 
Plasmid DNA was prepared from 100 ml or 400 ml culture medium, isolated using the 
similar above-mentioned alkaline lysis method, and purified through a specific ion-
exchange spin column according to the suppliers protocol (iNtRon, Korean).  As a result, 
300~600 µg (high-copy) of plasmid DNA was obtained from 100 ml, while 100~600 µg 
(low-copy) of plasmid was gotten from 400 ml culture medium. The plasmid was directly 
used in sequencing, transfection experiments and microinjection. 
2.2.2.2 Gel electrophoresis of DNA  
2.2.2.2.1 DNA eletrophoresis on native agarose gels 
DNA Agarose gel electrophoresis was performed with horizontal gel for the separation of 
larger DNA fragments (70 bp-25 kb), while DNA migrating through the gel remains 
double-stranded and retains alternate conformations. Appropriate amount (0.5-1.5%) of 
low-melting-point (LMP) powered agarose was added to 1 × TAE elelctrophoresis 
runnubg buffer [50 × TAE: 242 g Tris base, 39.1 ml Glacial Acetic Acid, 100 ml 0.5 M 
EDTA (pH 8.0)] and melted by heating in a microwave oven. After cooling to 60ºC, 
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ethidium bromide (EB) was added (0.5% µg/ml final), the warm agarose solution was 
poured into a horizontal precast gel mold (ReadyAgarose TM precast gel system, Bio-
Rad) to a thickness of 4-8 cm and the comb was immediately clamped for setting the 
sample loading slots. After the gel was completely set (about 20-30 min at RT), the comb 
were removed, and the gel was mounted in the electrophoresis tank. 1 × TAE buffer was 
added into the tank to cover the gel to a depth of 2-3 mm. Samples were mixed with 
appropriate amount of gel loading buffer (GLB, Ferementas) and loaded into the slots of 
the submerged gel by pipeting. 2-5 µl DNA ladder (Promega or Fermentas) was added 
for estimating the molecular size of DNA samples. Electrophoresis was run at 10-30V/cm 
for about 30 min or at 2-10V/cm for 4-10 h (genomic DNA). By the end of 
electrophroresis, the gel was visualized and under UV-light at 254 nm photographed with 
a thermal paper (Mitsubishi) in Electronic UV transilluminator (Advanced American 
Biotechnology). The band of DNA fragment to be isolated could be cut off under UV-
light for recovery. 
2.2.2.2.2 DNA eletrophoresis on native polyacrylamide gels 
DNA polyacrylamide gel eletrophoresis (PAGE) was performed with vertical gels for the 
separation of synthetic oligos or DNA short fragments (6-2000 bp). For separation of 
small, double-stranded DNA fragments, the DNA samples were into a mini PAGE gel 
following the instructions provided with the Mini-PROTEAN II system (Bio-Rad). The 
appropriate concentration of acrylamide gel (4-20%) was determined depending on sizes 
of the DNA fragments to be separated. For a 60 bp of  dsDNA, 6 % native acrylamide gel 
of 6cm × 8cm × 1mm was prepared by sequentially adding the following solutions: 1.4 
ml of  30% Acrylamide/Bis,  0.7 ml of  5 × Tris-Borate-EDTA buffer (TBE: 1.1M Tris; 
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900 mM Borate; 25mM EDTA; pH 8.30), 4.9 ml of ddH20, 50 µl of 10% ammonium 
persulfate (APS), 6 µl of  TEMED. The gel solution was agitated for 1 min and poured 
onto the gel casting apparatus. After polymerization, the preparative gel was pre-
electrophoresed in prechilled 0.5 × TBE buffer for 10 min at 100 V using Bio-Rad power 
supply. The entire electrophoresis process was operating in a 4°C coldroom. The DNA 
Samples mixed in 1 × glycerol loading buffer[GLB (10 ×): 50% of glycerol, 0.4% of  
bromphenol blue and 0.4% of xylene cyanol], was loaded on top of the gel and 
electrophoresed for 3.5 h at a constant power of 150 V until the dye was seen to reach 
one inch from the bottom of the gel. After running, there were three applications for the 
gel: 1) to detect nucleic acids, the gel was stained by GelStar Stain (Camberx Bio.); 2) to 
recovery the separated dsDNA, the band of DNA was cut off; 3) to further analysis of 
DNA-protein interaction, the gel was transferred to a nylon membrane.  
2.2.2.2.3 Recovery of DNA fragments following gel electrophoresis  
After LMP-agarose gel eletrophoresis, the band of the DNA fragment of the interest was 
cut off under UV-light. The DNA was recovered using UltraClean 15 DNA 
Purification Kit (MO BIO Laboratories, USA) following the suppliers procedure. Briefly, 
agarose gel band slice was melted by adding 3 volumes of Ultra Salt (0.3ml/ 0.1 mg slice) 
at 65º C for 10 min. After Ultra Bind was resuspended by vortexing about 1 min, the 
melted solution was mixed with appropriate volume of Ultra Bind (6µl/1µg DNA to be 
recovered) and incubated at RT for 5 min. The Ultra Bind - DNA complex was pelleted 
by centrifugation at 10, 000 rpm for 10 sec and resuspended with 1 ml UltraWash 
solution.  After centrifugation twice before, the pellet was dissolved in ddH2O or TE 
buffer (2 volumes of UltraBind added earlier) at RT for 5 min, spun down at 14,000 rpm 
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for 5 min. The supernatant was transferred into a new tube and ready to use for restriction 
digest, ligation, labeling, or PCR.  
2.2.2.2.4 Purification of synthetic oligonucleotides by PAGE 
For PAGE purification of oligonucleotides with several copies, a nondenaturing 6 % TBE 
polyacrylamide gel (12% if the oligonucleotide is longer than 30 nucleotides) was 
prepared. Oligos were dissolved in 15 ml of TE buffer, mixed with 4 ml of loading buffer 
and subjected to electrophoretic separation (at 150 V for 2.5 h).  After running, the gel 
was stained on the glass plate in a TBE/EB bath with the fluid just barely covering the gel 
with gentle agitation for 30 min. The gel was lifted out of the bath with the glass plate, 
covered with plastic film and carefully inverted onto UV light box. The bands were cut 
out corresponding to different copies of the oligonucleotide. The gel was sliced with 
plastic pestle homogenizer. The gel slices were in Eppendorf tubes. Add 1 ml TE and 
incubate overnight at 37°C or for 3 h at 55°C. Following centrifuge 1 min, the supernant 
was transferred to a new tube were precipitate for 30 min at -20°C with the addition of  
0.5 ml glycogen, 50 ml NaAc and 1 ml Ethanol. After precipitation, the mixture was spun 
for 15 min at 4°C. The pellet was washed with 70% ethanol air-dried pellet and 
resuspended in 10 ml of TE. 
2.2.2.3 Polymerase Chain Reaction (PCR) 
2.2.2.3.1 Standard PCR 
PCR is an in vitro method to exponentially amplify a specific nucleotide sequence from 
minute quantities of DNA or RNA samples in the presence of template sequence, two 
oligonucleotide primers, a thermostable (Taq) DNA polymerase. The following 
components for a typical 25 µl of PCR reaction was set up in a thin-wall PCR tube: 2.5 µl 
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of 10 × PCR buffer (Mg_), 2.5 µl of 10 × PCR buffer (Mg+), 1 µl of 2.5 pM each of 
primers, 1 µl of 2.5 pM dNTP mix, 2 µl of 50-200 ng template, 15.8 µl of ddH2O and 0.2 
µl of 1 unit Taq DNA polymerase (Fermentas). PCR was performed on a GeneAmp PCR 
System 9700 (Applied Biosystems) running with such temperature profile as:  94°C/10 s, 
50-65°C/30 s and 72°C/1 min for 30 cycles, after samples were denatured at 94°C for 1 
min. The annealing temperatures varied depending on the melting temperature (Tm) of 
the primer pairs. Usually, temperatures 5°C lower than the Tm of primers were used. 
After the end of PCR running, 1/10 µl of the reaction was usually analyzed on a 1 % 
agarose gel, prior to other applications.  
2.2.2.3.2 Reverse Transcription Polymerase Chain Reaction (RT- PCR) 
RT-PCR remains a very commonly used technique for measuring changes in gene-
expression in small sample numbers. The reverse transcription was performed with 
traditional method using Moloney murine leukemia virus (MMLV) reverse transcriptase 
(Promega). Following denaturation of RNA sample (2 µg) in PCR tube at 72ºC for 5 min, 
the tube was sequentially added the following components:1 µl of 5 × MMLV first strand 
buffer, 1µl of 10 mM dNTP, 1 µl of 10 mM oligo dT primer, 4 µl of 0.1% DEPC-treated 
ddH2O, and 2 µl of MMLV reverse transcriptase. The reaction was incubated on a 
thermacycler running such temperature profile: 42°C for 90 min, 72°C for 5 min and 4 °C 
for ever. The first strand cDNA was diluted into 36 µl of TE buffer in DEPC-treated 
water and stored at -20°C. 1 µl of cDNA was used for each of PCR amplification of 
cDNA. RT-PCR was performed as described in ordinary PCR. As an internal control 
gene (β-actin), the reaction was amplified from equal quantity of cDNA primers Am1 and 
Am2 at an annealing temperature of 60°C for 28 cycles. For a given gene, the reaction 
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was carried out with a gene-specific primer pair. After PCR amplification, 10 µl of each 
sample was electrophoresed on 1% agarose gels.  
2.2.2.3.3 Degenerate PCR  
Degenerate PCR is mainly used to fish out conserved sequences of a gene or genes from 
the genome of an organism, also to get the nucleotide sequence after having sequenced 
some amino acids from a protein of interest. Here, an embryonic cDNA was constructed 
from embryos of mid-blastula stage using the cDNA was used as the template for 
amplification of related fragment cDNAs by PCR using two degenerate primers against 
the conserved region. The amplification conditions were as follows: 96°C, 30 s; 48°C, 50 
s; and 72°C, 1 min, performed 35 cycles. PCR products were analyzed by electrophoresis 
on a 2% agarose gel for the gene. A predicted fragment was obtained and cloned. After 
sequencing, a novel sequence was defined.  
2.2.2.3.4 Rapid Amplification of cDNA End-PCR (RACE- PCR) 
RACE-PCR was performed to amplify both 5' and 3' of cDNA ends, following the user 
manual of SMART RACE cDNA Amplification Kit with small modification.  
RACE-Ready cDNAs syntheses 
5'-RACE cDNA was synthesized using a modified lock-docking oligo (dT) primer, 
termed the 5'-RACE CDS Primer (5'-CDS)  and the SMART II A oligo, while the 3'-
RACE cDNA was synthesized with a special oligo (dT) primer, termed  3'-RACE CDS 
Primer A. Briefly,  two PCR tubes were prepared. One for 5RACE was added into 3 ml 
RNA sample, 1 ml 5'-CDS primer and 1 ml SMART II A oligo. Another for 3RACE 
was added into 13 ml RNA sample, 1 ml 3'-CDS primer A and 1 ml sterile H2O. 
Following mixing and briefly spin, the tubes was put in a thermalcycler and incubated at 
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such temperature profile (70°C for 5 min, then hold at 4°C). After incubation, The tubes 
were briefly spun was separately added into the 5 µl of transcription reaction mix [2 ml 5 
× First-Strand buffer, 1 ml DTT (20 mM), 1 ml dNTP Mix (10 mM), 1 ml PowerScript 
Reverse Transcriptase]. The tubes were briefly spun and incubated at 42°C for 2h in an 
air incubator. Then, the synthesized RACE-Ready cDNAs were resuspended in 50 µl of 
TE buffer (in DEPC-treated water).  
RACE PCR reactions 
The gene-specific 5′ RACE primer and 3′ RACE primer, designed based on the known 
sequence of the degenerate PCR fragment, were used for amplification of 5′ and 3′ cDNA 
ends, respectively. A 50 µl of RACE-PCR reaction were assembled by adding the 2 µl of 
RACE cDNA, 5 µl UPM (10 ×), 1 µl RACE primer (10 pM) and 42 ml of PCR Master 
Mix [35 µl of ddH2O, 5 ml of 10 × Advantage 2 PCR Buffer, 1 ml of dNTP Mix (10 
mM), and 1 ml 50 × Advantage 2 Polymerase Mix]. PCR was performed on an 
Eppendorf thermocycler Gradient (Eppendorf). The amplification conditions were as 
follows: 94°C/10s.; 68°C/20s; and 72°C/2min performed 35 cycles. PCR products were 
analyzed by electrophoresis on a 0.8% agarose gel for the gene. The amplified RACE 
fragments were subcloned into pGEMT-easy vector (Promega) or directly sequenced.  
2.2.2.3.5 Colony PCR 
Colony PCR allows rapid detection of transformation success when primers are available 
to allow determination of correct ligation products by size or hybridization. A small sized 
colony (2-3 mm in diameter) was picked from bacterial colonies and resuspended with 5 
µl of H2O in a PCR tube, heated for 5 min at 95°C and then spin the condensation down 
in a microfuge. PCR reaction mix was set up as an ordinary PCR described earlier and 
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then added to the tube.  After running PCR under appropriate conditions for primers and 
expected product, 10 µl of the PCR reaction on an agarose gel to identify which cultures 
to keep for plasmid DNA isolation. 
2.2.2.4 Cloning DNA fragment into Plasmids 
2.2.2.4.1 Digestion of DNA with restriction endonucleases 
Digestion of DNA with restriction endonucleases is the first step in many gene 
manipulation projects. Plasmid DNA was incubated with 2-5 U restriction enzyme(s)/µg 
DNA in a total volume of 20 µl containing 1 × restriction buffer at 37ºC or other 
appropriate temperature for 1-2 h. At the end of the restriction digestion, the digested 
DNA may be used to be loaded on an agarose gel for analysis or inactivated by heating at 
65-80ºC for ligating DNA to another DNA or purified DNA for other purposes. Genomic 
DNA was digested with 10 U enzyme(s) /µg DNA overnight for PCR or southern blot. 
2.2.2.4.2 Filling in of 5´-Protruding terminal of DNA fragments 
The 5´-3´ polymerase activity of Klenow Fragment (Promega) can be used to fill in 5´-
protruding ends with unlabeled dNTPs.  5´-overhang was generated by digesting 14 µg 
of DNA (in a volume of 20 µl) with an appropriate restriction enzyme. The optimal 
reaction conditions for filling are: 50 mM Tris-HCl (pH 7.2), 10 mM MgSO4, 0.1 mM 
DTT, 40 µM of each dNTP, 20 µg/ml acetylated BSA and 1 unit of klenow fragment per 
microgram of DNA. Incubate the reaction at room temperature for 10 min. The reaction 
was stopped by heating the mixture for 10 min at 75°C, extracted once with 
phenol/chloroform and precipitated by ethanol. Thus, the 5´-protruding ends were 
changed into blunts ends for self-ligation.  
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2.2.2.4.3   5 phosphorylation of DNA with T4 polynucleotide kinase 
Synthetic oligos carry no 5 phosphate group, so is the case for PCR products amplified 
by oligo primers. In order to clone such PCR fragments into plasmid, they were 5 
phosphorylaed with T4 polynucleotide kinase (Promega). A typical reaction was 
composed by adding 1-5 pM DNA (5 ends), Kinase 4 µl of 10 × Buffer, 2 µl of 100 mM 
ATP and  1020 µ of T4 Polynucleotide Kinase, followed by plus  deionized water to a 
final volume of 50 µl. The reaction was incubated for 30 min at 37ºC and stopped by 
adding 2 µl of 0.5 M EDTA. Phosphorylated DNA was further extracted once with 
phenol/chloroform and precipitated by ethanol. 
2.2.2.4.4   DNA ligation 
For the joining linear DNA fragments together with covalent bonds, ligation was 
performed with 10 µl of reaction in 1 × ligation buffer ( dilution of 5 × ligation buffer, 
Invitrogen) containing 1 weiss unit of T4 DNA ligase (Invitrogen) and 50-200 ng DNA 
with a 1:1 up to a 3:1 molar ratio of insert DNA termini to vector DNA. After the 
reaction was incubated at 16°C or 4°C for 1-12 h, the resulting ligation reaction mixture 
can be used directly for bacterial transformation. 
2.2.2.4.5 Transformation of E.coli 
Preparation of competent E.coli cells 
E.coli strain was used for all transformation experiments throughout the work. Two 
methods were used alternatively for preparation of competent bacterial cells. 
CaCl2 method 
This method was used for rapid production of competent cells. 1ml overnight culture was 
added to 100 ml LB medium in a 500 ml flask, grown to an OD600 of 0.2-0.4, iced 15 min 
Chapter II  Materials and Methods 
   49   
and then sedimented at 4000 rpm at 4ºC for 10 min. All steps following the collection of 
bacterial were carried out at 4C. The pellet was resuspended in 2 ml of ice-coldCacl2 
buffer A (100mM CaCl2 in ddH2O), and then 8 ml of the same buffer was added and 
mixed gently but thoroughly. The suspension was incubated on ice for 30 min and 
sedimented again as above. The pellet was carefully resuspended in 5 ml of CaCl2 buffer 
B (85 mM CaCl2, 15%v/v Glycerol). The suspension was divided to 100µl aliquots in 1.5 
ml Eppendort tubes, immediately frozen in liquid N2 and then stored at -80ºC. 
RbCl2 method 
This method was used to produce highly competent cells. 2ml of SOB broth (1L: 20.0 g 
of Bacto tryptone, 5.0 g of Bacto yeast extract, 0.6 g NaCl, 0.5 g of KCl, 10 mM of 
MgCl2, and 10 mM of MgSO4) was inoculated overnight in a 15-ml tube with bacteria to 
be transformed from a single colony on a fresh plate. 1 ml of culture was added to a 500 
ml flask containing 200 ml of SOB broth. When reached an OD600 of 0.4, the culture was 
collected in 2 sterile polypropylene centrifuge tubes, and chilled on ice for 15 minutes. 
The cells were spun down by centrifugation at 4000 rpm for 15 min at 4°C. The pellet 
was drained thoroughly, resuspended with 40 ml cold transformation buffer 1 [TfbI (pH 
5.8): 100 mM RbCl, 50 mM MnCl2·4H2O, 30 mM Potassium acetate, 10 mM 
CaCl2·2H2O, 15%v/v Glycerol] and iced 15 min. the cells were pelleted as before, 
resuspended  in 4 ml of cold transformation buffer 2 [TfbII (pH 6.5):10 mM MOPS, 10 
mM RbCl, 75 mM CaCl2·2H2O, 15%v/v Glycerol]  and iced 15 min. The cell suspension 
was aliquoted into 1.7-ml microcentrifuge tubes and flash frozen in liquid N2 for storage 
at -80°C. 
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Transformation of competent E.coli cells with plasmid DNA 
After a 100-µl aliquot of frozen competent cells was slowly thawed on ice for 10 min, 10 
µl of ligation reaction was added, gently mixed and incubated on ice for 30-60 min.  The 
mixture was heat-shocked by incubating at 42°C for 90 s, immediately cooled on ice for 
5 min and 800 µl of LB-medium was added. The tube was incubated at 37°C on a roller 
for 45 min to 1 h to allow for plasmid expression. Following centrifugation at 3000 rpm 
for 1 min, the pellet was resuspeneded in 200 µl of LB-medium. 20-100 µl of suspension 
was plated onto LB-Amp plates, which, in the case of plasmids pGEM-T and pBluescript, 
had been pre-coated with 40 µl of 2% X-gal and 10 µl of 0.8 M IPTG for white/blue 
selection. The plates were incubated overnight at 37°C, wrapped with parafilm and 
placed at 4°C for 2-6 h for promoting color development. For further amplification, 
single colonies were transferred with sterile toothpicks into 3 ml of antibiotic LB medium 
in 15-ml tubes and cultured overnight at 37°C with vigorous shaking. 
2.2.2.5 DNA Sequencing and sequence analysis 
All DNA cycle sequencing reactions were carried out following the protocol of BigDye® 
Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems).Following determination of 
appropriate amount of DNA template dependent on the length and purity of DNA (PCR 
product or plasmid), cycle-sequencing reactions for 96-well plate was made up in a final 
volume of 5 µl (20 ng 1-kb PCR product or 200 ng plasmid in 3µl ddH2O, 1µl of 3.2 pM 
primer and 2 µlof BigDye). The PCR condition for 25 cycles was: 96°C for 10 s, 50°C 
for 5 s and 60°C for 1 min. Then, sequencing PCR product was precipitated by adding 20 
µl of ethanol/sodium acetate solution (3.0 µl of 3 M sodium acetate, pH 4.6, 62.5 µl of 
non-denatured 95% ethanol, and 14.5 µl of deionized water) for 30 min at RT. After spun 
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at the maximum speed, the pellet was washed twice with 70% ethanol and air-dried for 
further sequencing analysis. DNA sequence was analyzed on the ABI PRISM 3100 
genetic analyzer after the pellet was dissolved in 12 µl of HIDI formamide (Applied 
Biosystems). Sequence analysis and database searching were carried out using the 
BLAST 2.0 at NCBI. Alternately, multiple DNA sequence alignments were generated 
using the software Vector NTI (version 7.0) or DNAMAN (Lynnon Corp.).   
2.2.2.6 Labeling of DNA probes and Southern blot analysis of DNA. 
Southern blot analysis was performed based on ECL random-prime labeling and 
detection systems, version II, (Amersham Biosciences, Freiburg, Germany).  
Random primer labeling 
 In this procedure, the fluorescein-11-dUTP/dTTP mix is hybridized to a partially 
denatured DNA and used as random primers for the synthesis of complementary strands.  
A 50 µl of typical reaction was mixed in order: 14 µl of H2O; 20 µl of denatured DNA 
(50-100 ng); 10 µl of Nucleotide mix; 5 µl of Primers; 1 µl of Klenow enzyme. The 
reaction was Incubate at 37°C for 1 h and than stopped by the addition of 5 µl of 0.2 M 
EDTA. Without purification, labelled probe can be used directly in hybridization, 
following denaturation.  
Electrophoresis and capillary blotting  
Following the electrphoresis separation on 0.7% native agarose gel, there were three steps 
to process the gel at RT. These steps were: 1) depurination with depurination solution 
(250 mM HCl) for 10 min; 2) denaturation with denaturation solution (1.5 M NaCl, 0.5 
M NaOH) for 25 min; 3) neutralization with neutralization solution (1.5 M NaCl, 0.5 M 
Tri-HCl, pH 7.5) for 30 min. By capillary blotting method according to the suppliers 
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protocol (New England), genomic DNA was overnight transferred to positively charged 
nylon membrane (Roche) in 10 × SSC as transfer buffer. 
Hybridization and stringency washes 
After transferred DNA was fixed to the membrane by GS Gene Linker UV Chamber 
(Bio-Rad), the membrane was put into a plastic bag (Roche) containing preheated 
hybridization buffer (5 × SSC, 0.1% SDS, 5% Dextran sulphate, 10 fold dilution of liquid 
block, 100 µg/ml denatured sheared calf thymus DNA) and prehybridized for at least 30 
minutes at 65°C in a oven. After prehybridization, the membrane was hybridized 
overnight at 65°C upon the addition of denatured probe (10ng/ml) into the 
prehybridization buffer. Following the hybridization, the membrane was processed by of 
stringency washes at 65°C for 15-30 min each. Three washing conditions used were: 1) 
low stringency: twice in 1 × SSC -0.1% SDS; 2) moderate stringency: twice in 0.5 × SSC 
-0.1% SDS; 3) high stringency: twice in 0.1 × SSC -0.2% SDS.  
Antibody incubation and signal detection 
 
Before antibody incubation, the membrane was rinsed with 50 ml buffer A (100 mM 
Tris-HCl, 600 mM NaCl, pH7.5) for 1 min and then incubated for 30 min in 25 ml block 
solution (20 fold dilution of liquid block). After blocking, the membrane was incubated 
for another 30 min in 25 ml of diluted anti-fluorescein-HRP conjugate (1: 1000). Prior to 
the detection stage, the membrane was washed for 3 × 10 min in excess 0.1% Tween-20 
in buffer A. The drained wet membrane placed on a wrap was covered by the addition of 
15 ml of detection solution (1:1 mixture of detection solution 1 and 2), and then 
incubated for 1 min at RT. The membrane was drained again and put into the film 
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cassette (DuPont). In the dark, a sheet of film (Fuji) was placed on top of the membrane 
and exposed for 5 min with machine (Kodak X-OMRT 3000RA).  
2.2.3 Protein work 
2.2.3.1 Protein extraction  
The initial treatment of isolated tissues and disassociation of adherent cells were 
undertaken as described in 2.2.1.1. Homogenized tissues or disassociated cells were lysed 
in ice-cold lysis buffer (50 mM Tris, pH 7.8; 150 mM NaCl; 1% IGEPAL CA360 (Sigma) 
with Complete Protease Inhibitor Cocktail (Roche) and 1mM PMSF (Sigma) for about 30 
min.  Following centrifugation at 14, 000 g for 10 min, the resultant total cell lysate 
protein (in the supernatant) was transferred to a new tube, aliquoted and frozen at -80°C. 
2.2.3.2 Protein assay  
Coomassie brilliant Blue changes its maximal absorption from 465 nm to 595 nm when 
bound to proteins. Protein concentrations were determined with the protein dye reagent of 
Bio-Rad.  2-5 µl of the cell lysate was added into a volume of 798-795 µl ddH2O in an l-
ml plastic cuvette, and then 200 µl of the dye reagent was added and thoroughly mixed. 
After incubation 5 min, the samples were read at 595 nm against a blank cuvette 
containing all components except the cellular extract. Protein concentrations were 
determined by comparing with a calibration curve which was made using BSA of known 
concentrations (0.2-0.9 mg/ml).  
2.2.3.3 SDS-PAGE  
SDS-PAGE is a very common method for separating proteins by electrophoresis through 
a discontinuous polyacrylamide gel as a support medium and SDS to denature the 
proteins. Briefly, an 8 × 6 × 0.75 polyacrylamide gel was cast by preparation of 5 ml of 
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10% separating gel (1.7 ml of 30% Polyacrylamide, 1.3 ml of 1.5M Tris (pH8.8), 1.9 ml 
of H2O, 50 µl of 10% SDS, 50 µl of 10% APS, and 2µl of TEMED) in the bottom layer 
and 3 ml of 5% stacking gel [0.5 ml of 30% Polyacrylamide, 0.38 ml of 1.5 M Tris 
(pH6.8), 2.1 ml of H2O, 30 µl of 10% SDS, 30 µl of 10% APS, and 3 µl of TEMED] in 
the upper layer in a BioRad MiniProtein Gels apparatus with a 10 wells of comb (Bio-
Rad). Isolated protein samples were denatured by mixing them with equal volume of 2 × 
protein sample loading buffer [130 mM Tris-Cl, pH 8.0, 20 %( v/v) Glycerol, 4.6 %( w/v) 
SDS, 0.02% Bromophenol blue, 2% DTT]. Some membrane samples should be heated to 
speed up the process of denature. 10µl of protein samples (20-40 µg) were loaded into the 
wells of the gel against a standard sample with 5 µl of Precision Plus protein TM 
Standards (Bio-Rad). Electrophoresis was performed in 1 × Tris-glycine electrophoresis 
buffer (10 × transfer buffer: 0.25 M Trizma base, 1.92 M glycine, 1% SDS) at 4°C and 
100 V until the marker reached the bottom of the gel. Then, isolated proteins were stained 
with Coomassie Blue R250.  
2.2.3.4 Anti-peptide antibody production 
A 14-residue synthetic peptidecorresponding to amino acid residues CSENPQDMYKI- 
ERVF of OlOct4 protein was prepared with an amino-terminal cysteine included and the 
carboxy-terminal amidated to resemble an internal peptide fragment. The synthetic 
peptide, Cys-14-NH2, was characterized by its amino acid composition and by mass 
spectral analysis. Cys-14-NH2 was linked to limulus polyphemus hemocyanine (LPH) 
The LPH-conjugated Cys-14-NH2 was injected into two rabbits using a standard protocol 
for antibody production. 40 ml of antiserum was harvested and the titer of immunized 
serum is 1: 200.000 measured by ELISA (Biogenes, Germany).  
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2.2.3.5 Western blot analysis 
Western blot is a method to analyze and identify one protein in a mixture of any number 
of proteins. The procedure include the subsequent  steps following the above-mentioned 
protein extraction and SDS-PAGE:  
Electro-blotting  
Proteins were electrotransferred onto a PVDF (polyvinylidene difluoride) membrane 
(Bio-Rad) in 1 × transfer buffer [10 × transfer buffer: (0.25 M Trizma base, 1.92 M 
glycine)] for 90 min at 100V using Bio-Rad Miniprotein II system. Here, the PVDF 
membrane (6 × 8 cm) had been activated by dipping it in 100 % methanol for 30min 
before it was placed in transfer buffer containing 20% methanol. The gel-PVDF 
sandwich was assembled with the following layers in order from cathode (-) to anode (+): 
1) sponge, 2) filter paper (1 sheet) soaked in transfer buffer, 3) gel, 4) membrane, 5) filter 
paper (1 sheet) soaked in transfer buffer, 6) sponge. Importantly, the PVDF membrane 
must be on the positive (red) side of the gel. 
Incubation with antibodies and signal detection  
Before incubation with a first antibody, the membrane was blocked with 5% nonfat milk 
in Tris-Based Saline Tween-20 buffer [TBST: 10 mM Tris (PH 8.0), 150 mM NaCl, 
0.05% Tween-20] for 2 h at room temperature. Following blocking, membrane was 
incubated with primary antibody diluted in TBST Blocking buffer containing 2% nonfat 
milk (1:200 for OlOct4 anti-peptide anti-rabbit serum) for 2-4 h, and incubated overnight 
at 4°C under agitation. The buffer containing primary antibody was poured off and the 
blot was washed 4-5 times with shaking in TBST about 10 min for each wash. After 
washing, the membrane was incubated for 1 h with the secondary antibody diluted in 
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TBST blocking buffer (1:10,000 for secondary antibody conjugated with alkaline-
phosphatase). The membrane was washed three times in TBST buffer for 10 min each. 
Then Antibody binding was detected by incubation with NBT/BCIP. Following 
incubation 5 min in 10 ml of alkaline phosphatase buffer, the membrane was incubated in 
the dark in 10 ml fresh alkaline phosphatase buffer, with the addition of  chromogen [66 
µl of NBT  (50 mg/ml) and 33 µl of BCIP (50 mg/ml)],  until the desired bands were 
visualized. The chromogen reaction was stopped by washing in many changes of H2O. 
Air-dried membrane was documented with optical scanner (Hp scanjet 3970).  
2.2.3.6 Immunohistochemistry  
Immunohistochemistry is a method of detecting the presence of specific proteins in cells 
or tissues. Embryos and gonads were fixed with 4% paraformaldehyde in PBS for 10 min, 
and then washed with PBS three times. For cryosections, embryos were serially 
dehydrated in 10 and 20% sucrose for 10 min each, and soaked in 1:1 mixture of sucrose 
and OCT compound (Tissue-Tek) at 4ºC overnight. They were embedded in a 1:3 
mixture of 20% sucrose and OCT compound and sectioned at a thickness of 10 µM. The 
sections placed on slide glasses were rinsed with PBS three times for 10 min each, and 
permeated with 0.1% triton X-100 in PBS three times for 10 min each. Following 
pretreatment with blocking solution (PBST containing 0.4% gelatin and 2 % non-fat milk) 
for 1 h at RT, the sections were reacted with rabbit anti-OlOct4 polyclonal antiserum 
diluted l: 200 at 4ºC overnight. After being rinsed with PBST three times, the sections 
were treated with FITC-conjugated anti-rabbit IgG (1:400) for 2 h at room temperature. 
Being rinsed with PBS three times for 5 min each, the slides were mounted with a 
Slowfade Light Antifade Kit (Molecular Probes).  
Chapter II  Materials and Methods 
   57   
2.2.4 DNA-Protein interaction: Electrophoretic Mobility Shift Assay    
(EMSA)  
EMSA technique can be used qualitatively to identify sequence-specific DNA-binding 
proteins or to identify the important binding sequences within a given genes upstream 
regulatory regions. This procedure was performed with the following steps: 
Preparation of cell nuclear extract (NE)  
NE was made from blastula-staged embryos, cultured cells and tissues.  For embryonic 
NE, the procedure for preparation of cells at blastula stage was as follows: 1) blastoderms 
were excised from 100-200 embryos as described by Hong et al. (1996). Alternatively, 
individual blastoderm can be obtained by microinjection needles aspiration. 2) The cells 
were dissociated using a pippte and collected into a tube at 500 × g for 3 min. 3) The cell 
pellets were resuspended in 200 µl PBS buffer and washed twice by pippetting through 
20 µl of a cushion of 87% glycerol to remove york proteins. 4) Cells were pelleted at 
6,000 rpm for 10 min.  
Cellular NE was obtained using NE-PER® nuclear and cytoplasmic extraction reagents 
according to the manual (PIERCE, IL, USA). Briefly, appropriate volume of 100 × 
Halt Protease Inhibitor Cocktail (Pierce) was respectively diluted to 1 × into 
cytoplasmic extraction reagent I (CER I) and nuclear extraction reagent (NER), after 
determining the volumes of three regents based on the quantity of cell paste (500 × g for 
2-3 min). For example, for 20 mg cell pellet, the volumes of three regents needed were 
100, 5.5 and 50 µl, respectively. 100 µl CER1 was added to resuspend the cell pellet 
through vortexing the tube vigorously for 15 s. After incubated on ice for 10 min, 5.5 µl 
pre-chilled cytoplasmic extraction reagent II (CERII) was added into the tube, votexed 
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again as earlier for 5 s and iced for 1 min.  Following votex for 5 s again, cytoplasmic 
extract was obtained from the supernatant by centrifugation (~16,000 g, 5 min). The 
pellet fraction was resuspended with 50 µl ice-colded NER, vortexed 4 times for 15 
seconds every 10 min. Then, nuclear extract was immediately transferred from the 
supernatant after centrifuging (~16,000 g, 10 min).  All extracts were stored at -80ºC after 
determining the protein concentrations.   
Preparation of labeled oligos  
Biotin 3' End DNA Labeling Kit # 89818 was used to label 5 pmoles of 3'-OH ends of ss-
DNA with 1-3 biotinylated ribonucleotides (Biotin-11-UTP). A typical labeling reaction 
for 50 µl of total volume was: 25 µl of ultrapure water, 10 µl of 5 × TdT reaction buffer, 
5 µl of 1µM unlabeled oligo, 5 µl of 5 µM Biotin-11-UTP and 5 µl of 2U/µl diluted TdT). 
The reaction was mixed gently , incubated at 37°C for 30 min and stopped by adding  2.5 
µl of  0.2 M EDTA. To remove the enzyme TdT, the reaction was mixed with 50 µl of 
chloroform: isoamyl alcohol (24:1), vortexed briefly and centrifuged at (~16,000g, 2 min). 
Labeled oligos were contained in the top aqueous phase, transferred to a new tube and 
stored at -20°C or  80°C, following the determination of labeling efficiency by dot blots 
using hand spotting. 
Annealing of labeled ssDNA oligonucleotide 
 
For EMSA, complementary oligos should be annealed after end-labeled separately. After 
dilution of oligonucleotide mixture (1:1 molar ration)  to a final concentration of 1 
pmol/µl with annealing buffer [10 mMTris, 1 mM EDTA, 50 mM NaCl (pH 8.0)],  
oligonucleotides were annealed  using one of the annealing methods: 1) to incubate the 
mixture for 1 h at RT for oligos with low TM; 2) to perform a program on a thermocycler 
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(e.g., denatures at 95°C for 5min, then slowly cool and incubate at the TM  for 30 min 
until the oligos have reached room temperature) for oligos with high TM. 
Binding reaction and electrophoresis 
 
 Binding reaction is to incubate the biotin endlabeled dsDNA (25 pmol) containing the 
binding site of interest with a nuclear extract or purified factor. Following the protocol of   
LightShift® Chemiluminescent EMSA Kit (Pierce), the components of 10 µl of the 
binding reaction including the extracts of interest and labeled probe were usually set up 
on ice in the order [4.5 µl of ddH2O,1 µl of poly-dIdC (1 µg/µl in TE),  0.5 µl  NP-40 
(1%), 1 µl of Binding Buffer [10 × Binding Buffer (1 ml): 100 mM Tris, 500 mM KCl, 
10 mM DTT; pH 7.5], 2 µl of Nuclear extract (10 µg protein), 1 µl labeled probe (25  
pmol)]. For a competition reaction, a 50-400 fold molar excess of unlabeled target was 
added to the binding reaction mixture before adding the labeled probe. In case of a 
supershift reaction, 1 µl of 1 µg/µl antibody was added to the binding reaction mixture 
before adding the labeled probe. After addition of all components, spin reaction tubes 
was spun briefly in microfuge and incubated 30 min at RT, the samples were prepared to 
load on a nondenaturating 8 % polyacrylamide gel, with the addition of 3 µl of 6 × 
loading buffer (0.05 g bromophenol blue, 8 g sucrose, ddH20 to 20 ml).  
The 8 % native polyacrylamide gel was prepared in 0.5 × TBE. The components were 
mixed in to a 10ml tube: 0.75 ml of 5 × TBE, 2 ml of 30% Acrylamide/Bis, 216 µl of 
87% Glycerol, 4.42 ml of ddH2O, 112.5 µl of 10% APS and 7.5 µl of TEMED). After the 
gel was pre-electophoresed at 100 V for 30-60 min at 4ºC, 10 µl of each sample was 
added onto the polyacrylamide gel. Electrophorese samples were carried out until the 
bromophenol blue dye migrated approximately 3/4 down the length of the gel. The gel 
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was electro-blotted to a positively charged nylon membrane (Roche) at 100V for 30 min 
as described in western blot, except that 0.5 × TBE was the only buffer used in all the 
procedures. When the transfer was complete, the membrane with the bromophenol blue 
side up was place on a dry paper towel for 1 min. The membrane is immediately cross-
linked at 120mJ/cm2 with a commercial UV-light cross-linker instrument (Bio-Rad). 
Detection of DNA-protein complex 
 
The detection of DNA complex was performed with Chemiluminescent Nucleic Acid 
Detection Module (PIERCE, # 89880).The UV-cross-linked membrane (6 × 8 cm) was 
put into a clean plastic tray with 12 ml pre-warmed blocking buffer at 50°C and 
incubated for 15 min with gentle shaking. Then, the membrane was incubated 
continuously after adding 40 µl of the stabilized streptavidin-horseradish peroxidase 
conjugate to 12 ml blocking buffer (1:300 volume of dilution). About 15 min later, the 
membrane was washed four times for 5 min each in 20 ml of 1 × pre-warmed wash 
solution with shaking. After washing, the membrane was transferred to a new container 
containing 15 ml of substrate equilibration buffer and incubated 5 min with gentle 
shaking. After equilibration, the membrane was taken out and blotted on a paper towel to 
remove excess buffer. The membrane was completely covered by pippeting 4 ml of 
chemiluminescent substrate working solution (1:1 volume of luminol/enhancer solution 
peroxide solution), and then incubated for 5 min without shaking. After removed excess 
buffer as earlier, the moist membrane was wrapped with plastic wrap in a film cassette 
(DuPont) and exposed by Xray film (Fuji) for 2-5 min. 
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2.2.5 Gene transfer into eukaryotic cells and expression analysis in vitro 
Transient gene transfer is a method to test the effects of regulatory or ORF sequences of 
gene on expression in eukaryotic cells via the reporter plasmid, in which the DNA region 
to be analyzed is linked to a reporter gene (e.g. Green fluorescence protein or luciferase) 
2.2.5.1 Construction of plasmid of DNA 
The construction of the medaka Oct4 promoter-luciferase fusion plasmid, pO-2091luc 
was generated with 2.1kb putative promoter of PCR product (-2091/+28) inserted into the 
XhoI and Hind III sites of pGL3-basic. 5 deletion plasmids such as pO-1896luc, pO-
1192luc, pO-1038luc, pO-813luc and pO-554luc were generated by digesting pO-
2091luc with the restrictions KpnI, PstI, SmaI, SwaI and SpeI, respectively, followed by 
dephosphoration and religation. In addition, pO-1525luc was synthesized by cloning 1.5 
kb promoter fragment into pGL3-basic digested with KpnI and Hind III sites. The three 
deletion plasmids: pO-911luc, pO-349luc and pO94luc were also created by cloning 
different promoter fragments into XhoI and Hind III sites of pGL3-basic. Expression 
vector pCMV-OlOct4 was constructed by inserting the open reading fream of OlOC4 into 
the EcoRI and NotI sites of pCMVpr. To generate several tanderm repeat mutants, 
complementary pairs of synthesized oligonucleotides were annealed, phosphorylated, 
ligated, blunted, and inserted into the KpnI site of pTATA-Tkluc. The sequences of the 
sense and antisense strand of the oligonucleotides were shown in Fig. 3-23A. Plasmids 
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2.2.5.2 Cell culture 
2.2.5.2.1 Culture conditions 
Medaka stem cells were cultured in specific embryonic stem cell medium 4 (ESM4: 
Hong et al., 1996). ESM4 was based on Dulbecco's modified Eagle's medium (GIBCO) 
supplemented with15% heat-inactivated fetal bovine serum (GIBCO) Supplemented with 
15% heat-inactivated fetal bovine serum, 1 mM sodium pyruvate, 2 nM sodium selenite, 
0.05 mM 2-β-mercaptoethanol (GIBCO), 2 mM L-glutamine (GIBCO), 1 mM minimal 
essential medium with nonessential amino acids (GIBCO), 5,000-U/ml penicillin-
streptomycin (GIBCO), and 10 ng/ml of human fibroblast growth factor b (bFGF) 
(Chemicon,), with the additional self-made 1% fish serum andmedaka embyo extracts (1 
embryo/ml). The cells were maintained in 0.1% gelatin-coated plates or dishes at 28°C 
without CO2. As cells grow and divide, nutrients and growth factors are depleted from the 
cell culture. Thus, the cell culture periodically needs to be subcultured.  Monolayer cells 
were washed by PBS, treated with Trypsin-EDTA solution and then splitted into two 
parts.  
2.2.5.2.2 Freezing and thawing of the cells 
For the adherent cells that are growing rapidly and confluent, fresh medium was needed 
to add into dishes the day before freezing. Cells were washed once with PBS, loosened 
by treating with Trypsin-EDTA solution (1 ml/10-cm dish) for 2 min at RT. Following 
the removal of the trypsin solution, 5 ml of culture medium was added, the cells were 
thoroughly pipetted for dispersion. The cells were counted, collected by centrifugation 
for 5 min at 500 rpm and adjusted to 2 × 106 cells/ml by the ice-cold normal medium. 
Then equal volume of precooled medium containing 15% FCS and 20% DMSO was 
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slowly added and gently mixed. The cell suspension was aliquoted (1.8 ml) into the pre-
chilled 2 ml tube (Nalgene). The tubes were slowly cooled down overnight in a closed 
polystyrene box at -80ºC, and then transferred into liquid nitrogen for storage.  
For thawing, cells were thawed rapidly at 37ºC after the tube was removed from liquid N2, 
and then diluted slowly into pre-warmed growth medium in 10-cm dish. The cells were 
mixed gently pippeting and cultured under proper condition. The next day, medium was 
exchanged to remove DMSO in the freezing medium. 
2.2.5.2.3 Transfection of cells with plasmid DNA by the GeneJuice 
For transfection of cells with plasmid DNA, the GeneJuice transfection reagent (Novagen) 
was used throughout this study. Briefly, the day of transfection, adherent cells in 50−80% 
confluency were plated at serum-free ESM4 media. After incubating the mixture for 15 
min at RT, 100 µl of plasmid: GeneJuice in serum-free media (1 µg of DNA, 4 µl of 
GeneJuice) was added drop-wise directly to the cells in 24-well plates. After 8-12 h 
incubation, the cells were washed once in PBS and exchanged to complete medium. The 
cells were cultured under proper conditions for 24-72h and then harvest cells for 
characterization or reporter assays.  
2.2.5.3 Promoter analysis of Luciferase  
Promoter analysis was performed with Dual-Glo luciferase Assay System (Promega). 
This system enables the fastest and simplest, independent measurement of stable 
luminescence from two reporter genes (Firefly and Renilla luciferases) in a single sample.  
Cell transfection 
For luciferase assays, the cells were seeded at a density of 25,000 to 30,000/well in 96-
well plates (Nunclon), and vectors for reporter constructs (≈200 ng), overexpression 
Chapter II  Materials and Methods 
   64   
vectors (80 ng ), and cytomegalovirus  40-Renilla (1 ng) were transfected in triplicate 
using GeneJuice (Novagen) after the total amount of DNA had been equilibrated using 
empty vectors. Cells were incubated for 40 to 48 hr after transfection before measuring 
Luc+ activity. For cells exposed to RA (Sigma), these were added to the medium to a 
final concentration of 10 µM for 3 days before transfection. 
Firefly and Renilla luciferase assay  
Before assay, the medium in each well was replaced by 20 µl of fresh ESM4 medium 
with 9 % FCS instead of previous complete ESM4 medium (15% FCS) and also the plate 
was put at room tempreature to equilibrate the cells. For measuring firefly luciferase 
activity, 20 µl of Dual-Glo Luciferase reagent equal to the culture medium volume was 
added to each well and mixed. After the plate was incubated at least 10 min, the firefly 
luminescence was measured in the Veritas  Microplate luminometer (Turner- 
Biosystems). For measuring Renilla luciferase activity, 20 µl of Dual-Glo Stop & 
Glo® Reagent (1:100 dilution of substrate to buffer) equal to the original culture medium 
volume was added to each well and mixed. Then, the Renilla luminescence was measured 
in the same plate order as the firefly luminescence was measured, after the plate was 
incubated at least 10 min.  
Calculation and statistical analysis  
The ratio of luminescence from the experimental reporter construcys to luminescence 
from an internal control reporter was calculated. A comparison of this ratio to a control 
sample was made to normalize so that relative activity values were normalized. Relative 
Response Ratios can then be calculated from the normalized ratios. As a result, reporter 
gene activity was calculated, after normalization, as activity (n-fold) over that in 
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untreated controls. One-way analysis of variance (ANOVA) followed by Bonferroni's or 
Welch's t test were employed to determine means that were statistically different. 
Differences were considered significant when P was <0.05. All experiments were 
repeated at least three times, and representative individual experiments or compiled 
results are presented. 
2.2.6 Gene transfer into fish embryos and expression analysis in vivo 
Medaka eggs were harvested from matings of wildtype fish 10 min after the appearance 
of the first fertilized eggs. Embryos were put into a petridish with 5 ml of ERM solution 
and remaining traces of attachment filaments of embryos are removed manually by 
forceps. Isolated embryo were transferred to agar coated petridish (1.5% agarose in water) 
filled with 1 × Yamamoto Ringers solution (7.5 NaCl, 0.2 KCl, 0.2 CaCl2, 
0.02 NaHCO3) with groove (1 × 0.9 mm) to fix the embryos. Then, promoter construct 
linked with GFP or RFP (50 µg/ml in Ringers solution with 0.1% phenol red) was 
microinjected into 1-2 cell stage of embryos in 1 × Ringers solution through a self-made 
microinjector mounted on the micromanipulator with microscope (Leica, Germany). The 
injected embryos were transferred to hatching solution and kept at 28°C till hatching. 
Expression in the different-staged embryos regulated by the inserted promoter was 
directly observed via fluorescense microscope (Leica, Germany). 
2.2.7 Miscellaneous 
 
2.2.7.1 Microscopy and photography 
 
Images of frozen sections were taken using a Zeiss AxioCam MRc digital camera 
mounted on a Zeiss Axiovert invert microscope equipped with optics for phase contrast 
and DIC. AxioVsion 4 software was used to capture color images. Embryos were 
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visualized using a Leica MZFLIII stereo microscrope and photographed using a Nikon 
digital camera (Nikon Corp.).  
2.2.7.2 Promoter sequence analysis 
Putative DNA motifs and the transcription factor binding sites were predicted by 
MatInspector, TFSEARCH, Multiple Em for Motif Elicitation (MEME, 
http://meme.sdsc.edu/meme/meme.html), and Transcription Element Search System 
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Chapter III    Results 
3.1   Cloning and characterization of medaka oct4 
 
3.1.1 Cloning and identification of medaka oct4 cDNA 
To isolate oct4 cDNA from medaka, a pair of degenerate primers, Pou5 and Pou3 were 
designed complementary to the most conserved POU domain among known members of 
Oct4 family and used to amplify the cDNA fragments from the midblastua-staged 
embryos (Fig. 3-1). With BLAST searches in GenBank databases, the amplified cDNA 
fragment showed high similarity to zebrafish pou2 (an ortholog to mouse oct4; Takeda et 
al., 1994). This sequence was allowed to use 3 and 5 RACE-PCR to amplify a full-
length of cDNA. The full-length cDNA clone is 2412 bp in length containing a 1407-bp-
long open reading frame (ORF) (Fig. 3-2; Gene Bank Accession No. AY639946). This 
cDNA sequence (named as Oloct4) showed no clear similarity with any medaka EST 
sequence in medaka databases. 
Oloct4 predicts a protein of 469-amino acids with a calculated molecular weight of 51 
KD. Sequence alignment analyses of putative medaka Oct4 with several Oct4 proteins 
revealed that medaka Oct4 has a conserved POU domain composed by two structurally 
independent subdomains: POU specific domain (POUs) and POU homeodomain (POUh) 
(Fig. 3-3). POU domain in mouse Oct4 was shown to be required for the maintainance of 
ES cell self-renewal (Niwa, 2002). A comparison of sequence in POU domain of OlOct4 
with with those of known members of the POU domain proteins indicated that OlOct4 
share 94% identity in the POU domain with the zebrafish Oct4, and the percentage 
identity in POU domain between OlOct4 and its other counterpart (eg. axolotl, bovine, 
mouse and human) is over 70% (Table 3). However, relatively low homology of the 
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amino acid sequences outside the POU domains is quite low, which is also a common 
feature among the Oct4 proteins (Table 3). In addition, OlOct4 has a relatively high 
degree of sequence similarity to the class III POU domain protein (Brn-1): 67% identity 
in the whole POU domain, 81% identity in the POUs, 68% identity in the POUh, and 
16% in the linker region (data not shown). However, within Class V type proteins (Oct4), 
the POUs subdomains have >85% identity and the POUh subdomains have >75% 
identity. Therefore, on the basis of the amino acids sequence similarity in these two 
subdomains and whole POU domains, OlOct4 seems to belong to Oct4 group. By 
comparison with other known Oct4 sequences, results showed that the overall sequence 
of OlOct4 shared 67% homology with the zebrafish Pou2 and ~41% with mouse Oct4 
(Table 3). The level of sequence identity seems to be typical in the POU family, e.g. the 
zebrafish Brn-2 shares only 52.1% identity with the mouse Brn-2; the zebrafish Pou2 is 
30% identical to the mouse Oct4 over the entire sequence. Thus, multiple sequence 
alignments support that the medaka OlOct4 is likely a homolog of the human and mouse 
Oct4. 
To determine the phylogenetic relationship among members of Oct4, overall sequences 
were analyzed by the phylogenetic program of distance calculated by the DNAMAN 
software. As shown in Fig. 3-4, OlOct4 is clustered in the clade of mammalian Oct4 and 
its putative counterparts from axolotl and zebrafish. It is not grouped into a member of 
POU transcription factors, mouse Oct-1. Thus, phylogenetic analyses further support that 
medaka Oloct4 may represent a homolog of the human and mouse oct4. 
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Degenerate PCR
Extraction of total RNA
1st strand cDNA synthesis





 G  Y T  Q  A  D  V  G 
GGNKWYACICARGCIGAYGTIGG
 W  F  C  N  R  R  Q   
TGGTTYTGYAAYIMGNCARAA 
Seq known by degenerate PCR  
5- -3
d(T)






Fig. 3-1. Cloning strategy of the medaka oct4. The left part shows the general strategy for synthesis of a 
full-length cDNA. The Right part indicates the cloning strategy of degenerare and RACE PCR.
Degenerate primers for amplication of oct4 fragment, Pou5 & Pou3, were designed based on highly
conserved regions in the POU domain comprised by two subdomains (POUs &POUh), as shown in red. 
The corresponding primer sequences are shown below the selected amino acids sequences, N=A, C, G or
T; R=G or C; Y=C or T. The sequence of amplified fragment is also shown in alighment with the
counterpart sequences from zebrafish, mouse and human. Two gene specific primers, PR52 and PR53 
were designed based on the obtained fragment and they were used in combination with the Clontechs
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                                  1    CTGATTGGGAAAACCTGTGGGGCCAGAAGCTCAGATGATCATTTGAGCTTGAAGGT 
91   GAGCTGCATCTTATGGGCTTAATGGAGTCCGCCGCAGCTTTGGTTATGTCTCACTAAAAAGCTGCGCCATTTTCAGAAACTGCAGGGGAG 
148  ATGTCTGACAGGCCGCACAGCCCCGGGTCCAAAGTCCGGACCTACGACTTCAGCCGGGCTTGCAACCAGGTTTTGGATCAGGAAAGTTTG 
1     M  S  D  R  P  H  S  P  G  S  K  V  R  T  Y  D  F  S  R  A  C  N  Q  V  L  D  Q  E  S  L   
238  GGGAACTCTTCGTCTTTCCACTTCTCTCCTATGCTAACGGATCCGGGCCTGCTCTACAACAAGCCCACTTATGGCGGCATCACGCCCGCA 
31    G  N  S  S  S  F  H  F  S  P  M  L  T  D  P  G  L  L  Y  N  K  P  T  Y  G  G  I  T  P  A   
328  TCCACGCAGGGCTTTTTCCCGTTTCCCCACGTCACTAGTGACTACCGGGGATCCGAGCTGCAGGCTGGGGAGTTCGGCCAACCGAAGCAT 
61    S  T  Q  G  F  F  P  F  P  H  V  T  S  D  Y  R  G  S  E  L  Q  A  G  E  F  G  Q  P  K  H   
418  TGGTATCCGTTCGCTGCGCCCGAGTACACTGGCCAGGTACCCGGCGCGACTGCAGCCACCCAGCCCTCTAACCTCAGCCCCCCAATAGCC 
91    W  Y  P  F  A  A  P  E  Y  T  G  Q  V  P  G  A  T  A  A  T  Q  P  S  N  L  S  P  P  I  A   
508  CAGACCCGAGAACAGATCAAAATGCCCGAAATCAAGATTGAGAAGGACACGGATGAGGAGTATTCAACGGAGATGAGGGTTCAGCAGTAC 
121   Q  T  R  E  Q  I  K  M  P  E  I  K  I  E  K  D  T  D  E  E  Y  S  T  E  M  R  V  Q  Q  Y   
598  CCCACGTCCTCTGCGCCCATGCCCCATGGGGTCTTCTACCCTGCGGCCTGGAATCCGTCCTTGTGGCCCGGGATCACCCACATTGCGCCA 
151   P  T  S  S  A  P  M  P  H  G  V  F  Y  P  A  A  W  N  P  S  L  W  P  G  I  T  H  I  A  P   
688  CCTGGAAGCAGCAACCAGCTCCCCACGATGTCCTCCATACCCTCCCCATCCATGTCTCCTTCGCCCCCAAACAACGCGGCCCCAGGGGCC 
181   P  G  S  S  N  Q  L  P  T  M  S  S  I  P  S  P  S  M  S  P  S  P  P  N  N  A  A  P  G  A   
778  CCGGCTTTCTTTGGCGTAAACTCGTCTCAAGGAGCCGCGGAGCCGCAAGCGCAGAACCCGACCTCCACGCGGAGCAGCGGGTCATCCAGT 
211   P  A  F  F  G  V  N  S  S  Q  G  A  A  E  P  Q  A  Q  N  P  T  S  T  R  S  S  G  S  S  S   
868  GGGGGCTGCAGCGACTCTGAGGAGGAGAACCTTTCAACAGAGGAGCTGGAGCAGTTCGCGAAGGAGCTGAAACACAAAAGGATCACTTTG 
241   G  G  C  S  D  S  E  E  E  N  L  S  T  E  E  L  E  Q  F  A  K  E  L  K  H  K  R  I  T  L   
958  GGTTTTACGCAAGCAGATGTTGGCCTTGCATTGGGGAATCTATATGGTAAGATGTTCAGCCAGACAACAATTTGCCGCTTTGAGGCTTTA 
 
271   G  F  T  Q  A  D  V  G  L  A  L  G  N  L  Y  G  K  M  F  S  Q  T  T  I  C  R  F  E  A  L 
   
1048 CAGCTGAGCTTCAAGAACATGTGCAAGCTGAAGCCCCTTCTCCAGAGATGGCTAGATGAAGCAGAGACTTCAGAAAATCCCCAGGACATG 
 
01   Q  L  S  F  K  N  M  C  K  L  K  P  L  L  Q  R  W  L  D  E  A  E  T  S  E  N  P  Q  D  M   
1138 TACAAAATTGAGCGCGTATTTGCTGACACCAGGAAGAGGAAGCGGAGGACCAGTCTGGAGGGAGCGGTGCGTTCTGCTCTGGAGGCGTAC 
331   Y  K  I  E  R  V  F  A  D  T  R  K  R  K  R  R  T  S  L  E  G  A  V  R  S  A  L  E  A  Y 
   
1228 TTCATCAAGTGCCCTAAACCAAATACTCAGGAGATCACACACATATCAGACGATCTGGGTTTGGAGAGAGACGTGGTGCGTGTTTGGTTC 
 
361   F  I  K  C  P  K  P  N  T  Q  E  I  T  H  I  S  D  D  L  G  L  E  R  D  V  V  R  V  W  F 
   
1318 TGCAACCGGAGACAAAAAGGAAAGCGTTTGGCCTTGCCCCTAGATGAGGAGGGCGATATCCAGTACTATGAGCAGAGTGCGTCTCCACTC 
 
391   C  N  R  R  Q  K  G  K  R  L  A  L  P  L  D  E  E  G  D  I  Q  Y  Y  E  Q  S  A  S  P  L   
1408 AACCTGGCACATTCTCCCATTACCACTCAAGGCTACCCACCGTCTGGATATCCCGGAGCCCCCCCACAACTCTACATGCCCCAGCTTCAC 
421   N  L  A  H  S  P  I  T  T  Q  G  Y  P  P  S  G  Y  P  G  A  P  P  Q  L  Y  M  P  Q  L  H   
1498 CGACCTGATGTAATGAAACCAGGCCTGCATCCTGGACTGGTAGGTCACCTGACAGGATGATGGGAGACACTGCAGGCCTCCACCCATTCA 











     AAAAAAAAAAAAAAAA 
 
Fig. 3-2.  Sequences of Oloct4 cDNA and its deduced protein. Numbering of nucleotides and protein  sequence is   
indicated on left side. The stat codon ATG is boxed while the Stop codon TGA is indicated by asterisk. The two 
subdomains POUs and POUh are underlined and highlighted. The sequences for primers design are boxed and 
indicated by arrows. Pou5/Pou3 pair primers are or degenerate PCR, PR52 or PR53 together with UPM (universe 
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     POU specific domain 
 Linker      POU homeodomain 
    BvOct4    (1) ----------------------------------------------------------MAGHLASDFAFSPPPG-GGGDG 
  HuOct4    (1) ----------------------------------------------------------MAGHLASDFAFSPPPG-GGGDG 
  MuOct4    (1) ----------------------------------------------------------MAGHLASDFASSPPPG-GG-DG 
  AxOct4    (1) ---------MAGHLGQEIGRAAYGFGAQALHLGAGGLEAGG------------PGFLSESYGPYAGFKALEYAH-GGAEG 
  XOct25    (1) ----------------MYSQQPFPAFAFNAGLMQDPANCHFG------------GYTGLGHPQPFSFAFSTLKSENGESG 
  ZfOct4    (1) MTERAQSPTAADCRPYEVNRAMYPQAAGLDGLGGASLQFAHGMLQDPSLIFNKAHFNGITPATAQTFFPFS----GDFKT 
  OlOct4    (1) MSDRPHSP-GSKVRTYDFSRACN-QVLDQESLGNSSSFHFSPMLTDPGLLYNKPTYGGITPASTQGFFPFPHVT-SDYRG 
                81                                                                           160 
  BvOct4   (22) PGGPEPGWVDPRTWMSFQGPPGGSGIG------------PGVVPGAEVWGLP---------------------------- 
  HuOct4   (22) PGGPEPGWVDPRTWLSFQGPPGGPGIG------------PGVGPGSEVWGIP---------------------------- 
  MuOct4   (21) SAGLEPGWVDSRTWLSFQGPPGG----------------PGIGPGSEVLGIS---------------------------- 
  AxOct4   (59) EGRP-GAHGLARAWYPFSEAWGPVYGQ------------SGAGAGFESSRVEVK-------------------------- 
  XOct25   (53) VQGMGDCTTPVMPWNSLASFDHQVQMENNQQGNPPRAPSPTLSDSRIKVKEEVVHETDSGEESPEPKYPS------P--- 
  ZfOct4   (77) NDLQGGDFTQPKHWYPFAAPEFTGQVAGATAATQPANISPPIGETREQIKMPSEVKTEKDVEEYGNEENKPPSQYHLTAG 
  OlOct4   (78) SELQAGEFGQPKHWYPFAAPEYTGQVPGATAATQPSNLSPPIAQTREQIKMP-EIKIEKDTDEEYSTEMR--VQQYPTS- 
                161                                                                          240 
  BvOct4   (62) ----------PCPPPYDLCGGMAYCAPQVGVGPVPPGGLETP-----QPEGEAGAGVESNSEGAS----PDPCAAPAGAP 
  HuOct4   (62) ----------PCPPPYEFCGGMAYCGPQVGVGLVPQGGLETS-----QPEGEAGVGVESNSDGAS----PEPCTVTPGAV 
  MuOct4   (57) ----------PCPPAYEFCGGMAYCGPQVGLGLVPQVGVETL-----QPEGQAGARVESNSEGTS----SEPCADRPNAV 
  AxOct4  (100) ------------VERPDKEAGYGQQHQQAWAGYFVPQLAVPARSPASVASGGQVPAAPASPSDDSP--HSSTASSSSASP 
  XOct25  (124) -------PN-PSLYYPNAWTGAPFWQVNPTPGNNINPMPNQTLVKNTSLPGNTTYPTPANQSPNTPVDCVTSSMESSRCS 
  ZfOct4  (157) TSSVPTGVNYYTPWNPNFWPGLSQITAQANISQAPPTPSASSPSLSPSPPG-NGFGSPGFFSGGTAQNIPSAQAQSAP-- 
  OlOct4  (154) SAPMPHGVFYPAAWNPSLWPGITHIAPPGSSNQLPTMSSIPSPSMSPSPPNNAAPGAPAFFGVNSSQGAAEPQAQNPTST 
 
                241                                                                          320 
  BvOct4  (123) KLDKEK----------------LEPNPEESQDIKALQKDLEQFAKLLKQKRITLGYTQADVGLTLGVLFGKVFSQTTICR 
  HuOct4  (123) KLEKEK----------------LEQNPEESQDIKALQKELEQFAKLLKQKRITLGYTQADVGLTLGVLFGKVFSQTTICR 
  MuOct4  (118) KLEK------------------VEPTPEESQDMKALQKELEQFAKLLKQKRITLGYTQADVGLTLGVLFGKVFSQTTICR 
  AxOct4  (166) DLGAGG----------------APRDLDSGDEEGGTSADLEQFAKELKQKRITLGFTQADVGLALGALYGKMFSQTTICR 
  XOct25  (196) STNSPNGAINERATTIPNGEMLDGGQSSDNEEEVPSESEMEQFAKDLKHKRVSLGYTQADVGYALGVLYGKMFSQTTICR 
  ZfOct4  (234) RSSGSS----------------SGGCSDSEEEETLTTEDLEQFAKELKHKRITLGFTQADVGLALGNLYGKMFSQTTICR 
  OlOct4  (234) RSSGSS----------------SGGCSDSEEE-NLSTEELEQFAKELKHKRITLGFTQADVGLALGNLYGKMFSQTTICR 
 
                321                                                                         400 
  BvOct4  (187) FEALQLSFKNMCKLRPLLQKWVEEADNNENLQEICKAETLVQAR-KRKR-TSIENRVRGNLESMFLQCPKPTLQQISHIA 
  HuOct4  (187) FEALQLSFKNMCKLRPLLQKWVEEADNNENLQEICKAETLVQAR-KRKR-TSIENRVRGNLENLFLQCPKPTLQQISHIA 
  MuOct4  (180) FEALQLSLKNMCKLRPLLEKWVEEADNNENLQEICKSETLVQAR-KRKR-TSIENRVRWSLETMFLKCPKPSLQQITHIA 
  AxOct4  (230) FEALQLSFKNMCKLRPLLQRWLVEADTNENLQELCNLENALQQARKRKR-TSIENSVKDNLEAFFLKCPKPTHQEIAHIS 
  XOct25  (276) FESLQLSFKNMCQLKPFLERWVVEAENNDNLQELINREQVIAQTRKRKRRTNIENIVKGTLESYFMKCPKPGAQEMVQIA 
  ZfOct4  (298) FEALQLSFKNMCKLKPLLQRWLNEAENSENPQDMYKIERVFVDTRKRKRRTSLEGTVRSALESYFVKCPKPNTLEITHIS 
  OlOct4  (297) FEALQLSFKNMCKLKPLLQRWLDEAETSENPQDMYKIERVFADTRKRKRRTSLEGAVRSALEAYFIKCPKPNTQEITHIS 
 
                401                                                                          480 
  BvOct4  (265) QQLGLEKDVVRVWFCNRRQKGKR--SSSDYSQRE----DFEAAGSPFTG-------------GPVSSPLAPGPHFGTPGY 
  HuOct4  (265) QQLGLEKDVVRVWFCNRRQKGKR--SSSDYAQRE----DFEAAGSPFSG-------------GPVSFPLAPGPHFGTPGY 
  MuOct4  (258) NQLGLEKDVVRVWFCNRRQKGKR--SSIEYSQRE----EYEATGHLSQGGLYPFLCPQVPTLAPQAMEAPTSPHSTQSLF 
  AxOct4  (309) EDLNLEKDVVRVWFCNRRQKGKR--SICREEYDGFQQYPGMQPGPP-----------------ALSHLPTSYIAQGYNGA 
  XOct25  (356) KELNMDKDVVRVWFCNRRQKGKRQGMPTVEENDGEGYDVAQTMGSP-----------------PVGHYALQQVVTPQG-- 
  ZfOct4  (378) DDLGLERDVVRVWFCNRRQKGKR--LALPFDDECVEAQYYEQSPPPP---------------PHMGGTVLPGQGYPGPAH 
  OlOct4  (377) DDLGLERDVVRVWFCNRRQKGKR--LALPLDEEG-DIQYYEQSASP----------------LNLAHSPITTQGYPPSGY 
                481                                        526 
  BvOct4  (326) GGPHFTTLYSSVPFP------EGEVFPSVSVTALGSPMHAN----- 
  HuOct4  (326) GSPHFTALYSSVPFP------EGEAFPPVSVTTLGSPMHSN----- 
  MuOct4  (332) LRARPFPLFPSLLWALPCIQTEAPALPGDAVSQGKGGRQENLELWG 
  AxOct4  (370) AAAFAAVYMQPFHDS------------EMYSQTVSRHLHSN----- 
  XOct25  (417) YMAAPQIYASAFHKN--------DLFPQTVPHGMAMGGHIG----- 
  ZfOct4  (441) PGGAPALYMPSLHRP--------DVFKNGLHPGLVGHLTS------ 
  OlOct4  (438) PGAPPQLYMPQLHRP--------DVMKPGLHPGLVGHLTG------ 
 
 
Fig. 3-3. Alignment of medaka Oct4 protein and its homologs. Analysis of putative medaka Oct4 protein (OlOct4) with bovine (BvOct4), human 
(HuOct4), mouse (MuOct4), axolotl (AxOct4), Xenopus (XOct25) and zebrafish (ZfOct4) POU V proteins was carried out by VectorNTI.  
Identical (Red) and similar (blue) residues identified by the program were indicated; POU specific and homeodomains are in frame; the linker 
regions between two domains are showed by dot line; arrows indicated the boundary between two exons. For the amino acid sequences used in this 
figure, please refer to corresponding Genbank accession numbers in legends of Fig. 3-5.  
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Tabel 3 Identity between Oct4 proteins 
          













Fig. 3-4. Phylogenetic relationship of medaka Oct4. GenBank accession numbers foolow the organisms. 
The bootstrap confidence values shown at the nodes of the tree were based on 100 bootstrap replicates. The 
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3.1.2 RNA expression of medaka oct4  
3.1.2.1. Expression patterns by RT-PCR 
RTPCR analysis was carried out to detect medaka oct4 transcriots using total RNA from 
developing embryos, adult tissues and cell lines. As shown in Fig. 3-5A, expression of 
Oloct4 was found at high level in ovary, intermediate level in brain and very low level in 
testis. No expression was seen in other tissues such as intestine, heart, skin and kidney. 
During early embryogenesis (Fig. 3-5B), Oloct4 transcripts appeared soon after 
fertilization. Subsequently, it persisted at high level until mid-blastula stage. It decreased 
greatly from gastrulation onwards and eventually disappeard at 28-somite stage. In 4 cell 
lines (Fig. 3-5C), Oloct4 was expressed at moderate level in medaka embryonic stem 
(MES1) cells and at low level (a faint band seen with eyes) in adult spermatogonia stem 












Fig. 3-5. Expression of Oloct4 in tissues (A), embyos (B) and cell lines (C). The Oloct4 cDNA sequence 
was amplified by RT-PCR using primers complemetary to exon 5 and partial 3UTR. Cytoplasmic β-actin 






































































































Chapter III                                                                                       Results-Medaka oct4  
   74   
3.1.2.2. Spatiotemporal RNA expression during embryogenesis 
To examine the expression pattern of Oloct4 during embryogenesis, whole-mount in situ 
hybridizations (WISH) was carried out using a digoxigenin-labeled Oloct4 antisense 
probe containing part of Oloct4 exon 1 and 2, with a sense Oloct4 probe as a negative 
control. Positive control hybridizations were performed with an antisense probe for 
paired homeobox 6 (pax6) or for germ cell marker gene vasa.  
Oloct4 transcripts were found at the early stages of embryogenesis assayed (Fig. 3-6) 
including the one cell stage (data not shown). Oloct4 was ubiquitously expressed in 
embryos at 4-cell stage (Fig. 3-6A). These transcripts must be maternally contributed 
since there is no transcription prior to midblastula transition in medaka (Aizawa et al., 
2003). This was also supported by high expression of Oloct4 in ovary by RT-PCR. The 
transcripts were envenly distributed in the undifferentiated cells of blastoderm at 
midblastula stage 11 (Fig. 3-6B, C). At this stage weak Oloct4 was also present in the 
marginal cells of the blastoderm (Fig. 3-6B, C). When the gastrula has covered 1/3 of the 
yolk sphere in embryos (stage 14), Oloct4 expression was limited to the dorsal layer of 
the embryos and strong in embryonic shield which arises from blastoderm (Fig. 3-6D, E). 
At late gastrula (stage 16), Oloct4 was reduced (Fig. 3-6F). When rudimentary head 
forms in the embryonic body of embryos (stage 17), Oloct4 increased in the entire 
embryonic body (Fig. 3-6G). In embryos at 2-somite stage (stage 19), Oloct4 was weak 
in midbrain and hindbrain, but strong in areas close to notochord (Fig. 3-6H). In control 
embryos, Olpax6 was strong in eye, forebrain and hindbrain but weak in notochord (Fig. 
3-6P). However, in embryos at 6-somite (stage 21), Oloct4 expression became prominent 
in the telecephalon, midbrain and tailbud (Fig. 3-6I). Gradually, expression was 
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concentrated in the midbrain and tailbud of the embryos at stage 24 (Fig. 3-6J, K). In 
embryos at stage 26, Oloct4 expression was only distinct in the tailbud (Fig. 3-6L). In 
embryos from stage 27 onwards, expression was not detected (data not shown). Mouse 
oct4 was expressed in PGCs of early embryos (Pesce et al., 1998). Intriguingly, Oloct4 
was not detected in the early gonad region of the embryos at stage 32 (Fig. 3-6M), where 
medaka vasa, a germ-cell specific gene was present in this region (Fig. 3-6N). The 




Fig. 3-6. In situ hybridization of Oloct4 during embryogenesis. Embryonic Oloct4 RNA expression was 
detected by whole mount in situ hybridization. A-M, Hybridization with an antisense Oloct4 RNA 
probe. N, Hybridization with an antisense Olvasa RNA probe. O, Hybridization with a sense Oloct4 
RNA probe. P, Hybridization with an antisense medaka pax6 RNA probe. ea: otic (ear) vesicle; em,
embryonic body; es, embryonic shield; ey, eye; fb, forebrain; kv, Kuffers vesicle; ic, inner cell; mc, 
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3.1.2.3 Spatiotemporal RNA expression during gametogenesis 
Mouse oct4 was only expressed in germ cells of adult tissues, not in somatic tissues 
(Scholer et al., 1990). To address the question as to whether Oloct4 transcripts were also 
in female and male germ cells during gametogenesis, the spatiotemporal expression was 
examined by in situ hybridization. WISH using antisense RNA probe revealed that the 
Oloct4 RNA was in individual cells in the peripheral region of adult testes where 
spermatogonia are located (Fig. 3-7A). This indicated Oloct4 expression is limited in 
stem cells of testes. In the ovary, Oloct4 was also limited in germ cells (Fig. 3-7B). In 
contrast to restricted expression spermatogonia, Oloct4 is expressed throughout oogenesis.   
Oloct4 mRNA signals were strong in stage I and II oocytes (Fig. 3-7C). When oocytes 
developed to previtellogenic stages, the signals were high and homogeneous in the cells 
(Fig. 3-7C,).  In oocytes where vitellogenesis proceeded into the midvitellogenic stage, 
the signals was reduced to the animal hemisphere (Fig. 3-7C) and later concentrated to 
the animal pole (Fig. 3-7C).  In matured oocyte, Oloct4 transcripts were barely detectable 
(Fig. 3-7D). By in situ hybridization on ovary sections, subcellular localization of the 
Oloct4 was detected. In stages I and II, the transcripts are found throughout the cytoplasm 
and a stronge signal was present in oocytes (Fig. 3-7E).  In stage III oocytes, signal was 
detected weak throughout the cortex (Fig. 3-7F) while in ealrly stage IV oocytes, the 
mRNAs were condensed to the cortex of animal pole, which is the position containing 
newly migrated Germinal Vesicle (GV) (Fig. 3-7G). A sense probe did not give rise to 
staining (Fig. 3-7H). Therefore, Oloct4 expression in ovary reaches its peak at the 
previtellogenic stage and changes its localization around the entire cell to along the 
cortex region near animal pole. These expression patterns suggested that Oloct4 are 
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active during oogenesis, particularly at the early stages of oocytes development. These 
results are consistent with the previous observations in zebrafish oct4 (Howley etal., 
2000), axotol oct4 (Bachvarova  et al., 2004) and the mammalian oct4 that was in 
oogonia and in oocytes of growing follicles or GV-staged oocytes, but not in early 
meiotic oocytes (Pesce etal., 1998; Van Eijk etal., 1999).  
 
 







Fig. 3-7. In situ hybridization of Oloct4 during embryogenesis. A, Testis after whole mount in situ 
hybridization. The signal is seen in individual cells in the periphery where spermatogonia are located.
B-D, Ovary after whole mount in situ hybridization. The signal is strong and uniform in early oocytes (I
and II), werker and localized in advanced oocytes (III) and nearly undetectable in maturaing oocytes 
(IV) E-G, Ovary sections after in situ hybridization showing subcellular distribution of Oloct4 RNA in
oocytes at different stages. An antisense Oloct4 RNA probe was used for A-G. H, Ovary section after in 
situ hybridization with a sense probe as the negative control. Roman numerals indicate stages of 
oocytes (not all oocytes are marked). AP, Animal pole. Red star points micropyle at the animal pole
where sperm enter into an egg.  
 
*AP 
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3.1.3. Expression of medaka Oct4 protein  
 
3.1.3.1 Production and Characterization of medaka Oct4 antibody  
A polyclonal antibody was generated against linker sequences between two subdomains 
of medaka Oct4. Immunisation was been carried out according to a standard protocol 
(Biogenes, Germany). After immunisation of two rabbits 5 week, enzyme-linked 
immunosorbent assay (ELISA) was performed to determine whether antibody in 
collected serum can efficiently bind to peptide antigen. Antiserum of each individual 
rabbit was titered by serial dilution from 1/100-1/218,700 in plates. As a control, 
preimmune-serum was tested in parallel. Following incubation with antigen and anti 
rabbit peroxidase (POD), POD substrate was added to develop color and plates was read 
at 450 nm. As shown in Fig.3-8, titer of preimmune-serum was very low (1/100) while 
titer of immune antiserum was high (>1/200,000), suggesting that concentration of 
antibody is relatively high in antiserum.  
To further characterize the specificity of antiserum, western blot was performed to detect 
endogenous Oct4 protein in medaka stem cells. Western blotting showed this antibody 
against medaka Oct4 at a dilution of 1:3000 can detect single band about 50 KD in whole 
cell lysates from two stem cells (MES1 and SG3) (Fig.3-9). The detected protein band 
was consistent with the calculated molecular weight of 51 KD. In contrast, preimmune-
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Fig. 3-8. Titration of rabit antiserum against medaka Oct4 using ELISA. Immune antsera diluted from 
1/100 to 1/218,700 were added in duplicate per well of a 96-well plate coated with peptide-BSA-conjugate 
and incubated with anti-rabbit lgG-POD. The plate was read at 450 nm to measure the absorption of the 
color enzymatic reaction after adding POD substrate. As a control, preimmune sera diluted at 1/100, 1/300 










Fig. 3-9. Protein expression of medaka Oct4 by western blot. Cell lysates from MES1 and SG3 cells were 
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3.1.3.2 Medaka Oct4 expression by immunofluroscense 
To examine whether OlOct4 protein is expressed in oocytes from developing follicles or 
in other cells of the adult ovary, the expression of OlOct4 protein was examined by 
immunoflurescence on ovary sections incubated with an antibody against OlOct4 and 
FITC-conjugated goat anti-rabbit IgG (green fluroscence), respectively. In ovaries from 
two weeks post-hatching medaka, OlOct4 was detected in the oogonia and cytoplasm of 
young oocytes,  but not in granulosa or other somatic cells (Fig.3-10, A-B). Similarly, in 
ovaries from two-month post-hatching medaka, OlOct4 was located in early staged 














Fig. 3-10. Immunostaining of medaka OlOct4 protein in female germ cells. Immunofluorescence of single 
ovary sections at 15-day posthatching (AB), 60-day posthatching (C-D) showing oogonia and oocytes 
labeled with OlOct4 antibody (A, C, D green). B shows no expression of OlOct4 with preserum control 
while D is enlarged picture of C (100×). Arrow in (A, C, D) shows an example of OlOct4 cytoplasmic 







Chapter III                                                                                       Results-Medaka oct4  
   81   
3.1.4. Subcellular localization of Medaka Oct4 
Mouse Oct4 protein is localized in the nucleus since it harbors a putative nuclear 
localization signal (NLS) in its POU domain (Pan et al., 2004). This cellular localization 
was examined for medaka Oct4 (OlOct4). An OlOct4EGFP fusion protein was created 
by subcloning the coding region of OlOct4 into an EGFP-containing vector, in frame 
with the EGFP coding sequence. MES1 cell line was transiently co-transfected with a 
ratio of 4:1 amount of the EGFP-tagged OlOct4-coding vector and a blank control vector 
PCMVpr containing red flurescence protein (RFP) coding sequence. After 24h 
transfection, cellular localization was observed under a flurescence microscope. Red 
signals were diffusely distributed throughout the cell (Fig. 3-11B, D), whereas green 
signals showed a limited distribution into the cells (Fig. 3-11C, F). When merged 
together, yellow signals indicate overlapping localization, compared to cells in phase 
contrast (Fig. 3-11E, G). The distribution variation between red and green signals 
indicates at least to some extent that exogenous OlOct4 is not localized in the cytoplasm, 
which coincides with another experimental result showing nuclear localization of 
endogenous OlOct4 expression in MES1 cells (Li MY, unpublished data). The cellular 
localization of OlOct4 is reminiscent of its functional character as a transcription factor 
like its mammalian orthologs (Pesce et al., 1998; Boiani et al., 2002; Pan et al., 2004; Lee 
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Fig. 3-11. Subcellular localization of OlOct4. MES1 cells were co-transfected with the pCV-Oloct4:gfp 
fusion vector and blank vector pCMVpr. Cells are imaged in phase cantrst (A). The blank vector (pCMVpr) 
shows a uniform distribution of red fluorescence throughout the cell (B and D) while the fusion protein 
(green fluorescence) is localized in the area like nucleus (C and F). Transfected cells are visualized by 
merged images of green and red flurorescence (E and G).Yellow color shows the colocalization. White 
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3.1.5. Binding of medaka Oct4 to an octamer consensus sequence  
 
The mouse Oct4 was named after its ability to bind to a classical consensus octamer 
sequence ATGCAAAT (Scholer et al., 1990). This biochemistry property was checked 
for the medaka Oct4. EMSAs were performed in such a way that the nuclear extract from 
SG3 cells transfected with OlOct4 expression plasmid, which expresses the full-length 
cDNA driven by the strong human cytomegalovirus (CMV) promoter or expresses the 
OlOct4: EGFP fusion protein, was incubated with the biotin-labeled octamer sequence 
(named as OC1 corresponding to the classical octamer sequence within the human 
immunoglobin light chain gene promoter). As shown in Fig. 3-12, when incubated with 
the nuclear extracts from cells with transfection of pCMV-OlOct4: EGFP, the OC1 
sequence formed only one major DNA-protein complex C1. The binding specificity of 
this complex was determined by the competition assay with excess unlabeled OC1 
sequence. Data revealed that complex C1 could not be competed off by 10× excess molar 
of unlabeled OC1 sequence (Fig. 3-12, lane 3) but was totally diminished with 50-fold 
excess molar of unlabeled probe (Fig. 3-12, lane 4), indicating that the complex C1 was a 
specific DNA-protein complex. Similar data was observed when OC1 probe was 
incubated with cell nuclear extracts transfected by pCMV-OlOct4 (Fig. 3-12, right panel). 
Taken together, these data indicated that medaka Oct4 protein is capable of binding the 
classical octamer motif, as would be predicted for functional POU transcription factors.  
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Fig. 3-12. EMSA of the nuclear proteins binding to the octamer consensus oligos in transfected SG3 cells. 
Protein-DNA complexes are indicated as C1 and C2. C1 is larger than C2 due to a large size of fusion 
protein OlOct4: GFP. Lane1, with the nuclear extract of transfected SG3 cells; lane 2 an 5, with the nuclear 
extract of transfected SG3 cells and the labeled oligo probes; lane 3 and 6, with the nuclear extract of 
transfected SG3 cells and the 10-fold excessive unlabelled cold oligo; Lane 4 and 7, with the nuclear 
extract of transfected SG3 cells and the 50-fold excessive unlabeled oligo to compete off with labeled oligo.  
Note that the endogenous cellular OlOct4 is not eaily detectable by EMSA (lanes 2-3, left), in consistence 
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3.1.6. The medaka oct4 gene organization and evolution 
3.1.6.1 Single copy oct4 gene 
As gene and genomic duplications are very important and frequent events in fish 
evolution (Volff and Schartl, 2003), we performed southern blot analysis to estimate the 
gene copy number for the oct4 gene in medaka. Medaka genomic DNA digested with 
BamHI, BgI II, EcoRI and HindIII was gel fractionated and hybridized 3′-probes 
representing exons 4, 5 and partial 3UTR of oct4 cDNA, respectively. Single bands were 
found in the experiments (Fig. 3-13). These bands correspond to restriction fragments 
predicted from the oct4 gene map (data not shown). Moreover, probe hybridized to single 
genomic restriction fragments, indicating that oct4 may be present in medaka genome as 
a single copy gene. 
3.1.6.2. Exonintron structure of oct4 gene 
Further searches in medaka genomic database by the Oloct4 cDNA sequence revealed 
one Scafford and its genomic structure is basically similar to that of mouse oct4 (Sooden 
et al., 2001). The medaka oct4 gene matched to Scaffold483 (Gene Bank Accession 
No.DF069692) is located in chromosome 12 and spans a genomic region of over 3 kb 
consisted of 6 exons and 5 introns.  
Comparison of the exonintron organization medaka oct4 gene with that of oct4 genes in 
mouse,  human, zebrafish are shown in Fig. 3-14. The oct4 homologues contain similar 
numbers of intros and exons in structure and position, and the sizes of them are almost 
identical in the exons which encodes POU domain. The sizes of exons for the POU 
domain (112, 131, and 165 bp) are completely identical in medaka and zebrafish, while 
these corresponding sizes are 121, 131 and 159 bp, respectively, in mouse and human. 
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Especially, among them, the exon of 131 bp encodes helix B part in POU specific domain, 
which is very important for DNA-binding ability of Oct4. The similarities in these exons 
reflect the previous results showing high identity in POU domain of Oct4 proteins. In 
addition, the exonintron boundaries of the medaka oct4 gene are very similar but 
different from those in mammalian and zebrafish oct4. All medaka oct4 exon/intron 
splice junctions belong to the predominant gt-ag class of junctions, similar to those 
counterparts in mouse, human and zebrafish. The 5′ end of medaka Oloct4 gene has one 
more exon and intron than the other homologues, which is generated by alternative 
splicing in 5UTR, so its ATG codon is present in exon 2. Moreover, in agreement of its 
genome of smaller-size, the introns in medaka oct4 are much smaller than those in its 
counterparts from mouse, human and zebrafish (Fig.3-14).  
In addition, Oloct4 cDNA contains 2 nucletides (GG) in the corresponding sites of the C-
terminal POUh domain (VVRVW), instead of one potential 3 acceptor site (AG) like its 
zebrafish homolog, pou2 (Fig. 3-15). This may exclude the possibility of additional 
isoform production like zebrafish pou2. There are two pou2 cDNAs in zebrafish. pou2 is 
generated by the use of the proximal 3splice site in intron, whereras t-pou2, an 
alternatively spliced form of the pou2 is generated by the use of the distal 3 splice site 
(AG) in the POUh domain (Takeda et al., 1994).   
3.1.6.3. Conserved synteny between oct4 genes  
 
A recent study demonstrated that there is conserved oct4-clic1 (a) synteny in zebrafish, 
mouse and human (Morrison and Bricman, 2006). To provide eveidence that the Oloct4 
is indeed the ortholog of the mammalian oct4, genes adjacent to the Oloct4 was searched 
by blasting up- and downstream genomic sequences of the Oloct4 locus at Scaffold 483 
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in chromosome 12 against an EST database (http://medaka.lab.nig.ac.jp) or NCBI 
database. Although several genes informative for the synteny were not identified,  fut7A 
(Gene Accession Number AJ879578) was found to be arranged with Oloct4 head to head 
juxtaposition in medaka genomic sequences and the intergenic region is about 1 kb. This 
new oct4-fut7A locus was used to further investigate the synteny relationship among the 
corresponding loci in zebrafish, mouse and human.    
By searching the oct4 genes at the NCBI database, Zebrafish (Zf) oct4 is located on the 
reverse strand of chromosome 21 (the region from 28000317 to 27995548 bp). By careful 
examining the Zfoct4 locus, fut7A was also found in the reverse upstream of oct4 and in 
the tail and tail arrangement with clica gene. Fut7A was not found near the oct4 locus of 
mouse and human genome, but clic1 gene was clustered at the same chromosome with 
oct4 from mouse and human (Muoct4 and Huoct4, respectively). In human locus, oct4 
and clic1 genes are arranged with tail to tail juxtaposition while with tail to head 
juxtaposition in mouse oct4 locus. The intergenic regions in the human and mouse 
genomes are about 556 kb and 452 kb, respectively. In addition, contiguous tap2-psmb9 
clusters exsist in the far up-stream of oct4 regions of the human, mouse and medaka. 
Other homologous genes near the oct4 gene in the both mouse and human genome 
include tcf-19, cchcr1, hla-c, psoslc2 and cdsn. However, location of these genes in 
medaka and zebrafish are currently unknown. Taken together, the relative localizations of 
tap2, psmb9, bf, clic1(a,), fut7A and oct4 in the chromosome are conserved among human, 
mouse, zebrafish, medaka (Fig. 3-16). Therefore, there is conserved synteny among oct4 
loci in human, mouse, zebrafish, medaka, i.e, human chromosome 6, mouse 17, zebrafish 
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21 and medaka 12. This highly conserved synteny strongly supports that the medaka oct4 





























Fig. 3-14. Schematic genomic structure of Oloct4. The black boxes represent exons while the gray boxes 
represent UTR. And the thin line indicates introns. The upper numbers indicate introns length (bp) and 
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Fig. 3-13. Southern blot analysis of the Oloct4. Genomic DNA was digested with
indicated restriction enzymes, electrophoresed and hybridized with a labeled Oloct4
DNA probe spanning exon 5 and part of 3UTR. The blot was washed at high
strigency conditions and exposed to X-ray film for 3 min. Size markers are shown
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                                                  pou2               CTG GAG AGA GAT GTA GTG CGT GTA TGG  
                                                                            L      E       R       D       V      V       R     V      W      
   
 zebrfish                CTG GAG AGA GAT gt.....................agGTA GTG CGT GTA TGG  
                                    L       E        R     D                                                V       V       R     V      W      
 
                                                       t-pou2                     CTG GAG AGA GAT TGC GTG TAT GGT  
                                                                                         L       E        R       D     C       V       Y      G        
 
 
  medaka             TTG GAG AGA GAC gt....................ag GTG GTG CGT GTT TGG  
                                     L     E      R       D                                                 V       V       R     V      W     
 
                                                     OlOct4           TTG GAG AGA GAC GTG GTG CGT GTT TGG  
                                                                              L       E        R       D    V       V       R     V      W      
 
Fig. 3-15.  C-terminal oct4 sequence comparison between medaka and zebrafish. Comparison of the medaka 
oct4 genomic sequence with zebrafish pou2 encoding the C-terminal POUh domain. The zebrafish pou2 can 
generate two splicing pouducts: pou2 and t-pou2 while the medaka oct4 generates only one product. The 
consensus splicing donor and acceptor sites were highlighted. Arrows indicat the 3 splicing sites. 
  
 
Fig. 3-16. Syntenic relationships of oct4-bearing chromosomes in vertebrates. Syntenic relationships 
between the medaka sequence scaffold 483, human chromosome 6, mouse chromosome 17 and zebrafish 
chromosome 21. Synteny of oct4-containing chromosome regions is showed. Genomic sequences up- and 
downstream of the Oloct4 locus were used to blast-search against NCBI database. The human, mouse and 
zebrafish chromosome maps are according to http://www.ncbi.nlm.nih.gov/mapview. A lighter dashed line 
indicates the ortholog genes around Oct4 loci, which is highlighted in red colr and linked by wighted dash 
line. Note that the gene order and transcription directions (arrows) are indicated. Cdsn, corneodesmosin; 
Psors1c2, psoriasis susceptibility 1 candidate 2; Cchcr1, coiled-coil alpha-helical rod protein 1; Tcf19, 
transcription factor 19; HLAc, major histocompatibility complex, class I, C; Clic1, chloride intracellular 
channel 1; Clica, chloride intracellular channel a; bf, complement factor B; Tap2, transporter 2; Psmb9, 
proteasome subunit, beta type 9; Fut7A, alpha3-fucosyltransferase; LOC573194, similar to polyhomeotic 
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3.1.7 Promoter sequence analyses of medaka Oct4 
By blasting the full-length sequence of medaka oct4 cDNA with the medaka sequence 
scaffold 483, the upstream promoter region was identified. The major transcription start 
site (TSS) determined by previous 5 RACE PCR, position + 1, corresponds to a cytosine 
residue at position − 245 relative to the translation start codon. To analyze the regulatory 
mechanisms controlling medaka oct4 gene expression, the 5′-flanking region at 
nucleotide − 2091 to + 28 from genomic DNA was cloned and sequenced (Fig.3-17).  
The promoter of medaka oct4 gene is A+T rich (60%) which is similar to zebrafish pou2 
(ZfOct4) gene (unpublished data), whereas the regulatory regions of mammalians oct4 
genes are often G+C rich (Nordhoff et al., 2001). This difference in the nucleotide 
compositional properties in promoter region had been described in a lot of genes between 
fish and mammals (Bermardi and Bemardi, 1990). Moreover, human, bovine, and mouse 
Oct4 promoters contain 4 highly conserved overlapping GC-rich regions: CR1-4. The 
CRs, with the exception of CR3, all contain high G+C content: 67.7%, 59.2% and 62.1% 
(Nordhoff et al., 2001). The similar CR1-4 regions in the promoter regions of Oloct4 and 
Zfoct4 genes were not identified by alignment of the corresponding promoter sequences 
of oct4.  
To search important cis-elements and potential trans-acting factors in the medaka Oct4 
promoter, comparison analysis of medaka, zebrafish, mouse and human Oct4 promoters 
was carried out using TESS and TFSEARCH. In the proximal promoter of medaka oct4, 
no typical TATA box sequence was found near the transcription start site, although three 
TATA boxes locate far upstream of TSS at -271, -226 and -149 bp, respectively. But one 
CCAAT box was present at approximately 42 bp from the TSS. In addition, a number of 
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E-box (CANNTG) and CCCA/TCCC motifs also exist in medaka Oct4, like in the mouse, 
bovine and human Oct4 promoters. There is also a sequence fragment containing three 
neighboring binding sites respectively for SP1 (speicificty protein1), hormone response 
element (HRE) and RARE (retinoid acid responsive element) in the downstream region 
very close to TSS, similar to that mammalian Oct4 promoters (Nordhoff et al., 2001). 
Moreover, there are several conserved sequence elements that are likely binding sites for 
transcription factors among four species. These transcription binding sites (TFBs) include 
GATA-1(GATA binding protein 1), AP-1 (activator protein 1), SP1/3 (speicificty 
protein1 or 3), Pit-1 (pituitary specific transcription factor 1), Oct-1 (Octamer binding 
protein 1), PEA3 (polyoma enhancer. activator 3), Pax (paired box factors) and RAR-α 
(retinoic acid receptor α). Conservation of these TFBs in the upstream promoter 
sequences between medaka and mammalian oct4 genes suggest there are overlapping 
mechanisms that regulate oct4 expression. However, there are some putative transcription 
factor binding sites that are unique to the medaka Oct4 promoter, including 16 sites of E-
box, 4 sites of RARE [(A/G)G (G/T) TCA, and one STATx site (TTN5AA). Interestingly, 
two putative binding sites for Oct4-Sox2 elements (OSE) were found by searching the 
similar consensus sequences that reported in mouse and human Oct4 promoters (Loh et 
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  -2091   GATAGAAGTTGAGTCAGATTTATTAGACAGGTATAAAAGAGTCTGAGTCTGCAAAGCCAAACAGGAAAAT 
           GATA-1  Ap-1/C-Fos                                    NF-1    PEA3 
 -2031    TAGTTCAGTCATTTAAGTCAAAATAATAAAAGTTATACTCAGTAAGAGCAAATAAATAGATTTTAACTAA 
           GR/RARE  Oct-2 
 -1961  TTTATTCATTCATTTTTTTAAATTTATTTTTGTGTGGTAAGTCTGTTATAATACTCTGTACTCAGTGAGA 
 -1891    ATTGCAAACATTTAAGAAGTAATACTATACACATGCTATGTTACAGCAAAAGCAATCTATTACTGTTAAA 
 -1811  TCTAGAACTGGTACCACCAGGTCCCCCTTTGGTCTGACTTTCTATCTGAGCTTGAAAAGTTTTCCTCATT 
 -1741 TCTGGAAGATCCTCGAAGAAGAGGTCACTTGAAAAGAACAAAAAAAAACCTGCAGAAGACAAGATCTGAG 
                               RARE E-box  
 -1671 CCATCTGTGGGGGTTTCAGCCAAATCCTCCTCTCAACATCTCCCCCCTGACTGTACCAAAGCCATTCAAA 
 -1601 GCTGACCCCCTCCTCCCTTCTTCAGGCTCTGTTGTCCCTTTCTCTCAGGCCCAGCCTGCAGTCTGTATCT 
          RXR-α/RARE   Sp1                  GR                SP1         GATA-1 
 -1531 CTATTCCCTTTTGCATGACAATTCTTCTCTCAAGTCCATGGCCCAGGATAATGCTTGTGTGGATGGAGTC 
                     OSE2  GR/PU.1                                         Ap-1 
 -1461   AGATCTCTGTAAAGCTAGAAGGTTCTCTGCTTGTGAGTCTGGATTTTCGGTGAAGAGAAAAACTCTGGCA 
                                                          IL-6 
 -1391    GGTTTCAGGAAACCCACCTGAGTTTCCCTTTTGGACATCTCTAATCTGGAATCAACTGCCGTCATGTGGT 
             STAT PEA3  Sp1                        GATA-4 
 -1321    AAAAATGTGAACAATCCAACACTTTCAGACACATTCCAGAAGACCTGGCTGCGACACCTGCAGAAATGTT 
 -1251    GCTCCACAGACCAGTTTTGGACCTTCAGGCCATTTGGGACTGGATGCCAGGGCAGGACCAGAGCGAAACT 
 -1181    CCAGTCAGATGGAGAGGGGAGGGGGTAGAGGGGTCGTCGGTGTAGGCCGGAATCAAAGGGTTGAGACTTA 
 -1111 TTGTTCTGATGTGAAAAGGAGCTAATGGTCGACCATCGCAACTCGGGATCTGAGAGCCACGGGGTGCCCC 
 -1041    GGGGCCTCGTCGTACAATGGCACCCCCTCTCCTGTCCCGCAGTGCGTCTTCTGCCGCAATCTGCGCCCAC 
 -971    AGTATTCACGCCGGGGGAGCGCATCTGCACCGCGGCCACGCAGGCCACTGAATGGCTGCCGATCAAAAGG 
 -901 TGAATGAGCTTCACCTGAAAGCAGAAGGGTTTCCGTGATGGTCCATGCCACCAACAGATAATGGAAAAAA 
 -831    ACAAAACAGCATGGTAAAAAAAAAAAACAGAGGCTGAAAAGAGACCAACTTTTGTATCAAATGTTTTATT 
 -761    TTAGGAAAAAAACAGGAAAAAAAGCATAAATTTGGGTAAATGAAACCACTATTTAAATAAATGAATGAAT 
 -691   GACCTAAGAATTTGGTTAAAGAAATAAAAAGCGTTTGAACAGTGCAAGAATTTAAGCGCCTCAGATATTA 
 -621    ATGTATGATTTACCTATTTTTTTGTCACTTTGTAATTTTGTGGCTTTGGTTACTTAAAATAACTAGTGTT 
  -551    TAATAAACAGAAAAATGATTATAGAAAGATAAAAACACATTTAACTTTTATTCTTAGTTTATCTTCAATT 
 -481 TTCAAAATAAAAGCCATTTCCTTCTCCATAAACTTTCTGAGCCAAAACCTCAAATTCCCCACTGGTTATG 
 -411 GCATCTTAACTAATTAGGTAAATGTCTCTGATAACAGGACAATGTTATTATTTAATGGGTTGATTCAGAC 
 -341 TAAAGCTCAGACCTGAAGAGATTTTCATTTCAAAGCCATGACAGATGAATAATTTAAACAAACGCATCAT 
                                   OSE1 
 -271 TATAATTCATGACAAGGTGAGCAATTTAGTGTTAGAAAATGTATTTATAGAAGTAGGGCCTGTTTAGCAA 
             Oct4     Pax2 RARE 
 -201 TGTAAATATGTTTTCAAAATGAATTATTAAAGTCTGTGATGTTTGTTCGGTATACATCCCATAAAAAACA 
 -131 TTAAAAGATCTGCTCATGAGAAAGATCTCTGGGAGGAATCAAGGTCATTCACAAACTCGTAATCAGCTGT 
                                                    RARE                  +1 
 -61 GCGCAATTGTCTGCGTCAGCCAATGAGAGAGGAGAAATGGGGACCTCACGCTCCCTCCGTCCTGATTGGG 
 +10    AAAACCTGTGGGGCCAGAAGCTCAGATGATCATTTGAGCTTGAAGGTGAGCTGCATCTTATGGGCTTAAT 
          NF-ATx    Sp1      HRE          E-box      RARE 
 +80    GGAGTCCGCCGCAGCTTTGGTTATGTCTCACTAAAAAGCTGCGCCATTTTCAGgtatgtttgtgcgtaat 
                                                      YY1 
 +150 ttttgcgatttaaaaaacgggtaaacactgaataatgacaaagaaagtttgtaacattttgcttttctgg 
   +220   aattctcctcagAAACTGCAGGGGAGATG                                     IL-6 
Fig. 3-17. Nucleotide sequence of the the OlOct4 promoter. Numbering is relative to the major 
transcription start site (bent arrow). Transcription binding sites (TFBSs) predicted by TESS are underlined. 
TFBSs present also in the mammalian Oct4 promoter (Nordhoff et al., 2001) are boxed. The initiation 
codon ATG is indicated in bold. There are two Oct4-Sox2 composite elements (OSE1 and OSE2). The 
TFBSs highlighted were experimentally determined in this study: OSE2, STAT and RARE. 
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3.1.8 Activity of the medaka Oct4 promoter in vivo in medaka embryos. 
It has been shown that the mouse Oct4 promoter can be activated in the early developing 
medaka embryos and ES cells (Hong et al., 2004). Also the Oloct4 RNA was detected by 
RT-PCR in early medaka embryos (Fig. 3-5) and more importantly, by in situ 
hybridization, in female and male germ cells (Fig. 3-7). These suggested that the medaka 
Oct4 might be active in pluripotent stem cells. To address this issue, the medaka Oct4 
promoter of 2.1-kb was linked to rfp resulting in pO2.1-RFP. This construct was 
microinjected into medaka embryos at the 1-cell stage and RFP expression was 
monitored at various developmental stages. Interestingly, the RFP signal was earsily 
detected (Fig. 3-18), as early as at stage 10.5  a stage shortly after the miblastula blastula 
transition for zygotic genome transcription. Therefore, the 2.1-kp medaka Oct4 promoter 
is indeed  like its mouse counterpart - active in early medaka embryos, suggesting that 
















Fig. 3-18. Activation of medaka Oct4 promoter in medaka embryos. A) Schematic structures of plasmid 
pO-2.1RFP; B) Transient expression in early embryos by microinjection with pO2.1-RFP promoter 
reportor (a: control; b: blastula;). 
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3.1.9 Activity of the medaka Oct4 promoter in vitro in medaka cells 
3.1.9.1. 5 deletion analysis of the medaka Oct4 promoter 
In order to localize DNA elements that are important for promoter activity and to 
determine the core promoter region for medak oct4 gene expression, 10 constructs were 
generated by cloning the complete 2.1 kb fragment or its truncated fragments into a 
promoterless luciferase (LUC) expression vector pGL3-basic (Promega). Transcriptional 
activities of the promoterluciferase constructs were measured by a Dual-Glo 
luciferase assay (Promega) and were compared to that of positive control vector 
pTATAluc, which was considered to be a fold introduction of 1 for each experiment, 
since it has a minimal promoter containing a TATA box of the herps simplex virus 
thymidine kinase linked into pGL3-basic. The cloned 5′-flanking fragements were shown 
to be transcriptionally active in SG3 cells (Fig. 3-19A). The pO-2091luc containing the 
longest 5flanking region (+28 to -2091) displayed significant activity relative to the 
control plasmid. Deletion constructs pO-1896Luc and pO-1525luc, however, have 
increased promoter activity by 2.2 and 4.1 fold over pO-2091luc. The highest promoter 
activity was observed in the construct of pO−1525luc, indicating that the region (-1525 to 
-1896) may contain stronger negative regulatory elements while the region (-1525 to -
1192) may contain positive regulators. Further deletion to positions -1192 (pO-1192luc),-
1038 (pO-1038luc), -813 (pO-813luc), -349(pO-349luc) and -94 (pO-94luc) resulted in a 
gradual decrease in the promoter activity. However, within this region (-1192 to -94), 
detailed deletion to positions -911 (pO-911luc) and -554 (pO-554luc) showed slightly 
increased activities compared with pO−1038luc and pO-813luc. The pO-94luc only has 
122 bp but showed a 3-fold increase in luciferase activity compared to the control vector, 
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which indicating that the promoter of Oloct4 retains some basic minimal activity within 
122 bp. In line with this, there are conserved binding sites for E-box, CCAAT box, Sp1, 
and HRE in this small region and they should be responsible for regulation of medaka 
oct4 in a similar fashion as they were suggested to be for mammalian oct4 genes 
(Nordhoff et al., 2001; Yang et al., 2005).  
To further characterize the core promoter region and check whether possible positive 
elements reside in the exon 1 and inron 1 of Oloct4, truncated luciferase constructs 
consisted of exon1 and intro1 were generated and transfected into SG3 cells (Fig. 3-19B). 
The fragment (-94/+245) was found to possess higher promoter activity than the previous 
fragment (-94/+28), which coincides with the results showing that promoter activity of 
the construct with a fragment (2091/+245) is much higher than that of construct with a 
fragement (-2091+28). These data suggest that the region from +28 to +245 may harbor 
positive regulatory elements. When a fragment -94/+245 was divided into two 
overlapping fragments (+39/+245 and +98/+245), both fragements exhibited increased 
promoter activities. Moreover, the promoter activity of the +98/+245 region  was higher 
than that of the +39/+245 region, suggesting that there are inhibitory elements within the 
region from +39 to +245 while there are some enhance elements within the region from 
+98 to +245. Take together, theses data imply that positive activity of medaka Oct4 
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Fig. 3-19. Deletion analysis of the OlOct4 promoter. (A) The promoter activity of gene redisues in the 
region form -2091 to +28. A diagram of the promoter region is shown, with locations of restriction sites 
used to create the deletion end-points. (B). the promoter activity of the proximal promoter region from -94 
to +245. Position +1 denotes the transcription start point. The promoter fragments with different 5 ends as 
indicated were fused to the luciferase reporter vector (Luc) and analyzed by transient transfection in SG3 
cells as described in chapter II. Firefly luciferase activities were normalized to internal control of Renilla 
luciferase activities. The pRL-CMV vector containing the Renilla luciferase gene downstream of the CMV 
promoter was used as the internal control to normalize the activity of the experimental reporter. The 
relative luciferase activity of the samples transfected with the pTATAluc was arbitrarily set to 1.0, which 
has a minimal promoter containing a TATA box of the herps simplex virus thymidine kinase. Results for 
each construct are average ±S.E.M. for 3 experiments, each performed in triplicate. 
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3.1.9.2. Retinoic acid (RA) responsive element: RA down regulation of medaka oct4 
The mouse oct4 expression is down-regulated upon stem cell differentiation via the 
retinoic acid (RA) responsive element in the promoter region (Okazawa et al., 1991; Gu 
et al., 2005). The proximal medaka Oct4 promoter contains three putative RA-responsive 
elements (RARE) near the transcription star site (Fig. 3-17), indicating the possibility that 
the medaka oct4 expression would also be regulated by retino acid (RA). To test this 
possibility, the effect of RA on OlOct4-driven reporter expression was examined. The 
cells were cultured in the medium with 10-6 µM RA for 3 days and 6 days, respectively. 
The promoter activity was reduced by 51% and 86% when the cells were cultured in the 
medium with 10-6 µM RA for 3 days and 6 days, respectively (Fig. 3-20). For a 
comparison, RA induced 22% and 67% reduction of HuOct4 promoter activity in the 
same condition. These data suggest that medaka Oct4 promoter is negatively regulated by 




Fig. 3-20. Downregulation of OlOct4 promoter activity by retinoic acid. SG3 cells were treated or not 
treated with RA (10-6 υM) dissolved in ethanol for 3 or 6 days before pO-1525luc was transfected. The 
cells were not treated for 3-4 days before harvest for LUC assay. Activity of the pO-1525luc and 
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3.1.9.3. Autoregulation of medaka oct4  
The mouse Oct4 can autoregulate its own transcription (Chew et al., 2005). To see 
whether this was also the case in the medaka, SG3 cells were cotransfected with pO-
1525luc reporter and the effector plasmid pOlOct4 expressing the OlOct4 from the CMV 
promoter (Fig. 3-21A). The promoter was activated by OlOct4 by a 9.66-fold compared 
to that of transfection without the effector (Fig. 3-21B). For a comaprison, the medaka 
Oct4 promoter was activated also by using pHuOct4 as an effector that expresses the 
human Oct4. Here the increase was 5 fold. Therefore, Oct4 is able to positively regulate 
its own expression in a feeder-forward manner. To test whether OlOct4 can replace 
HuOct4 to activate the human Oct4 promoter, a similar cotransfection was done with 
pHuOct4luc as a reporter and pOlOct4 or pHuOct4 as an effector. A 2-fold increase in 
promoter activity was observed with either pOlOct4 or pHuOct4 (Fig. 3-21C). These data 
indicate that OlOct4, like its mammalian homologs, can indeed autoregulate its own 
transcription across species, indicating the conservation of the gene in expression 
regulation and function between fish and mammals. 
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Fig. 3-21. Autoregulation of medaka oct4. Luciferase activity from the pO-1525luc reporter (A) or 
pHuOct4luc (B) was cotransfected with same amount of OlOct4 and HuOct4 expression plasmid as 
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3.1.9.4. Cooperative regulation of medaka Oct4 by Oct4 and Sox2 
3.1.9.4.1 Identification of Oct4-Sox2 elements on medaka Oct4 promoter 
 Recent studies have shown that Oct4/Sox2 complex cooperatively regulate oct4 and 
nanog expression by binding Oct-Sox element (OSE) to their promoter region (Chew et 
al., 2005; Kuroda et al., 2005; Rodda et al., 2005). To enhance the phylogenetic footprint, 
it was sought to investigate whether this regulatory mechanism was conserved in medaka 
oct4 homologue. Analysis of putative transcription factor binding sites (TFBs) exposed 
no similar contiguous OSE in the upstream region of medaka oct4 gene. However, two 
similar OSE (OSE1 and OSE2) were found in the promoter region (-2091/+28) of 
medaka Oct4 promoter after searching the matched sequence. By careful examining the 
sequence, OSE2 was particular noted since it clearly resembles the cis OSE which is 
involved in regulating the transcription of mammalian oct4 and nanog (Fig. 3-22A). The 
Oct (TTTTGCAT) in this OSE2 sequence is identical to that found in mouse Nanog 
promoter while differing little from that in human Oct4 promoter (Fig. 3-22A). This 
difference is normal among variants of octamer-binding sequences (Loh, et al., 2005). 
Immediately adjacent to this octamer element is a strong consensus sequence for a Sox 
element (GACAATT), differing only 1 or 2 of the 7 position with the corresponding 
sequence of Sox elements in OSE of human Nanog and mouse Nanog (Fig. 3-22A). 
Furthermore, this OSE2 on medaka Oct4 promoter varies between species at very small 
number of the 15 positions (Fig. 3-22A) and both of these positions are also the most 
variable positions in the known Oct-Sox target genes. This evidence suggested that 
medaka Oct4 may also be a target of the Oct4/Sox2 complex through binding to OSE2.  
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3.1.9.4.2 Synergestic regulation by Oct4 and Sox2  
As the highly conserved Oct4-Sox2 element OSE2 is located on the medaka Oct4 
promoter, this promoted to test whether this element is an effector on transcription 
activity of medaka oct4. To this end, a luciferase assay was performed to observe the 
effects of Oct4 and or/Sox2 on activation of medaka Oct4 promoter. SG3 cells were 
transiently transfected with Oct4 expression plasmid, either alone or together with Sox2 
expression plasmid to examine luciferase activity of the construct pO-1525luc, which 
contains the medaka Oct4 promoter fragment (-1525 to +28) previously showing the 
highest promoter activity compared to other tested fragments. Luciferase activities was 
measured as described in chapter 2 and were compared to the activity of  a cDNA-less 
expression vector, whose value was set at 1.0. In addition, as a control, activation of 
human Oct4 promoter or mouse Nanog promoter was similarly examined on effects of 
Oct4 and or/Sox2. 
Medaka Oct4 promoter showed increased activity when cells were transfected with an 
Oct4 or Sox2 expression plasmid alone (Fig. 3-22B, bar 2-5). This increase also was 
found when control construct HuOct4luc or Nanog5Pluc was co-transfected in the same 
way (Fig. 3-22, C, bars 2-5 or D, bars 2-5).  Relative to a cDNA-less expression vector, 
OlOct4 activated activities of OlOct4, HuOct4 and Nanog5P promoters by 9.66, 2.06-, 
and 4.86-fold, respectively (Fig. 3-22, bar 2 in B, C, D), while mouse Oct4 (MuOct4) 
activated activities of the same promoters by 5.46, 1.91, and 3.07-fold (Fig. 3-22, bar 4 in 
B, C, D), respectively. These results indicate that OlOct4 is capable of activating OlOct4, 
HuOct4 and Nanog5P promoters to a level higher than that of mouse Oct4. Similarly, 
OlSox2 activated activities of OlOct4, HuOct4 and Nanog5P promoters by 6.7, 3.7-, and 
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5.41-fold, respectively (Fig. 3-22, bar 3 in B, C, D), while MuSox2 activated activities of 
the three promoters by  4.04, 1.92, and 3.91-fold (Fig. 3-22, bar 5 in B, C, D), 
respectively. These data indicate that OlSox2 is capable of activating OlOct4, HuOct4 
and Nanog5P promoters to a level equivalent to that of mouse Sox2. Furthermore, when 
both Oct4 and Sox2 expression vectors were co-transfected into cells with the promoter 
contruct, significant enhancement of luciferase activity was observed (Fig. 3-22, bar 6-9 
in B, C, D). Cotransfection of the respective construct with two expression vectors, in 
which  either oct4 or sox2 cDNA from medaka, led to 21.04, 4.31, and 6.69-fold increase 
in luciferase activity of OlOct4, HuOct4 and Nanog5P promoters, respectively (Fig. 3-22, 
bar 6 in B, C, D). This enhancement is relative higher than that of luciferase activity 
induced by co-trnasfection with Oct4 and Sox2 expression vectors, in which oct4 or sox2 
cDNA are from mouse or medaka (Fig. 3-22, bar 7-9 in B, C, D). It is possible that 
medaka cells contain a medaka-specific factor necessary for inducing medaka promoter 
activation. Presumably, the absence of a mammalian-specific factor in the medaka cells is 
responsible for the decrease in activation. Taken together, Oct4 and Sox2, either alone or 
together, can produce the same activation on medaka Oct4 promoter as on human Oct4 
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Fig. 3-22. Synergistic regulatin of medaka Oct4 promoter by Oct4 and Sox2. (A) Schematic of the 
luciferase reporter constructs used to measure the effects of Oct4 and Sox2. Construct pO-1525-luc 
contains the 1.5 kb medaka Oct4 promoter region fused upstream of the luciferase reporter, while as control 
constructs, construct HuOct4luc contains the 3.0 kb human Oct4 promoter region  fused upstream of the 
luciferase reporter; Construct Nanog5Pluc comprises the mouse nanog promoter. All the three constructs 
contain the Oct-Sox composite element, the respective sequence and location is indicated. (B-D) Relative 
luciferase activity of medaka pO-1525luc (B), Huoct4luc (C) and Nanog5Pluc (D) in SG3 cells transfected 
with Oct4 and/or Sox2 expression plasmids from different species, medaka and mouse. Values represent 
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3.1.9.4.3 OSE2 is sufficient to regulate expression 
To examine whether Oct4 and Sox2 activate Oloct4 expression by binding to their 
respective elements, a reporter gene was constructed in which the luciferase gene was 
driven by the minimum TATA thymidine kinase (TK) promoter and three tandem repeats 
of the OSE2 (p3×OSluc). In the same manner, three reporter constructs (p3×OmSluc, 
p3×OSmluc, p3×OmSmluc) were generated with mutant sequences [Oct-m (Om), Sox-m 
(Sm) and Oct-mSox-m (OmSm)], as indicated in Fig. 3-23A. When p3×OSluc was 
introduced into MES1, SG3, Sok1 and Or1 cells, luciferase activity reached up to 17.32-, 
9.62-, 1.17- and 1.12-fold over that of the control plasmid pTATAluc, suggesting that the 
Oct-Sox complex was sufficient for the functional activity. Moreover, the results revealed 
that the activity was relatively higher in the medaka stem cells (MES1 and SG3) than in 
the somatic cells or mixed germ cells (Sok and Or1). Furthermore, point mutation of 
OSE2 altered the luciferase activity with the reduction of over 45%, especially in MES1 
and SG3 cells, while changed insignificantly in Sok and Or1 cells (Fig. 3-23B). In MES1 
and SG3 cells, the activity of the construct with a mutated Oct sequence decreased to 
9.62- and 4.25-fold over that of control plasmids, respectively. Similarly, the activity of 
the construct with a mutated Sox sequence was reduced by 5.33-and 3.16-fold in MES1 
and SG3, respectively. The mutated sequence at both Oct and Sox site led to a 4.02-fold 
decrease in luciferase actity in MES1 cells and a 3.3-fold reduced activity in SG3 cells. 
These data indicates that OSE2 is important factor to regulate medaka oct4 in medaka 
stem cells. 
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When the construct with wide type OSE was transfected together with an Oct4 or Sox2 
expression vector, significant enhancement of luciferase activity was achieved. 
Cotransfection of this construct with OlOct4 or OlSox2 led to an 8.49 or 5.12-fold 
increase in luciferase activity. In contrast, OlOct4 and OlSox2 did not greatly enhance a 
reporter gene that contained three-nucleotide modification in the Oct4 and/or Sox binding 
site (Fig. 3-24A).  
In order to confirm the positive enhance activity of wide-type OSE2, increasing amounts 
of the OlOct4 or OlSox2 expression vector were transfected (Fig. 3-24B). Begining with 
100 ng of p3×OSluc reporter vector and 25 ng of OlOct4 expression vector, the result 
obtained was 3.85-fold activation. This value increased 21%, 168% and 303% when 50 
ng, 100 ng and 200 ng of OlOct4 expression vectors were added, respectively. The same 
type of experiment was performed with OlSox2, starting again with 100 ng of p3×OSluc 
reporter vector and 25 ng of OlSox2 expression vector. The resulting activation of 
promoter achieved a increase of 23%, 175% and 321%, with addition of 50 ng, 100 ng 
and 200 ng of OlSox2, respectively (Fig. 3-24B). In the like wise, the cooperative 
enhance activity of wide-type Oct-Sox composite element increasing amounts of the both 
OlOct4 and OlSox2 expression vectors were tested. The significant synergetic 
enhancement was observed when the different increasing amounts of two plasmids were 
cotransfected into SG3 cells (Fig. 3-24C). Interestingly, the effects on enhancement 
seemed to be different when cotransfected the two plasmids together with variable ratio 
of molecular weight. The highest enhancement was obtained with the 2:1 ratio of OlOct4 
and OlSox2, instead of with 1:1 ratio (Fig. 3-24C). These data, taken together, 
demonstrate that Oct4 and Sox2 activate the OSE2 enhancer.  
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Fig. 3-23. Oct4-Sox2 element can drive expression in medaka stem cells. Effects of point mutations in the 
octamer-like sequence or the Sox recognition motif. Reporter plasmids containing the OCt-Sox complex 
sequence (WT) or mutated sequences (Om, Sm, and OmSm) were analyzed. WT sequences are shown in 
open boxes (Oct)/circles (Sox), while their mutants are in filled boxes/circles. Luciferase assays were 
performed with the three tanderm repeats with or without mutations in Octamer and/or Sox elements in 
MES1, SG3, Sok and Or1 cells. Luciferase activities are shown relative to those of pTATAluc. Bars 
represent the means ± standard errors of three independent experiments 
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Fig. 3-24.  Activation of the OSE by Oct4 and Sox2. A) Reporter plasmids containing three copies of the 
sequence (WT) or mutedted sequences were introduced into cells with or without 100 ng OlOct4 or OlSox2 
expression vectors.B) Reporter plasmids containing three copies of the sequence (WT) were introduced 
into SG3 cells with increasing amounts of OlOct4 or OlSox2 expression vectors. C) The same promoter 
plasmids were introduced into cells with increasing amounts of OlOct4 and OlSox2 expression vectors. A 
total DNA amount was maintained using pBS carrier DNA in each experiment. The SG3 cells were 
analysed for luciferase activity after 48 h transfection and the results of the average of three repetitions are 































OlOct4              -          25          50        100     200        100       100         100       100 (ng)
OlSox2              -          100        100        100        100         25           50          100       200           
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3.2 Cloning and characterization of two isoforms of the medaka stat3 
3.2.1 Isolation of stat3 cDNAs from the medaka  
Degenerate PCR and RACE PCR were used to clone the putative full-length Stat3 
cDNAs. Degenerate PCR was performed with primers ST1 and ST2 corresponding to the 
encoding sequence MAQWNQLQQ and KFICVTPTN (from a lab in German) to 
amplify conserved region. Sequencing of subcloned PCR products (about 2.1 kb) 
revealed that the presence of two distinct PCR products with high similarity to 
mammalian stat3 genes. Based on the obtained sequence fragments, two gene specific 
primers (GSP) SR51 and SR53 (Fig. 3-25) were designed to respectively clone the 5and 
3 ends of stat3 cDNAs by RACE PCR. Clones with inserts of correct sizes were 
sequenced.  
One full-length cDNA from medaka stat3 gene was recovered, comprising 3439 
nucleotides (nt; Fig. 3-26). Examination of the sequence of the longest open reading 
frame (ORF) present in this clone indicates a predicted protein of 765 amino acids with a 
calculated molecular weight of 87 566 and a pI of 6.19. Another independent full-length 
stat3 cDNA was isolated, possessing both start and in frame stop codon as well as a poly 
(A) tract, which was 3499 nt in length (Fig. 3-26 ), and the predicted size of the Stat3 
protein is 785 amino acids with a calculated molecular weight of 89 643 and a pI of 5.98. 
The shorter stat3 transcript is termed Olstat3a, and the longer, less abundant transcript is 
named Olstat3b. Notablely, these two medaka isoforms have same nucleotide sequences 
in the 5′-UTR (225 nt) and 3UTR (916 nt) that determined by the 5′ and 3-RACE 
procedure, confirming that they are derived from a single gene as a result of an 
alternative splice so that the two isoforms are almost identical but differ at their C-termini. 
Chapter IV  Medaka stat3 
   111   
Given the biochemical differences among the mouse isoforms and gene structure 
differences between the species, Olstat3b may be an interesting variant. One of the major 
differences between Olstat3b and other stat3 members is that Olstat3b contains a unique 
60 bp insert at the transcription activation domain. This 20 amino acid insert has only 
been found in the zebrafish Stat3 isoform (Oates et al., 1999). Database searching does 
not find a medaka match for this sequence and this isoform has not been found in the 
public EST databases. The absence of this isoform in public databases indicates that 
Olstat3b is a rare transcript. Examination of the medaka stat3 genomic sequence shows 
that the unique 60 bp insert is a complete exon, indicating that this variant is not the result 









Fig. 3-25. Scheme for cloning medaka stat3 cDNA. The SMART RACE Kit was used to amplify 5′ and 3′ 
cDNA fragments. ST1 and ST2  are degenerate primers designed on the base of alignment of sequences 
that had high homology to the mouse and zebrafish stat3 genes. Gene specific primers (GSP) for 




I: Overlap Region amplified by degenerate RT-PCR 
3GSP 
(SR51)
5 adaptor 5GSP (SR53)
5
3
II: Region amplified by 3-RACE 
III: Region amplified by 5-RACE
3 adaptor
A 
Chapter IV  Medaka stat3 
   112   
1   GGGGTGGGGGGGTACTTGTTTCTGAAAGTGTTTTCTCGTGGTGCGAAGATTACGGTTTGCGTTACATTATATTTGGGAGCACTTTTCCTC 
91  GTTTATGACGCTCAATTTCTACTTTTTCTTCGTTAAAAAGTTGTCGCTGACGTCTTTTTGAGCTTGTGTTTTTTGTGGGAAAGAGACCAA 
 
181  ACTGCTCCGGATCCAACGAAGGTGATTTGAGGCAGTGCTGTCAGGATGGCTCAGTGGAATCAGTTGCAGCAGCTGGAGACCAGGTATCTG 
                                                  M  A  Q  W  N  Q  L  Q  Q  L  E  T  R  Y  L 
271  GAGCAGCTCTACCACTTGTACAGCGACAGCTTTCCAATGGAGCTACGCCAGTTTCTTGCACCCTGGATTGAAAGTCAAGACTGGGCCTAT 
16   E  Q  L  Y  H  L  Y  S  D  S  F  P  M  E  L  R  Q  F  L  A  P  W  I  E  S  Q  D  W  A  Y 
361  GCTGCCAACAAAGAATCCCACGCCACCCTGGTGTTCCACAATCTCCTGGGAGAAATTGATCAGCAGTATAGCCGTTTCCTCCAGGAGAAC 
46   A  A  N  K  E  S  H  A  T  L  V  F  H  N  L  L  G  E  I  D  Q  Q  Y  S  R  F  L  Q  E  N 
451  AATGTCCTCTACCAACACAACCTGCGCAGGATAAAGCAGCATCTGCAGAGCAAGTATCTGGAGAAGCCAATGGAAATCGCCCGCATTGTC 
76   N  V  L  Y  Q  H  N  L  R  R  I  K  Q  H  L  Q  S  K  Y  L  E  K  P  M  E  I  A  R  I  V 
 
541  GCCCGCTGTTTATGGGAGGAACAGCGACTGCTGCAGACAGCCACCTCTACTTCCCAGGATGGTTCAGCAGCCCATCCCACCGGAACAGTC 
106   A  R  C  L  W  E  E  Q  R  L  L  Q  T  A  T  S  T  S  Q  D  G  S  A  A  H  P  T  G  T  V 
631  GTGACGGAGAAGCAGCAAATTCTGGAGCACAACCTTCAAGATATCAGGAAGCGCGTTCAGGACATGGAACAGAAGATGAAGATGCTTGAA 
136   V  T  E  K  Q  Q  I  L  E  H  N  L  Q  D  I  R  K  R  V  Q  D  M  E  Q  K  M  K  M  L  E 
721  AACCTGCAAGACGACTTTGATTTTAATTACAAAACCCTGAAAAGCCAAGGAGAGCTGAACCAGGACTTGAATGGAAACAGCCAGGCAGCT 
166   N  L  Q  D  D  F  D  F  N  Y  K  T  L  K  S  Q  G  E  L  N  Q  D  L  N  G  N  S  Q  A  A 
811  GCCACTCGACAGAAGATGGCTCAACTTGAGCAGATGTTGAGCGCTTTAGATCAGCTCAGGCGGCAAATTGTGACAGAAATGGGAGGCCTG 
196   A  T  R  Q  K  M  A  Q  L  E  Q  M  L  S  A  L  D  Q  L  R  R  Q  I  V  T  E  M  G  G  L 
901  CTGACTGCCATGGACTACGTACAGAAGAATCTAACGGATGAAGAACTGGCAGATTGGAAGAGAAGACAGCAAATCGCCTGCATCGGAGGG 
226   L  T  A  M  D  Y  V  Q  K  N  L  T  D  E  E  L  A  D  W  K  R  R  Q  Q  I  A  C  I  G  G 
991   CCACCAAACATCTGCCTTGATCGCCTTGAAACATGGATCACATCCTTGGCTGAATCCCAGCTCCAGATTCGTCAGCAGATCAAGAAGCTG 
256   P  P  N  I  C  L  D  R  L  E  T  W  I  T  S  L  A  E  S  Q  L  Q  I  R  Q  Q  I  K  K  L 
1081  GAGGAGCTTCAGCAGAAGGTGTCCTACAAAGGAGATCCAATCATTCAGCACCGGCCCGCCCTAGAAGAGAAGATAGTGGATCTGTTCAGA 
286    E  E  L  Q  Q  K  V  S  Y  K  G  D  P  I  I  Q  H  R  P  A  L  E  E  K  I  V  D  L  F  R 
1171  AACCTCATGAAAAGCGCCTTTGTGGTTGAGAGACAGCCGTGTATGCCCATGCATCCAGACAGACCTTTGGTCATAAAAACAGGAGTGCAG 
316   N  L  M  K  S  A  F  V  V  E  R  Q  P  C  M  P  M  H  P  D  R  P  L  V  I  K  T  G  V  Q 
1261  TTCACAAACAAAGTCAGGTTGCTGGTAAAGTTTCCTGAACTCAACTACCAACTGAAAATTAAAGTCTGCATTGACAAGGAGTCTGGAGAT 
346   F  T  N  K  V  R  L  L  V  K  F  P  E  L  N  Y  Q  L  K  I  K  V  C  I  D  K  E  S  G  D 
1351  GTGGCTGCCATTCGAGGGTCACGGAAGTTTAACATCCTCGGTACCAACACAAAAGTCATGAACATGGGGGAATCTAACAATGGCAGCCTG 
376   V  A  A  I  R  G  S  R  K  F  N  I  L  G  T  N  T  K  V  M  N  M  G  E  S  N  N  G  S  L 
1441  TCTGCAGAGTTTAAGCATTTGACCCTTCGAGAACAGAGGTGTGGGAACGGAGGAAGGACCAACAGCGATGCCTCATTGATTGTTACTGAA 
406  S  A  E  F  K  H  L  T  L  R  E  Q  R  C  G  N  G  G  R  T  N  S  D  A  S  L  I  V  T  E 
1531  GAGCTCCATCTGATCACTTTTGAGACAGAAGTCTATCACCAGGGATTAAAGATCGATCTGGAAACTCATTCCCTGCCTGTTGTGGTCATC 
436   E  L  H  L  I  T  F  E  T  E  V  Y  H  Q  G  L  K  I  D  L  E  T  H  S  L  P  V  V  V  I 
1621  TCAAACATCTGCCAAATGCCCAACGCCTGGGCTTCCATCCTGTGGTACAACATGCTCACGAATCACCCCAAGAACGTCAACTTTTTCACC 
466   S  N  I  C  Q  M  P  N  A  W  A  S  I  L  W  Y  N  M  L  T  N  H  P  K  N  V  N  F  F  T 
1711  AAGCCTCCTGTGGGGACTTGGGACCAAGTGGCTGAGGTGTTGAGCTGGCAGTTCTCCTCCACCACAAAGAGAGGCCTGACCATTGAGCAA 
496   K  P  P  V  G  T  W  D  Q  V  A  E  V  L  S  W  Q  F  S  S  T  T  K  R  G  L  T  I  E  Q 
1801  CTCACCACACTGGCTGAGAAGTTACTCGGGCCTTCTGTCAACTATTCTGGGTGCCAGATCACATGGGCCAAGTTCTGTAAGGAAAACATG 
526   L  T  T  L  A  E  K  L  L  G  P  S  V  N  Y  S  G  C  Q  I  T  W  A  K  F  C  K  E  N  M 
 
1891  GCTGGCAAAGGCTTTTCCTTCTGGGTGTGGCTGGACAACATTATTGACCTGGTGAAGAAGTACATCCTTGCGCTGTGGAACGAAGGATAC 
556   A  G  K  G  F  S  F  W  V  W  L  D  N  I  I  D  L  V  K  K  Y  I  L  A  L  W  N  E  G  Y 
1981  ATCATGGGCTTTATCAGTAAGGAGAGGGAGAGAGCCATTCTGAGCCCCAAACCTCCCGGCACCTTTCTGCTGCGCTTCAGCGAGAGCAGC 
586   I  M  G  F  I  S  K  E  R  E  R  A  I  L  S  P  K  P  P  G  T  F  L  L  R  F  S  E  S  S 
2071  AAAGAGGGTGGCATTACATTTACATGGGTAGAGAAAGACATAAGTGGAAAGACCCAAATCCAGTCTGTGGAACCGTACACCAAGCAGCAA 
616   K  E  G  G  I  T  F  T  W  V  E  K  D  I  S  G  K  T  Q  I  Q  S  V  E  P  Y  T  K  Q  Q 
2161   CTCAACAGCATGTCCTTCGCCGACATCATCATGGGTTACAAGATTATGGATGCCACCAATATCCTGGTGTCGCCTCTTGTTTACCTCTAC 
646    L  N  S  M  S  F  A  D  I  I  M  G  Y  K  I  M  D  A  T  N  I  L  V  S  P  L  V  Y  L  Y 
 
2251   CCTGACATCCCCAAAGAGGAAGCTTTCGGGAAGTACTGCAGACCGGAAGCAGCCCATGAACCCGAGGCAGGAGGAGATTCAGCAAGCATC 
676    P  D  I  P  K  E  E  A  F  G  K  Y  C  R  P  E  A  A  H  E  P  E  A  G  G  D  S  A  S  I 
2341   ACCCAGCCATACTTGAAGACAAAGTTCATCTGTGTGACCCCGTGTCCCTCCGTGTTCATGGACTTGCCGGACAGTGAGCTGCTTGGGAAC 
706    T  Q  P  Y  L  K  T  K  F  I  C  V  T  P  C  P  S  V  F  M  D  L  P  D  S  E  L  L  G  N 
2431   GGATTCCCAGGCACAAACTCTGGAAACACCAGCGACCTGTTTCCGATGATGTCACCTCGCACTCTTGATTCCCTGATGCACAATGAGCCC 
736    G  F  P  G  T  N  S  G  N  T  S  D  L  F  P  M  M  S  P  R  T  L  D  S  L  M  H  N  E  P 
2521   GAAGCTCACTCTGGACATTTGGATTCCATCACTTTGGACATGGACGTCGCTTCCCCCATGTGAAATTACCCATCAGCCTCTTCTTTTTCT 
  766   E  A  H  S  G  H  L  D  S  I  T  L  D  M  D  V  A  S  P  M  * 
2611   GTGTTTTTGGGATCTTTCATCATTTAAGGACTTTTAAAAGATGCATCTTCAGCTAGAGTGTACATCATCTGCCTGTACAGTTTATTTCTT 
2701   CTTCCTATGTATAATTCATTTTCTTAAATTACGGGGGAAAAGCATTTTAAAGGACATATATTCAAGTCGACGGTTCGTCTGCAGTTATGT 
2791   GTGTGAGACTTTGTGTTGAATGCAACATCCTTCTATCACGTTTACATTTTTACCTACTTTAAAACCATAGAGCATCAAAACTGTATTTTT 
 
2881   AAAGGACGATGTATTTGTTGGTTATGAACTTTTTTAAATGAATATAAATATTTTCTTTTCTTTAAGAGGAAAAAGGAATGATATGAGTTG 
2971   ATATATAAGCTGTTTCTGTATAACTGTAGCAGTTTTCATACGTTTTACTGTATGATTTATAAAATCCCTGCCAAATGTTTGGTGTCTCCA 
3061   TCCTGTTTTGATCACATTTGAAAATGACCTGATTCTTTATGGTTTTGTTAGCAGGAAATTGCTTTTTGAAGAGTCAAATGTTAAAAAATT 
3151   ATTTTTTCTTTCTCAATGGGGGCTCTTAGAACGTTTTTCCCCCTTCTTGTTTTTGTGTGAAATCTGAAATTGGGAGATGTGAATGTGGTG 
3241   CAGGTTTTCTTCCATCATGTTGTGTTTTTGGATCATAGATGTAGAATATCAGTTTTGTATTTGCAATGTAATATTTTTGGTTGCTCTTGA 
3331   TTTAACTTTTTATGATTAAACATGAAATGTAAATGACTGTATTAAGGTTTTAATATAGTTACGTTTCGGAATGCCCATAGGAAAACTGCA 
 3421   GTATTTTTCTTTAACCTTTCCCCCCAACAAGTAAAATCTGTCAGAAATGTAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
 
Fig. 3-26. Nucleotide sequence of medaka stat3 and its deduced amino acid sequence. Nucleotides are numbered to 
the left. The start codon is boxed while stop codon is indicated by asterisk. Polyadenylation signal is boxed. The 
additional 60 nuclear tides abscent in Olstat3a are underlined. GenBank Accession No. for medaka Ostat3a is 
AY639947 while OlStat3b is AY641434. Primers designed for RACE PCR (SR52, SR53) and for RNA/DNA probe or 
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3.2.2. Medaka Stat3 produces two isoforms Stat3a and Stat3b 
Alignment of the medaka Stat3 proteins with their mammalian and zebrafish Stat3 
homologs indicated that medak Stat3 shared 88% and 81% identity with zebrafish and 
mouse Stat3 (Fig. 3-27). In addition, the comparison revealed that medaka Sta3 proteins 
also contain most of functional domains and sequence motifs characteristic of functional 
Stat proteins, including the N-terminal oligomerization domain, the DNA binding domain, 
the SH2 domain, and C-terminal transactivation domain. Furthermore, a tyrosine (Y706) 
was also included in the YLKT motif, which is to be phosphorylated by JAK kinases 
upon activation. However, the island motif around the serine phosphorylation site in the 
activation domain of medaka Stat3 was found to be PMMSP instead of consensus 
PMSP in other homologues. This unique motif in medaka Stat3 also has not been 
reported in other STAT proteins. Furthermore, the position of the addition in the longer 
Stat3 cDNA (Olstat3b) was not identical to that in the mouse Stat3β homolog, which 
results from the omission of exon 23 due to alternate mRNA splicing (Schaefer et al., 
1995). In medaka OlStat3b, the putative 5splice site occurred in the codon of -P716- and 
the 3 splice site was in the codon of -T738-. The result is an addition in the reading 
frame of the 20 aa (Fig. 3-27, 3-29). These additional 20 aa in exon 21 were also found in 
zebrafish Stat3, in which the unique 18 additional amino acids in exon 24 are the results 
of a T to A transition in the stop codon (Fig. 3-27; Oates et al., 1999).  
In an effort to determine the evolutionary relationship between the different Stat3 
proteins, a phylogenetic tree was generated using the computer software DNAMAN. Six 
different Stat3 proteins and several other STAT members were used for the phylogenetic 
analysis. These can be seen to separate into different clades which reflect their evolution 
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(Fig. 3-28). Not surprisingly, the mouse, human and the cow Stat3 proteins are sisters in 
their own clade. The medaka, zebrafish and fugu Stat3 sequences appear as a sister-group 
in another clade of the phylogenetic tree. The Stat3 proteins appear as a single taxon 
which is a sister-group to the outgroup Stat92E in the phylogenetic tree. 
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 OlStat3a    (1) MAQWNQLQQLETRYLEQLYHLYSDSFPMELRQFLAPWIESQDWAYAANKESHATLVFHNLLGEIDQQYSRFLQENNVLYQHNLRRIKQHLQSKYLEKPME 
 OlStat3b    (1) MAQWNQLQQLETRYLEQLYHLYSDSFPMELRQFLAPWIESQDWAYAANKESHATLVFHNLLGEIDQQYSRFLQENNVLYQHNLRRIKQHLQSKYLEKPME 
 TnStat3     (1) MAQWNQLQQLETRYLEQLYHLYSDSFPMELRQFLAPWIESQDWAYAANKESHATLVSHNLLGEIDQQYSRFLQESNVLYQHNLRRIKQHLQSKYLEKPME 
 DrStat3a    (1) MAQWNQLQQLETRYLEQLYHLYSDSFPMELRQFLAPWIESQDWAYAANKESHATLVFHNLLGEIDQQYSRFLQENNVLYQHNLRRIKQHLQSKYLEKPME 
 DrStat3b    (1) MAQWNQLQQLETRYLEQLYHLYSDSFPMELRQFLAPWIESQDWAYAANKESHATLVFHNLLGEIDQQYSRFLQENNVLYQHNLRRIKQHLQSKYLEKPME 
 HsStat3α    (1) MAQWNQLQQLDTRYLEQLHQLYSDSFPMELRQFLAPWIESQDWAYAASKESHATLVFHNLLGEIDQQYSRFLQESNVLYQHNLRRIKQFLQSRYLEKPME 
 HsStat3ß    (1) MAQWNQLQQLDTRYLEQLHQLYSDSFPMELRQFLAPWIESQDWAYAASKESHATLVFHNLLGEIDQQYSRFLQESNVLYQHNLRRIKQFLQSRYLEKPME 
                 101                                                                                         *    200 
 OlStat3a  (101) IARIVARCLWEEQRLLQTATSTSQDG-SAAHPTGTVVTEKQQILEHNLQDIRKRVQDMEQKMKMLENLQDDFDFNYKTLKSQGELNQDLNGNSQAAATRQ 
 OlStat3b  (101) IARIVARCLWEEQRLLQTATSTSQDG-SAAHPTGTVVTEKQQILEHNLQDIRKRVQDMEQKMKMLENLQDDFDFNYKTLKSQGELNQDLNGNSQAAATRQ 
 TnStat3   (101) IARIVARCLWEEQRLLQTASTVAQDG-QAANPSGTVVTEKQQMLELNLQDIRKRVQDMEQKMKMLENLQDDFDFNYKTLKSQGELSQDLNGNSQASAARQ 
 DrStat3a  (101) IARIVARCLWEEQRLLQTATTAQQDG-QVAHPTGTVVTEKQQILEHNLQDIRKRVQDMEQKMKMLENLQDDFDFNYKTLKSAGELSQDLNGNSQAAATRQ 
 DrStat3b  (101) IARIVARCLWEEQRLLQTATTAQQDG-QVAHPTGTVVTEKQQILEHNLQDIRKRVQDMEQKMKMLENLQDDFDFNYKTLKSAGELSQDLNGNSQAAATRQ 
 HsStat3α  (101) IARIVARCLWEESRLLQTAATAAQQGGQANHPTAAVVTEKQQMLEQHLQDVRKRVQDLEQKMKVVENLQDDFDFNYKTLKSQG-DMQDLNGNN-QSVTRQ 
 HsStat3ß  (101) IARIVARCLWEESRLLQTAATAAQQGGQANHPTAAVVTEKQQMLEQHLQDVRKRVQDLEQKMKVVENLQDDFDFNYKTLKSQG-DMQDLNGNN-QSVTRQ 
                 201                                                                                *             300 
 OlStat3a  (200) KMAQLEQMLSALDQLRRQIVTEMGGLLTAMDYVQKNLTDEELADWKRRQQIACIGGPPNICLDRLETWITSLAESQLQIRQQIKKLEELQQKVSYKGDPI 
 OlStat3b  (200) KMAQLEQMLSALDQLRRQIVTEMGGLLTAMDYVQKNLTDEELADWKRRQQIACIGGPPNICLDRLETWITSLAESQLQIRQQIKKLEELQQKVSYKGDPI 
 TnStat3   (200) KMAQLEQMLSALDQLRRQIVTEMGGLLTAMDYVQKNLTNEELADWKRRQQIACIGGPPNICLDRLETWITSLAESQLQIRQQIKKLEELQQKVSYKGDPI 
 DrStat3a  (200) KMSQLEQMLSALDQLRRQIVTEMAGLLSAMDFVQKNLTDEELADWKRRQQIACIGGPPNICLDRLETWITSLAESQLQIRQQIRKLEELQQKVSYKGDPI 
 DrStat3b  (200) KMSQLEQMLSALDQLRRQIVTEMAGLLSAMDFVQKNLTDEELADWKRRQQIACIGGPPNICLDRLETWITSLAESQLQIRQQIRKLEELQQKVSYKGDPI 
 HsStat3α  (199) KMQQLEQMLTALDQMRRSIVSELAGLLSAMEYVQKTLTDEELADWKRRQQIACIGGPPNICLDRLENWITSLAESQLQTRQQIKKLEELQQKVSYKGDPI 
 HsStat3ß  (199) KMQQLEQMLTALDQMRRSIVSELAGLLSAMEYVQKTLTDEELADWKRRQQIACIGGPPNICLDRLENWITSLAESQLQTRQQIKKLEELQQKVSYKGDPI 
                 301                                                                                              400 
 OlStat3a  (300) IQHRPALEEKIVDLFRNLMKSAFVVERQPCMPMHPDRPLVIKTGVQFTNKVRLLVKFPELNYQLKIKVCIDKESGDVAAIRGSRKFNILGTNTKVMNMGE 
 OlStat3b  (300) IQHRPALEEKIVDLFRNLMKSAFVVERQPCMPMHPDRPLVIKTGVQFTNKVRLLVKFPELNYQLKIKVCIDKESGDVAAIRGSRKFNILGTNTKVMNMGE 
 TnStat3   (300) IQHRPALEEKIVDLFRNLMKSAFVVERQPCMPMHPDRPLVIKTGVQFTNKVRLLVKFQELNYQLKIKVCIDKESGDVASIRGARKFNILGTNTKVMNMEE 
 DrStat3a  (300) IQHRPALEEKIVDLFRNLMKSAFVVERQPCMPMHPDRPLVIKTGVQFTTKVRLLVKFPELNYQLKIKVCIDKESGDVAAIRGSRKFNILGTNTKVMNMEE 
 DrStat3b  (300) IQHRPALEEKIVDLFRNLMKSAFVVERQPCMPMHPDRPLVIKTGVQFTTKVRLLVKFPELNYQLKIKVCIDKESGDVAAIRGSRKFNILGTNTKVMNMEE 
 HsStat3α  (299) VQHRPMLEERIVELFRNLMKSAFVVERQPCMPMHPDRPLVIKTGVQFTTKVRLLVKFPELNYQLKIKVCIDKDSGDVAALRGSRKFNILGTNTKVMNMEE 
 HsStat3ß  (299) VQHRPMLEERIVELFRNLMKSAFVVERQPCMPMHPDRPLVIKTGVQFTTKVRLLVKFPELNYQLKIKVCIDKDSGDVAALRGSRKFNILGTNTKVMNMEE 
                 401                                                                                              500 
 OlStat3a  (400) SNNGSLSAEFKHLTLREQRCGNGGRTNSDASLIVTEELHLITFETEVYHQGLKIDLETHSLPVVVISNICQMPNAWASILWYNMLTNHPKNVNFFTKPPV 
 OlStat3b  (400) SNNGSLSAEFKHLTLREQRCGNGGRTNSDASLIVTEELHLITFETEVYHQGLKIDLETHSLPVVVISNICQMPNAWASILWYNMLTNHPKNVNFFTKPPV 
 TnStat3   (400) SNNGSLSAEFKHLTLREQRCGNGGRTNSDASLIVTEELHLITFETEVYHQGLKIDLETHSLPVVVISNICQMPNAWASILWYNMLTNHPKNVNFFTKPPV 
 DrStat3a  (400) SNNGSLSAEFKHLTLREQRCGNGGRTNSDASLIVTEELHLITFETEVYHQGLKIDLETHSLPVVVISNICQMPNAWASILWYNMLTNHPKNVNFFTKPPV 
 DrStat3b  (400) SNNGSLSAEFKHLTLREQRCGNGGRTNSDASLIVTEELHLITFETEVYHQGLKIDLETHSLPVVVISNICQMPNAWASILWYNMLTNHPKNVNFFTKPPV 
 HsStat3α  (399) SNNGSLSAEFKHLTLREQRCGNGGRANCDASLIVTEELHLITFETEVYHQGLKIDLETHSLPVVVISNICQMPNAWASILWYNMLTNNPKNVNFFTKPPI 
 HsStat3ß  (399) SNNGSLSAEFKHLTLREQRCGNGGRANCDASLIVTEELHLITFETEVYHQGLKIDLETHSLPVVVISNICQMPNAWASILWYNMLTNNPKNVNFFTKPPI 
                 501                                                                                              600 
 OlStat3a  (500) GTWDQVAEVLSWQFSSTTKRGLTIEQLTTLAEKLLGPSVNYSGCQITWAKFCKENMAGKGFSFWVWLDNIIDLVKKYILALWNEGYIMGFISKERERAIL 
 OlStat3b  (500) GTWDQVAEVLSWQFSSTTKRGLTIEQLTTLAEKLLGPSVNYSGCQITWAKFCKENMAGKGFSFWVWLDNIIDLVKKYILALWNEGYIMGFISKERERAIL 
 TnStat3   (500) GTWDQVAEVLSWQFSSTTKRGLTIEQLTTLAEKLLGPCVNYSGCQITWAKFCKENMVGKGFSFWVWLDNIIDLAKKYILALWNEGYIMGFISKERERALL 
 DrStat3a  (500) GTWDQVAEVLSWQFSSTTKRGLTIEQLTTLAEKLLGPCVNYSGCQITWAKFCKENMAGKGFSFWVWLDNIIDLVKKYILALWNEGYIMGFISKERERAIL 
 DrStat3b  (500) GTWDQVAEVLSWQFSSTTKRGLTIEQLTTLAEKLLGPCVNYSGCQITWAKFCKENMAGKGFSFWVWLDNIIDLVKKYILALWNEGYIMGFISKERERAIL 
 HsStat3α  (499) GTWDQVAEVLSWQFSSTTKRGLSIEQLTTLAEKLLGPGVNYSGCQITWAKFCKENMAGKGFSFWVWLDNIIDLVKKYILALWNEGYIMGFISKERERAIL 
 HsStat3ß  (499) GTWDQVAEVLSWQFSSTTKRGLSIEQLTTLAEKLLGPGVNYSGCQITWAKFCKENMAGKGFSFWVWLDNIIDLVKKYILALWNEGYIMGFISKERERAIL 
                 601                                                                                              700 
 OlStat3a  (600) SPKPPGTFLLRFSESSKEGGITFTWVEKDISGKTQIQSVEPYTKQQLNSMSFADIIMGYKIMDATNILVSPLVYLYPDIPKEEAFGKYCRPEAAHEPEAG 
 OlStat3b  (600) SPKPPGTFLLRFSESSKEGGITFTWVEKDISGKTQIQSVEPYTKQQLNSMSFADIIMGYKIMDATNILVSPLVYLYPDIPKEEAFGKYCRPEAAHEPEAG 
 TnStat3   (600) SPKPPGTFLLRFSESSKEGGITFTWVEKDISGKTQIQSVEPYTKQQLNNMSFADIIMGYKIMDATNILVSPLVFLYPDIPKEEAFGKYCRPEAAPESEMG 
 DrStat3a  (600) SPKPPGTFLLRFSESSKEGGITFTWVEKDINGKTQIQSVEPYTKQQLNSMSFAEIIMGYKIMDATNILVSPLVYLYPDIPKEEAFGKYCRPEAHPDTEFP 
 DrStat3b  (600) SPKPPGTFLLRFSESSKEGGITFTWVEKDINGKTQIQSVEPYTKQQLNSMSFAEIIMGYKIMDATNILVSPLVYLYPDIPKEEAFGKYCRPEAHPDTEFP 
 HsStat3α  (599) STKPPGTFLLRFSESSKEGGVTFTWVEKDISGKTQIQSVEPYTKQQLNNMSFAEIIMGYKIMDATNILVSPLVYLYPDIPKEEAFGKYCRPESQEHPEAD 
 HsStat3ß (599)  STKPPGTFLLRFSESSKEGGVTFTWVEKDISGKTQIQSVEPYTKQQLNNMSFAEIIMGYKIMDATNILVSPLVYLYPDIPKEEAFGKYCRPESQEHPEAD 
                 701                                                                                              800 
 OlStat3a  (700) GDSASITQPYLKTKFICVTP--------------------TNSGNTSDLFPMMSPRTLDSLMHNEP------EAHSGHLDSITLDMDVASPM-------- 
 OlStat3b  (700) GDSASITQPYLKTKFICVTPCPSVFMDLPDSELLGNGFPGTNSGNTSDLFPMMSPRTLDSLMHNEP------EAHSGHLDSITLDMDVASPM-------- 
 TnStat3   (700) GDPTGTIQPYLKTKFICVTP--------------------TNSGNTSDLFPMS-PRTLDSLMHNEA------EANPGHLDSLTLEMDVASPM-------- 
 DrStat3a  (700) -DTGCVTQPYLKTKFICVTP--------------------TNSGNTSDLFPMS-PRTLDSLMHNEAA-----EANPGPLESLTLDMELSSDHASPMREGF 
 DrStat3b  (700) -DTGCVTQPYLKTKFICVTPCPSVFMDFPDSELLGNGFPGTNSGNTSDLFPMS-PRTLDSLMHNEAA-----EANPGPLESLTLDMELSSDHASPMREGF 
 HsStat3α  (699) --PG-SAAPYLKTKFICVTP--------------------TTCSNTIDLPMSP--RTLDSLMQFGNNGEGAEPSAGGQFESLTFDMELTSECATSPM--- 
 HsStat3ß  (699) --PG-SAAPYLKTKFICVTPFIDAVWK----------------------------------------------------------------------------  
                 801        814      species  Accession number  Identity 
 OlStat3a  (766) --------------  medaka    AAT64912     100% 
 OlStat3b  (786) --------------     medaka    AAt46364              93.6%   
 TnStat3   (765) --------------  Pufferfish  AAL09515            88.9% 
 DrStat3a  (773) AASTVSDMDTCRNA  Zebrafish   AAH68320              88.9% 
 DrStat3b  (793) AASTVSDMDTCRNA  Zebrafish   NP_571554             88.6%    
 HsStat3α  (771) --------------  human    P40763                81.5% 
 HsStat3ß  (771) --------------  human    NP_998827             84.1%  
 
Fig. 3-27. Comparison of vertebrate Stat3 proteins.  The six conserved domains are defined by horizontal arrows; Identical splicing sites in 
mouse and medaka Stat3 genes are indicated by vertical arrows, while different sites in mouse stat3 are shown by stars. The 20 aa-insertion 
in the transactivation domains of OlStat3b isoforms is boxed. Speice names, sequence accession numbers and percent identityies between 
OlStat3a and its homologs are given at the end of alignment. 
N-terminal interaction domain 
Coiled coil domain 
DNA binding domain 
Linker domain  
SH2 domain  
Transactivation domain 
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Fig. 3-28. Phylogenetic tree of Stat3 proteins. The amino acid sequences were derived from GenBank. 
Accession numbers are given in parenthesis. The bootstrap confidence values shown at the nodes of the tree 
were based on 100 bootstrap replicates. The horizontal branch lengths are proportional to the estimated 














Fig. 3-29. Schematic domain structure of medaka Stat3a and Stat3b proteins. Six conserved domains are 
marked by different box patterns as indicated in the legends above. The numbers below the boxes indicate 
the length (numbers of the amino acid residues) of protein(s). The two arrowheads indicate the two 





Fig. 3-30. Schematic structure of medaka stat3. Exons are shown in black boxes, whereas UTRs in gray 
boxes. And introns are indicated in solid thin line. Numbering of exon drawn in scare is listed below the 
exon (only part of number is labeled). Medaka genes are drawn in scale except introns 22 whose actual 
sizes are not known. The unique exons encoding b isoform in medaka and zebrafish are highlighted. The 
dotline and arrows indicate the corresponding fusion or splited exons between species. The mouse Stat3 
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NC_00714.2.  Note that medaka Stat3 is about 10 kb compared to 57 kb for the mouse gene and 37 kb for 
zebrafish gene.  
3.2.3. The medaka stat3 gene organization and evolution 
Medaka genomic database is a web-based source for mapping target sequences to the 
genome at http://dolphin.lab.nig.ac.jp/medaka. Medaka stat3 gene structure was 
determined by blasting Olstat3 cDNA sequences in the medaka genomic sequence (Fig.3-
30). Scaffolds 1682 and 29666 were identified corresponding to the medaka stat3 gene 
with high conservation of coding sequences and splice sites. Medaka Olstat3a is encoded 
by 22 exons whereas Olstat3b is encoded by 23 exons. All medaka stat3 exonintron 
splice junctions conform to the gtag rule. The sizes of the introns vary considerably, 
ranging from 72 bp (intron 15) to 2089 bp (intron 1). The second exon contains the 
translational initiation site while the stop codon located in the last exon.  
In contrast to the genomic structures of mouse stat3 (GeneBank Accession Number 
NC_000077.4) and zebrafish stat3 gene (GeneBank Accession Number NC_00714.2) 
which are essentially identical, the arrangement of some exons is altered in the medaka 
stat3 gene (Fig. 3-30). That is, as a result of exon rearrangement, the locations of exons 
are different in the medaka stat3 gene. Medaka stat3 gene has a unique exon 21 encoding 
20 aa of b isoform, whist this exon is absent in mouse stat3 but is equal to exon 22 in 
zebrafish stat3 gene. In addition, there is no additional intron insertion within exon 3 of 
the medaka stat3 gene, while mouse and zebrafish stat3 gene has such intron insertion 
resulting in exon 3 and 4. Exon 5 in medaka stat3 is corresponding to exon 6 and 7 of 
mouse and zebrafish stat3, which are located dependently downstream of exon 5. 
3.2.4. Medaka stat3 mRNA expression pattern 
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By using a primer pair covering exon 20 and exon 22 allowing for both stat3a and stat3b 
variants, multiple medaka tissues were examined by RT-PCR. As illustrated in Fig. 3-31, 
two specific products of Olstat3a and Olstat3b, 483 and 543 bp in size, respectively, 
were seen in most tissues. Expression of the Olstat3a isoform was found in all examined 
tissues, including brain, skin, eye, heart, spleen, kidney, testis, ovary, liver, intestine and 
pancreas. Therefore, Olstat3a is a ubiquitously distributed stat3 isoform. Olstat3b was 
also widely expressed except that it was barely detectable in the kidney. However, the 
expression levels of two isoforms were variable in different tissues. Relative Olstat3a 
expression was prominent in the eye, testis, ovary and pancreas, modest in the brain, skin, 
kidney, and intestine, but weak in liver, spleen and heart. For Olstat3b, the strongest 
expression was seen in eye; relative modest expression was seen in brain, skin, spleen, 
ovary, and intestine; weak expression was seen in heart, testis, liver and pancreas; the 
lowest expression was in kidney. Furthermore, even in the same tissue where the degree 
of expression of two isoforms was differential, although in brain, skin, eye, heart and 
intestine, the expression levels were more or less equivalent. In kidney, testis, liver, ovary 
and pancreas, expression of Olstat3a was much stronger than that of the longer isoform 
Olstat3b, while conversely in spleen, the Olstat3a expression was relative weaker than 
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Fig. 3-31. RNA expression pattern of medaka stat3 in adult tissues. RT-PCR was performed on RNAs 
isolated from medaka adult tissues. Note that stat3a is 60-nt smaller than stat3b. Expression of stat3b is 
essentially absent in the kidney. β-actin was used as a loading control. 
3.2.5. Medaka Stat3 regulates Oct4 and Nanog promoters 
To examine possible interactions among Stat3, Oct4 and Nanog at the transcriptional 
level, the transactivation activity of medaka Stat3 was determined. The analysis of 
putative transcription factor binding sites identified the presence of a putative STAT 
binding site TTCAGGAAA between -1394 and -1385 nt in the 2.1 kb medaka Oct4 
(OlOct4) promoter (Fig. 3-17). Similarly, the 3 kb human Oct4 (HuOct4) promoter also 
contains one putative STAT binding site TTTGGGGAA between -2621 and -2612 nt 
upstream of transcription start site. However, the STAT binding site is absent in the 2.5 
kb mouse Nanog (Nanog5P) promoter. The schematic constructs for these promoters are 
dispicted in Fig. 3-32A. In order to test the ability of two medaka Stat3 isoforms to 
activate the three promoters, vectors pCMVstat3a and pCMVstat3b were constructed that 
express Olstat3a and Olstat3b from the human cytomegalovirus immediate gene 
enhancer/promoter (Fig. 3-32B). SG3 cells were transiently cotransfected with reporter 
constructs together with effector plasmids pCMVstat3a and/or pCMVstat3b, and relative 
reporter activity was determined by LUC assay. As shown in Fig. 3-32C, three 
observations were made. First, OlStat3a but not Olstat3b enhanced reporter expression of 
the Oct4 promoter from the medaka (2 fold) and human (nearly 5 fold). Second, 
cotransfection of pCMVstat3a and pCMVstat3b at 1:1 ratio slightly reduced the 
enhancement by pCMVstat3a alone (p<0.05). Third, both OlStat3a and OlStat3b alone or 
in combination increased reporter expression from the mouse Nanog promoter by 3.5-6 
folds. Interestingly, for the Nanog promoter, pCMVstat3b (6 fold increase) appeared even 
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better than pCMVstat3a (3.5 fold increase). Therefore, OlStat3a but not Olstat3b can 
transactivate the medaka and human Oct4 promoters, whereas both OlStat3a and Olstat3b 







Fig. 3-32. OlStat3 isoforms differentially regulate Oct4 and Nanog promoters. A) Reporter constructs 
contain the medakaOct4, human Oct4 and mouse Nanog promoter. Putative STAT-binding sites are 
highlighted. B) Expression vectors pCVstat3a and pCVstat3b. The insertion of 20 aa in Stat3b is 
highlighted in black box. C) Reporter assays after cotransfection with reporter constructs and effector 
vectors. A total DNA amount was maintained by using pBS carrier DNA. The cells were analyzed for 
luciferase activity after 48h transfection and average of three repetitions are presented relative to the 
HuOct4- luc OlOct4- luc Nanog5P-luc
OlStat3a - + - + - + - + - + - +
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activity of each reporter plasmid without an effector. Reporter and effector plasmids were cotransfected at a 
1:1 ratio.  
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Chapter IV Discussion 
4.1. Medaka homolog of oct4 
This study describes the cloning and characterization of the medaka homolog of oct4, 
named as Oloct4. Oloct4 is a single copy gene mapped on chromosome 12 and is 
composed of 6 exons. Oloct4 encodes a protein which shares high structural homolgy 
within the bipartite POU domain to known oct4 othologus and forms a complex by 
binding to a classical octamer motif. Oloct4 is expressed in early embryogenesis and 
germ cells as well as medaka stem cell lines. Oloct4 has a functional TATA-less 
promoter, which can be regulated by positive and negative factors. 
4.1.1 Oct4 gene in medaka  
Orthologous genes of mouse oct4 have been identified in the mammalian genome such as 
human (Takeda et al., 1992), bovine (Van et al., 1999), possum (Frankenberg et al., 2001) 
and monkey (Mitalipov et al., 2003). Moreover, similarity of the encoded sequences 
among these species is higher than 85%. Further comparison experiments show that oct4 
orthologs from mouse, human and bovine are not only highly conserved in gene 
sequences but also in their structure, localization and regulatory regions, which suggest 
conservation of expression pattern and function among them (Nordhoff et al., 2001). 
These findings seem consistent with previous presumption that Oct4 is mammalian-
specific transcription factor since oct4 homolog was not found in C. elegans, Drosophila 
and even probably in chicken (Piece, 2001; Soodeen et al., 2001).  
However, recent studies show that oct4 gene also exists in non-mammals.  In xenopus, 4 
class V POU genes resemble that of oct4 (Piece et al., 1998). In zebrafish, two oct4-like 
pou2 cDNA sequences was isolated and only one is a functional gene (Takeda et al., 
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1994). Burgess et al (2002) suggested the pou2 is a true ortholog of mouse oct4 based on 
its chromosomal synteny, phylogeneic sequence homology, and expression and function 
data. More recently, Bachvarova et al. (2004) proposed axolotl oct4 is the most closely 
related ortholog of mammalian oct4s on the basis of its highly similar conserved 
sequence region and expression pattern in germline. Like zebrafish and axolotol oct4, 
medaka oct4 has relatively low identity in whole sequence (<50%) whilst is relatively 
highly identical in POU domain (>70%). The Oloct4 cDNA sequence is matched to that 
released in medaka genome database and no EST sequences were found in medaka EST 
database. A single-copy gene for medaka oct4, which contains the sequence for Oloct4, is 
located on one schaffold 483 in chromosome 12. Moreover, Oloct4 gene contains 6 exons 
and 5 intons, which is similar to its homologs in zebraifh, mouse and human. A salient 
difference between them is that there is an additional exon splited in 5UTR of Oloct4, 
which was not reported in other vertebrate genomes. The biological significance of this 
variant is not known. Further searching of genes adjacent to Oloct4 revealed that several 
genes are also present in the corresponding regions on the chromosomes where oct4 
orthologs from zebrafish, mouse and human exist. This conserved synteny relationships 
confirm the Oloct4 is an ortholog of mammalian oct4 genes, like zebrafish and axolotol 
oct4 (Burgess et al., 2002; Bachvarova et al., 2004). Since oct4 plays a pivotal role as a 
pluripotency gene in mammals, medaka ortholog of oct4 may have similar conserved 
function in pluripotent lineages of the embryos and medaka stem cells. Further 
characterization of its exact roles will be of great importance in understanding the 
molecular mechanisms underlying pluripotency in the medaka model.  
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4.1.2 Medaka oct4 expression 
In addition to the sequence similarity to the known Oct4 members in POU domain, the 
expression pattern of medaka oct4 resembles that of mouse oct4 and zebrafish pou2 
during early embryo development (Pesce etal., 1998; Takeda etal., 1994). Mouse oct4 is 
maternally expressed in oocytes. Its zygotic expression remains relatively low in the 
cytoplasma of all blastomeres at 2-, 4-and 8 cell stage. High levels of Oct4 is present 
equally in all nuclei of the blastomere of the morula stage, which is subsequently 
confined to the inner mass and then to the epiblast. At 8.5 dpc, oct4 expression is 
downregulated in primordial germ cells (PGCs) and later only restricted to the gonadal 
cells of adult animals. Zebrafish pou2 shows maternal and zygotic expression from one-
cell stage to the gastrula stage. Its transcripts are ubiquitously expressed in all cells 
including PGCs while the highest level of expression reaches at early gastrula stage after 
midblastula transition. In the same manner, medaka oct4 transcripts are abundant in 
embryos from one-cell stage to the blastula stage. The transcripts are gradually 
undetectable in embryos from stage 26 onwards, which may be due to low levels of 
transcripts in tissues or technical limitation of in situ hybridization. Meanwhile, these 
data indicates that Oloct4 expression may be lost upon additional differentiation and 
maturation.  
Notablely, medaka oct4 transcripts are detected in embryos at the cleavage stage and 
envenly distributed in the undifferentiated blastomere. These transcripts are maternally 
inherited since the zygotic transcription takes place after midblastula transition in medaka 
embryos at stage 10 (Aizawa et al., 2003). This maternal Oloct4 expression suggests that 
it is associated with maintenance of cellular undifferentiated state, just as mouse and 
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zebrafish oct4 (Scholer et al., 1990; Takeda et al., 1994). However, medaka oct4 are 
detected not only in the central blasomere but also in the marginal blastomere, contrasted 
with expression of zebrafish pou2 only in the central one (Takeda 1994; Hauptmann and 
Gerster 1995). The central blastomere is not specified, which gives rise to cells in the 
embryo proper. By contrast, the marginal blastomere is specified early, which may 
produce future extra-embryonic tissues like the enveloping layer (EVL) and yolk 
syncytial layer (YSL) and late form the endoderm and mesoderm derivaitives 
(Hauptmann and Gerster 1995). Thus, expression of Oloct4 in the central blastomere 
seems to be involved in the stem cell self-renewal and undifferentiation in the medaka 
early embryos. The unexpected expression of Oloct4 in marginal blastomere might imply 
that Oloct4 has an additional undefined function in early embryos at midblastula stage. 
The level of Oloct4 expression appears to be very low, as judged by the difficulty in 
detecting its transcripts after early gastrula stage by whole-mount in situ hybridization. 
Perhaps for this reason, we were unable to detect an early phase of its expression in 
neuroblasts. Oloct4 positive cells can be detected only when they reach the outer layer of 
the neural tube, which is in a position characteristic of differentiating neurons. Thus, 
expression of this gene can be detected by whole-mount in situ hybridization only during 
specific period. The observation that the Oloct4 is detected in the mid-hindbrain region at 
6 somite stage is accordant with recent reports on the additional roles of Oct4 in the 
neuron early development in zebrafish (Burgess et al., 2002; Hauptmann et al., 2002) and 
mouse (Shimozaki et al., 2003). In addition, two Xenopus PouV transcription factors 
(Xlpou25 and Xlpou91) have been shown to function in the developing anterior neural 
tissues and later in the posterior tube (Morrison and Brickman 2006). 
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The most salient feature of the mouse prototype Oct4 is the tight association of the 
expression with the totipotency cycle (Pesce et al., 1998): i.e. from the inner cell mass 
through PGCs of developing embryos to adult germ stem cells of male and femalre 
gonads. However, it is controversial concerning the expression of Oct4 homologs in the 
testis of other vertebrate speices. For example, the human Oct4 expression is not found in 
PGC-derived embryonic germ cells and down-regulated upon transition of 
prespermatogonia to type-A spermatogonia, which appears associated the pathogenetic 
initiation of texticular germ cells (Looijenga et al., 2003). It remains unknown whether 
the oct4 RNA expression takes place in the zebrafish testis. The bovine oct4 is not 
detectable in the adult testis (Van Eijk et al., 1999; Yoshimizu et al., 1999). By RT-PCR 
the medaka oct4 is present at a low level in the adult testis. A closer examination by in 
situ hybridization reveals that only minority of cell in the testis are positive for oct4. 
Interestingly, these cells are single cells that are located in the peripheral region. They 
appear to be spermatogonial stem cells. Interetingly, these cells exhibit a strong signal. 
Taken together, in the adult testis, the Oloct4 is highly expressed in a limited number of 
cells that are seemingly spermatogonial stem cells. This notion is supported by the 
observation that the spermatogonial cell ine SG3 derived from the adult testis does 
express the Oloct4 RNA, albeit at a lower level.  
Medaka oct4 RNA expression is detectable at high level in ovary by RT-PCR. Data from 
in situ hybridization on ovary revealed that Oloct4 signal is strong in oocytes at 
previtellogenic stage and weak in matured oocytes at vitellogenesis stage. The signal 
becomes weak, probably due to reduced expression or diffusion of RNA throughout the   
oocytes in large size. The presences of Oloct4 RNA in oocytes conform to its maternal 
Chapter IV  Discussion 
   127   
supply to early embryogenesis as observed by RT-PCR and whole mount in situ 
hybridization. The maternal Oloct4 RNA initially remains ubiquitously distributed 
throughout the young oocytes and later moves to the animal pole of matured oocytes. A 
similar expression pattern in oocytes has been reported for oct4 in zebrafish, axolotol and 
xenopus (Howley et al., 2000; Bachvarova et al., 2004; Morrison et al, 2006). It is well 
known that maternal mRNA localization in oocytes is associated with future 
establishment of the dorsal/ventral axis, anterior/posterior axis, and the germ line in 
animals. However, it is still unknown the reason why oct4 mRNA follows this specific 
localization pattern in oocytes. 
Except in early embryogenesis and germ cells , expression of medaka oct4 is not detected 
adult tissues like heart, kidney, intestine and skin, which is in agreement with previous 
observations in zebrafish and mouse oct4 (Scholer et al., 1989; Takeda et al., 1994; 
Nichols et al., 1998). Intriguingly, Oloct4 was expressed in brain, which is reminiscent of 
human oct4 present in adult stem cells or putative stem cells derived from adult tissues 
(Tai et al., 2005; Moriscot et al., 2005; Skmukler et al., 2006). It remains unknown for 
the exact roles of Oct4 in adult cells. But these recent reports challenge the thesis that 
Oct4 acts as a marker of pluripotent cells, implying that the presence of Oct4 is not 
sufficient to define pluripotency. Therefore, more cautions may be paid to clarify the 
detected Oct4. For example, is it a novel isoform or pseudogene of Oct4? Or it comes 
from PCR artifacts?  
Immunostaining results on ovarian sections indicated that OlOct4 protein is localized in 
the cytoplasm and the nucleus of oocytes. This subcellular localization in oocytes was 
also described in bovine, horse and human (Gandolfi et al., 1997; Van Eijk et al., 1999; 
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Cauffman et al., 2005; Choi et al., 2006), whist differs for mouse where Oct4 exists in the 
nucleus (Pesce et al., 1998). The role of OlOct4 in the cytoplasm of oocytes is unknown.  
Since Oct-4 is a transcription factor, its cytoplasmic localization implies that OlOct4 may 
not be active in oocytes due to its maternal supply or that Oloct4 might have additional 
functions. The presence of OlOct4 may await use in early embryogenesis. This is 
reminiscent of mouse Oct4 staining in preimplantation embryos, where Oct4 expression 
initially appears in the cytoplasm at early cleavage stage but is concentrated in the 
nucleus of cells at 16-cell-morula stage (Hubner et al., 2003). In concert with that, 
OlOct4 protein is mainly present in the nucleus of MES1 cells derived from medaka 
blastula-stage embryos. Therefore, cellular localization of Oct4 seems to coincide with its 
functional activity during oogenesis and embyogenesis. 
Overall, Oloct4 RNA and protein display overlapping expression patterns. However, 
Oloct4 RNA was expressed at moderate level in MES1 cells but at low level in SG3 cells, 
whereas OlOct4 protein was easily detectable in both MES1 and SG3 cells. This 
observation suggests that there is a cell difference in level of Oloct4 RNA and protein 
expression. The significance for this difference remains to be determined. 
4.1.3 Medaka oct4 regulation  
The pluripotent and fetal cell type-specific expression pattern of oct4 may be regulated 
by specific mechanisms. These mechanisms have been suggested to involve in regulatory 
elements, transcription factors and DNA methylation (Pan et al., 2002). The characterized 
elements include the TATA-less minimal promoter containing the GC box and two 
enhancer elements, which have been shown to be important in murine, bovine and human 
oct4 transcription (Okazawa et al., 1991; Yeom et al., 1996; Van Eijk et al., 1999; Yang 
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et al., 2005). Moreover, four conserved regions (CR1-4) were identified in the upstream 
promoter regions among murine, bovine and human oct4 genes (Nordhoff et al., 2001). 
The deletion of CR1-4 led to decrease of human Oct4 promoter activity in human EC 
cells (Yang et al., 2005). More recently, the CR4 region has been reported to be critical 
for human oct4 transcription in ES cells (Chew et al., 2005).  
In contrast to GC-rich sequences of mammalian promoters, the medaka Oct4 promoter is 
generally AT-rich sequence, whose G + C contents is approximately 60% in 2.1 kb 
region upstream its TSS. So it is not surprised that alignment of 5 upstream of promoter 
region of medaka oct4 with corresponding regions of murine, bovine and human oct4 
genes, didnt reveal the conserved GC box and CR1-4 in the medaka Oct4 promoter, 
which is same as the putative zebrafish Pou2 promoter (data not shown). In addition, 
there is also no conserved enhancer elements like proximal elements and distal elements 
in medaka Oct4 promoter, whereas these two elements have been shown to be crucial for 
regulation of oct4 expression in bovine, mouse and human (Pesce et al., 1998; Van etal., 
1999 and Nordhoff et al., 2001). The fact that the promoter sequence of medaka oct4 has 
less sequence conservation suggests species-specific cis-elements possibly regulate 
Oloct4 activity. The function of the medaka Oct4 promoter region was investigated by 
introducing a series of deletion constructs into medaka SG3 cells. The regions involved in 
regulating medaka oct4 transcription were identified and demonstrated that multiple cis- 
elements act in Oct4 promoter activity. The maximal promoter activity was detected for 
pO-1525luc construct (-1525 to +28 nt). In addition, the promoter region between -94 and 
+28 nt containing CCCAT box was sufficient to provide minimal promoter activity in 
SG3 cells. However, further characterization of these regions is needded. For example, 
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can this promoter bind Oct4-Sox2 complex directly in vivo and in vitro? Can other 
proteins bind this complex to influence the promoter activity? Can the promoter analyzed 
in this study recapitulate the endogeneous gene expression? Is there any promoter 
fragment directing its ovary-specific expression? It will be of interest to determine the 
nature of the factor(s) binding here, since potentially novel positive elements may be 
present in truncated promoter region.  
The precise molecular mechanism behind the activity of sequence-specific transcription 
factors that modulate the expression of oct4 is relatively little known. In the mouse Oct4 
proximal promoter, transcription factors Sp1 and Sp3 can bind to GC-1 box to regulate 
the promoter activity in mouse ES and EC cells (Pesce et al., 1999). In Sp1-/- mouse ES 
cells, Sp1 acts as a mild activator of Oct4 promoter and suggested the functional loss of 
Sp1 may be compensated by Sp3 (Pesce et al., 1999). In medaka Oct4 proximal promoter, 
a putative Sp1/Sp3 binding site was found. But, compared to the equivalent murine 
sequence, the putative GC box and HRE site are not highly conserved. This suggests that 
some of the mechanisms regulating medaka oct4 expression differ from that controlling 
murine oct4 expression. 
In the CR4 region of some mammalian oct4 genes, conserved Oct-Sox elements (OSE) 
have been identified in such six mammals as mouse, human, bovine, pig, dog, and rat 
(chew et al., 2005). And transcription factors Oct4 and Sox2 interacting with this element 
have been shown cooperatively regulate the human Oct4 promoter activity (Chew et al., 
2005). In the medaka promoter region from -2091 to +245, two putative Oct-Sox 
elements (named OSE1 and OSE2) were found. Reporter assay experiments in the 
present study has demonstrated that Oct4 and Sox2 can regulate medaka Oct4 promoter 
Chapter IV  Discussion 
   131   
activity positively, in agreement with the results from the analysis of human Oct4 
promoter (Chew et al., 2005). Point-mutation studies of OSE2 further indicated that this 
element is important for oct4 expression in medaka stem cells. This is the first time to 
show that the general mechanism underlying regulation of oct4 gene is conserved 
between fish and mammals. Further studies are needed to characterize the specific 
binding interactions between these two preoteins on the medaka Oct4 promoter.  
In addition, the examination of partner molecules with Oct4-Sox2 complex should 
provide another layer of important information about the function of Oct4 in stem cells 
since this complex may require some partners to be involved in maintenance of stemness. 
A large set of target genes of Oct4-Sox2 have been identified in mouse and human ES 
cells by CHIP and genome-wide strategies (Boyer et al., 2005; Loh et al., 2006), which 
enable to search the functional molecules upstream or downstream of Oct4-Sox2. In 
medaka stem cells, there should be such molecules to regulate Oloct4 expression as in 
mouse and human ES cells.   
Like its counterparts, medaka Oct4 has multiple regulatory elements existing in the 
promoter upstream region, suggesting that a multi-channel regulatory mechanism may 
participate in its oct4 gene regulation. Thus, not only the promoter itself but also the 
cellular context may regulate the expression of medaka oct4. The promoter analyses of 
medaka Oct4 in this study strongly support the notion that regulation of oct4 expression 
is probably a very complicated event cascade that involves both cis-regulatory elements 
and trans-activators. 
In summary, this study demonstrated that an ortholog of mouse oct4 exists in the medaka 
based on analysis of its sequence, expression and regulation.  
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4.2 medaka stat3 
 
4.2.1 Medaka stat3 
 
Alternative splicing is a process by which multiple mRNAs can be generated from a 
single pre-mRNA. This is accomplished by differential recognition of splice sites in the 
pre-mRNA. The generation of alternative transcripts is an important regulatory 
mechanism of gene function in the mammals (Stetefeld and Ruegg, 2005). With the 
completion of human genome project and the availability of genomic information of 
multiple species, more splice variants of different genes will be identified. In some cases, 
different splice variants display similar functions but are active in different tissues or 
physiological conditions. In other cases, alternative splicing may result in substantial 
changes in amino acid sequences and protein structure and function. Stat3 is the main 
mediators of IL-6-type cytokine signaling. One of the peculiar characteristics of Stat3 is 
its capability to activate different sets of genes in different cell types. Stat3 orthologs are 
found in diverse vertebrate species. Different kinds of alternative splicing in stat3 genes 
have also observed in mouse, human and zebrafish (Kato et al., 2004; Oates et al. 1999).  
Mammals produce two isoforms by alternative splicing: Stat3α and Stat3β, which have 
shown to display unique and specific functions (Schaefer et al., 1995; Caldenhoven et al., 
1996; Schaefer et al., 1997; Ilaria et al., 2001; Park et al., 2000; Ivanov et al., 2001; Yoo 
et al., 2002; Maritano et al., 2004).  
Here we have shown that multiple alternative splicing events occurred in medaka stat3 
gene which generated at least two isoforms. The alternative splicing event of medaka 
stat3 was produced by reading through the site into intron, which generated diverse 
transcripts only different in the 3′ region of gene. The sizes of the ORFs of two isoforms 
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are 3439 nt (Olstat3a) and 3499 nt (Olstat3b), respectively. The latter is a consequence of 
a 60 nt in-frame insertion into the former. The two isoforms are thus identical except for 
unique amino-terminal ends. The longer shorter isoform OlStat3b is more interesting 
because it has additional 20 aa on the C-terminals. This additional tail may affect the 
affinity or the activity of Stat3 in a significant way. Or it could also serve as a binding 
site for other regulatory proteins or cellular component. Sequence analysis did not reveal 
membrane anchoring sequences or proteinase recognition sites in these 20 aa. Such Stat3 
isoform as OlStat3b was not reported in mammals, but only mentioned in zebrafish 
(Oates et al, 1999). The fact that this Stat3 variant with a high level of conservation and a 
same insertion of 20 aa is constitutively present in the Stat3 of medaka and zebrafish, 
raises the possibility of an important biological role of this variant. The mechanism 
behind this precise exon insertion of this variant is not presently understood. In human 
and mice, the molecular basis for generation of stat3β mRNA was ever established based 
on the one findings that stat3β arises from use of an alternative 39 acceptor site (AS) 50 
nucleotides within exon 23 (Shao et al., 2001), so that Stat3β has a shorter C-terminus 
than Stat3α. Currently, very small number of studies for targeting human and mouse stat3 
through gene targeting methods have allowed assignment of the effects of targeting to the 
specific isoform, whereas many studies targeted both the α and β isoforms (Yoo etal., 
2002; Maritano et al., 2004). In the same manner, it will be of interest to identify the 
factors that regulate Olstat3 splicing to Olstat3a or Olstat3b. In addition, to gain better 
understanding roles of stat3 in medaka, future studies could be paid attention to employ 
some strategies for targeting the specific isoform by gene targeting or antisense methods. 
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4.2.2 Medaka stat3 mRNA expression  
There are consistencies and differences in the tissue expression of mRNAs for the stat3 
isoforms in mouse (Maritano et al., 2004) and human (Chakraborty et al., 1996; Biethahn 
et al., 1999). In all species, stat3 isoforms are widely expressed. Stat3α is normally main 
mRNA form in mouse and human, where the mRNA level of the stat3α and stat3β is 
different from each other and the ratio of them varies in cells and tissues ranging from 3:1 
to 10:1 (Chakraborty et al., 1996; Biethahn et al., 1999; Maritano et al., 2004). However, 
this ratio is completely shifted in some cells. For example, stat3β was uncommonly more 
strongly expressed in mature neutrophils (Biethahn et al., 1999). Here, the expression 
level of two isoforms of medaka varied from different tissues. Nearly equivalent level of 
Olstat3a and Olstat3b is expressed in most of tissues. And expression levels of Olstat3a 
were much higher than those of Olstat3b in kidney, testis, ovary, liver and pancreas while 
the balance of the two isoforms was shifted toward Olstat3b in spleen, suggesting that 
two isoforms may have different biological functions.  
Further studies need to examine expression of two isofroms at the mRNA or protein level 
in specific cell types, so that it may determine whether the balance of the two isoforms of 
medaka in some specific cells may influence the cellular pattern of gene activation and 
consequently the ability of these cells to response to some kind of cytokines or other 
factors. The activated protein expression level of two isoforms is more important for 
understanding of Stat3 expression since activated Stat3 can regulate some cellular events 
while Stat3 is latent protein in normal condition. The levels of proteins that translated in 
response to some growth factors in cell culture might be of much more importance than 
currently acknowledged, which presumably will be crucial for the determination of cell 
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fate. Candidate factors that may activate or surpress Stat3 expression in medaka stem 
cells will provide new insight into the roles of Stat3 
4.2.3 Trans-activation activity of medaka Stat3 
In human and mouse, some studies have shown that there are obvious differences 
between two constitutive isoforms, Stat3α and Stat3β, at the transcriptional activity. 
When Stat3α and Stat3β were overexpressed in Cos cells, the shorter form of Stat3α, 
Stat3β, was constitutively able to cooperate with c-Jun to activate a reporter construct 
containing a2-macroglobulin (Schaefer et al., 1995). Moreover, the Stat3β, unlike the 
longer form, can activate the promoter in the absence of added extracellular ligand 
(Schaefer et al., 1995). In contrast, Stat3β activated downstream of the interleukin 5 
receptor inhibited the ability of Stat3α to activate a reporter construct containing an 
intercellular adhesion molecule promoter suggesting that the β-isoform might act as a 
negative regulator of Stat3 (Chakraborty et al 1996). Stat3β cannot activate transcription 
of reporter genes as strongly as Stat3α (Schaefer et al., 1997).Transcriptional activity of 
Stat3α might even be inhibited by the β-isoforms (Biethahn et al., 1999).  
Since the unique sequence difference between two isoforms of medaka also lies in the 
transactivation domain, the function of these two variant was analyzed by their effects on 
the promoter activity.  The OlStat3b and OlStat3a isoforms both seemed to have weak 
transactivation of the medaka Oct4 promoter. OlStat3a showed a stronger trans-activation 
activity on the medaka Oct4 promoter than its shorter form, OlSta3b, suggesting that the 
additional 20 aa in OlStat3b may contain a negative regulatory element. This is also the 
case in the human Oct4 promoter. Comparable to these, mouse Stat3β is transcriptionally 
active activating a promoter containing the IL-6 responsive element of the α2-
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macroglobulin gene under no stimulated conditions where Stat3α is not (Schaefer et al., 
1995). When the OlStat3b and OlStat3a isoforms were coexpressed, the activity of the 
two Oct4 promoters was somehow reduced, suggesting that there is no obvious 
synergism between the two isoforms.  
The role of Stat3 in the regulation of Oct4 promoter has not been reported. Notably, one 
report showed that Stat5, another STAT family member, contains a motif in its C-
terminal that is similar to the POU interacting motif on two partners of Oct1 (obf-1-Bob 
and Snap90), suggesting that a physical interaction between Stat5 and Oct1 stabilizes the 
binding of Stat5 to its consensus binding motif (Magne et al., 2003). Stat3 also contains a 
similar motif, which activates Stat5 (Kirito et al., 2002) and modulates ES cell self-
renewal (Xie et al., 2002). The observation that medaka Stat3 is able to transactivate the 
Oct4 promoter, is in accordance with the presence of putative STAT binding site present 
in the Oct4 promoter sequence. This further underscores the presumption that Stat3 and 
Oct4 may interact at the transcriptional level, although several reports indicated that there 
is no direct interaction between Stat3 and Oct4 (Rao, 2004). Future studies may need to 
elucidate the formation of in vitro and in vivo complex between OlStat3 and OlOct4. 
In concert to the result in this study that OlStat3 and OlOct4 may interact at the 
transcriptional level, a recent study reports that there is a connecting molecule between 
Stat3 and Oct4 pathways, which are essential for self-renewal and pluripotency of mouse 
ES cells. Kinoshita et al. (2006) identified a cofactor between Stat3 and Oct4, GABPα 
(GA-repeat binding protein) by DNA CHIP analysis of Stat3ER-expressing mouse ES 
cells. GABPα is a downstream molecule of Stat3 pathway and it upregulates expression 
of oct4 via inhibiting expression of oct4 repressors like Coup-tf1 and GCNF.  
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Compared to Oct4 promoter, two Stat3 isoforms of medaka have stronger transactivation 
on the mouse Nanog5P promoter and both act cooperatively as transactivators. In 
agreement with this, Suzuki et al. (2006) reported that there is a synergism between Stat3 
and Nanog when Nanog functions to block BMP induced differentiation of mouse ES 
cells. The authors found that a putative STAT binding site exists from -4956 to -4945 nt 
in the 5 upstream promoter sequence of mouse nanog gene. By binding this site, Stat3 
can act with T (Brachyury) to enhance nanog up-regulation (Suzuki et al. 2006). One 
notable thing is that there is no STAT binding site on the 2.5 kb fragment sequence of the 
Nanog5P promoter used in this study, suggesting that there are other factors to influence 
the transactivity of two medaka Stat3 isoforms on this promoter activity. One possibility 
is that STAT proteins may recognize similar sequences other than the putative STAT-
binding sites in the promoter region, and the low promoter activity is due to this low-
affinity binding of STAT proteins to these sequences. 
The transactivation activity of OlSta3a or OlStat3b seems to be dependent on the 
promoter employed in the assays. It is still needed to examine whether the two isoforms 
can activate or repress the endogeneous expression of regulated genes. More studies are 
needed to understand the distinct functionality behind their differences in protein 
structure.    
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Chapter V Conclussion 
 
A major challenge for stem cell research and their exploration in medicine is to analyze 
the precise mechanisms underlying the self-renewal and pluripotency of stem cells. The 
fish medaka (Oryzias latipes) represents an ideal model for molecular analysis of stem 
cell biology because of successful establishment of medakafish embryonic stem cell lines 
and adult male germ stem cells. This work aimed at the structure, expression and 
regulation of the medaka oct4 and stat3 genes that are essential for mammalian stemness. 
5.1 The main findings  
Here, the main findings in this study are summarized below: 
Medaka oct4 (Oloct4) gene encodes a protein of 469 amino acids. Its transcript was 
expressed in early developing embryos and medaka stem cell lines; its adult expression 
was found in brain, testis and ovary. In situ hybridization analysis revealed Oloct4 was 
exclusively expressed in spermatogonia in testis and its strong expression was in early-
staged oocytes. Ovarian staining by anti-OlOct4 serum was also restricted to oocytes. 
Ectopically expressed OlOct4 was capable of forming a DNA-protein complex. In 
addition, medaka oct4 exists as a single copy gene. The Oloct4 gene located in 
chromosome 12 comprises of 6 exons and 5 introns, almost similar to mammalian 
counterparts. Analysis of the promoter region of Oloct4 gene showed several 
transcription factor binding sites (E-box, Sp1, GATA-1, Oct, and Pax sites) was also 
present in the mammalian Oct4 promoter. Deletion analysis of promoter region indicated 
that the minimal promoter resides in the region at -94/+28, which harbors some binding 
sites for SP1 and HRE that are known to regulate in human oct4 promoter. The region 
from +28 to +245 that contains additional exon1 and intron1 revealed the increased 
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promoter activity, suggesting that there are positive regulatory elements present in this 
region. Moreover, the promoter activity of OlOct4 was up-regulated by Oct4 itself and 
downregulated by retinol acids. OlOct4 promoter could be cooperatively regulated by 
Oct4 and Sox2. More importantly, an Oct4-Sox2 composite element on the OlOct4 
promoter was essential for the synergistic regulation by Oct4 and Sox2.   
Expression of stat3 gene, a member of the STAT family of transcription factors is 
important for signal transduction and gene regulation in many types of cells. Alternative 
splicing forms of this gene have been reported in mouse and human, with few functional 
studies. Apart from the stat3-wild-type (Olstat3a) with the expected length, in this work 
we isolated a novel splicing variant, Olstat3b, with a 60 bp insert in the trans-activation 
domain. Differential mRNA expression was detected by RT-PCR in the most tissues. 
Functional assays were performed to study the transactivation of Oct4 and Nanog 
promoters by the two splicing isoforms. Regarding Oct4 promoter, the OlStat3b 
presented reducing trans-activation capacity, relative to the wild-type alone. Concerning 
Nanog promoter, the OlStat3b isoform presented a trans-activation capacity higher than 
wild type alone. However, two isoforms interact in the activation of both Oct4 and Nanog 
promoters. This work presents, for the first time, the characterization of two splicing 
froms of sta3 genes in fish. 
Taken together, the medaka Oct4 and Stat3 identified in this study is the mouse orthlogs 
that plays similarly important roles in regulating expression of stemness genes in medaka, 
and will provide the first two molecules for analyzing mechanisms underlying stem cell 
renewal and differentiation in this excellent model. 
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5.1 Future direction 
This study describes the isolation and characterization of oct4 and stat3 for the first time 
in medaka model. The expression and regulation of medaka oct4 were carried out relative 
extensively, while the role of medaka stat3 was investigated preliminarily. In addition, an 
anlysis was touched on the possible interactions between OlStat3 and OlOct4 at the 
transcriptional level. Continuous efforts are required to gain a better understanding of the 
roles of Oct4 and Stat3, which involve the combination of many methods which can be 
employed to analysis of the molecular and genetic as well as biochemical properties at 
the different biological level. Some of the future directions are below. 
The answers for medaka oct4 functions were unsolved in this study. It is likely that 
medaka oct4 plays unique roles as described in mouse, human and zebrafish or it plays 
specific roles that uncharacterized in other animals. Study of this gene using proper 
method such as loss-of-function and gain-of-function should give the answers. RNAi 
technology is one of simple and popular methods for analysis of function by knock-down 
of expression. In fish, successful examples using this technology have been reported. 
Implication of this technology in medaka could be helpful to elucidate some functions of 
oct4. For example, is OlOct4 really not active in oocytes? If not, then do OlOct4 have 
distinct functions at different-staged oocytes or in early developing embryos? Are there 
some factors to mediate these functions? Medaka provides an excellent model to answer 
these questions as hundereds of oocytes and embyos can be obtained easily. In addition, 
since the medaka oct4 is the mouse oct4 orthlog that plays a similarly important role in 
regulating expression of stemness genes in medaka, identification of its molecular 
partners should contribut to understanding the mechanisms underlying medaka stem cell 
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renewal and differentiation. In all likelihood, genomics and proteomics hold some of the 
keys to screen such molecular parteners of medaka oct4. 
More studies are needed to understand the potential physiological relevance of medaka 
Stat3 isoforms and their possible functional differences. For example, analysis through 
introducing mutagenesis or deletion of unique 20 aa in the protein encoded by the longer 
isoform may reveal its biological functional difference from the shorter isoforms. 
Disruption of expression of Stat3 isoforms in medaka embyos may also expose their 
detailed differential cell-specific expression patterns. In addition, intensive efforts can be 
made to screen downstream Stat3-target genes in medaka, which will help to find and 
dissect the networking molecules among Stat3, Oct4 and Nanog in stemness. 
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Appendix 
               Table 1. The sequence of primers and oligonucleotides used for cloning cDNA 
Primers pair 5′ primer 3′ primer Size (bp) 
1. The sequence of primers used for cloning cDNA and RT-PCR 
1.1 For medaka oct4 
Pou5/Pou3 ggnkwyacicargcigaygtigg ttytgickickrttrcaraacca 354 








PP1/PP2 ccgccatggatgtctgacaggccgcaca cccgaattctcatcctgtcaggtgaccta 1407 
Pf1/pf3 cccaagcttgctgattgggaaaacctgt cccgagctcgagtttgaacacatttact 2412 
PR53/Psb gtggtgcgtgtttggttctgcaaccgg atttgcacggcatgaacacaagcagcc 616 
PR51/PP2 atgtgcaagctgaagccccttctccag cccgaattctcatcctgtcaggtgaccta 492 
PR51/Psb atgtgcaagctgaagccccttctccag atttgcacggcatgaacacaagcagcc 750 
       1.2 For medaka stat3 
ST1/ST2 cccggatccatgggcncartggaycay cccgaattcgtnggngtnacrcadatraa 2163 
SR31/Ssb ctgtggaacgaaggatacatcatgggc acaggatggagacaccaaacatttggc 1044 








PS1/RPS2 atggctcagtggaatcagttgcagcag catggggaagcgacgtccatgtccaa 2340 
SR31/RPS2 ctgtggaacgaaggatacatcatgggc catggggaagcgacgtccatgtccaa 563 
2. Primers used for generation of medaka Oct4 promoter deletion and enhancer reporter constructs 
Xh2.0/H35P1 cccctcgaggatagaagttgagtcagatt cgcaagcttttctggccccacaggttt -2091/+28
Xh1.5/H35P1 ccccctccagccttttgcatgacaattctt cgcaagcttttctggccccacaggttt -1525/+28
Xh1.0/H35P1 ccccctccaggatcaaaaggtgaatgagt cgcaagcttttctggccccacaggttt -911/+28 
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Primers pair 5′ primer 3′ primer Size (bp) 
2. Primers used for generation of medaka Oct4 promoter deletion and enhancer reporter constructs
XhOS2/H35P1 ccccctccagattcagactaaagctcag cgcaagcttttctggccccacaggttt -349/+28 
Xh6Oc/H35P1 ccccctccagatcaaaggtcattcacaaa cgcaagcttttctggccccacaggttt -94/+28 
Xh7Oc/H35p ccccctccagtcatttgagcttgaaggt caaaagcttggagtctttgacgtcccctc -39/+245 
Xh8Oc/H35p ccccctccagggttatgtctcactaaaa caaaagcttggagtctttgacgtcccctc -98/+245 
Xh6Oc/H35p ccccctccagatcaaaggtcattcacaa caaaagcttggagtctttgacgtcccctc -94/+245 
Xh2.0/H35p cccctcgaggatagaagttgagtcagatt caaaagcttggagtctttgacgtcccctc -2091/+245 
Xh1.5/H35p ccccctccagccttttgcatgacaattctt caaaagcttggagtctttgacgtcccctc -1525/+245 
Xh1.0/H35p ccccctccaggatcaaaaggtgaatgagt caaaagcttggagtctttgacgtcccctc -911/+245 
XhOS2/H35p ccccctccagattcagactaaagctcag caaaagcttggagtctttgacgtcccctc -349/+245 
3. the oligonucleotides used for EMSA 
Oct-1F/R       ggtgagctgcatctatgggctaatgagtc gactcattagcccatagatgcagctcacc  
Oc1 F/R       gcggtaactgcttcttaatttgctaaccct gcggagggtatgcaaattaagaagcagtta  
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